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The pleomorphic strains have also been shown to differ from the
i
monomorphic organisms in possessing U -keto-ucid oxidase systems for
ft
the decarboxylation of pyruvate and e<-oxoglutarate. These enzymes
* ,
have been investigated and shown to resemble the oxidative decarboxy-
ft
ft
lases of higher organisms. Despite the development of these enzjmse
ft
ft
complexes, the tricarboxylic acid cycle has been shown to have minimal
♦♦
ft
activity in pleomorphic T. rhodesiense due to the limiting levels of
citrate synthetase (E.G. 4 • 1»3.7 •) and succinate dehydrogenase (E.G.
ft
r.3.99'1'0* However, carbon balance studies show that the induced
ft •







The utilisation of oxygen by the pleomorphic trypanosomes involves
ft
the L~-glycerophosphate oxidase system previously reported in the
ft
monomorphic organisms. No cytochrome pigments could be demonstrated
ft
9




on the pleomorphic strain provides evidence for the existence of an
alternative, though minor route for oxygen utilisation.
ft
ft
The rapidity of the trypanocidal effect of the arsenical drug
ft
ft
melarsen oxide led to the hypothesis that the drug inhibits the supply
of metabolic energy to the organisms. The metabolic studies presented
indicate that glycolysis is the major pathway of energy production in
ft
ft
the pleomorphic organisms, and the glycolytic enzyme pyruvate kinase (
ft
ft




melarsen oxide both in vitro and in vivo. This enzyme is shown to be
ft
the major point of inhibition by this drug in vivo, and accordingly,
ft
ft
trypanosome PK has been purified and its properties have been extensively
ft
investigated.
Trypanosoma PK is a hydrophobic and exceptionally unstable enzyme
which is allosterically activated by it's substrate phosphoenolpyruvate
m
(PEP). The homotropic PE? binding interactions are abolished by the
presence of the heterotropic activator fructose-l,6-diphcsphate (FDP).
It appears probable that trypanosomal glycolysis is maintained in an
active state in vivo by the activation of PK by FDP, There is no
control exerted on PK by other glycolytic intermediates or by ATP.
Kinetic investigation of the interaction of this enzyme with it's
cosubstrates PEP and ADP, with FDP, and with melarsen oxide, has led
to the proposal of a model to describe the molecular mode of action of
drug. The inhibitory properties of the arsenicals appear to.be ■




inability of melarsen oxide to inhibit the non-allosteric PKs of such
host organs as heart, brain and skeletal muscle indicates that the
possession by the parasites of this allosteric enzyme is instrumental
in.allowing the arsenicals to exert their trypanocidal effect. This
|
9
hypothesis is borne out by the sensitivity of the allosteric PR' of host
liver to the. arsenicals.
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1) TII3 LIFE CYCLE OF BRUCFJ.-GROUP TRYPAN030M5S.
0
The sub-genus Trypanozoon of the Salivarian trypanosomes (Hoare,
f
1964) includes T.brucei, the causative agent of animal trypanosomiasis
in Africa, and T.rhodesiense and T.gambiense, the parasites producing
human sleeping sickness. These organisms are characterised by the
#
presence of multiple morphological forms in the bloodstream of the
,1
4
vertebrate host, and by the possession of a complex life-cycle involving
9
0
further changes of form in the insect vector.
The bloodstream forms of these organisms show large variations in
9
morphology, the relative numbers of the identifiable types being depen¬
dent upon the stage of the infection. When the parasitemia is rising
(relapse phase) the majority of the organisms are long (22-33yu) and
slender, possessing a free flagellum at the anterior end, whereas there
9
is a high proportion of short (l4-20yu) "stumpy" forms when the parasit-
#
aemia is falling (remission phase), (Pantham & Thomson, 1911; Asheroft,
9
1957)• These "stumpy" forms appear to be produced from the slender
organisms by the action of the host's immune response (Ashcroft, 1957;
Wijers, i960. See, however, Luckins, 19^9), and are characterised by a
m*
greater cell diameter in the region of the nucleus, and by the absence
0
4
of a free flagellum, although an undulating membrane is still present.
This multiplicity of form has led to the application of the term
polymorphic to the infection (Hoare, 1956; Brenner, 19^5)? however, Oehler
(1914) showed that as the variation in form persists in a cloned infection,
0
the multiplicity can have no genetic basis, and hence the terra pleomor-
<
»
phic i3 preferred in this work (Vickerman, 19&5; Ormerod, 1967)*
4
After ingestion of infected blood by the tsetse fly vector (Glossina
to









demonstrated (Robertson, 19'12f Reichenow, 1921s Wijers & Willett, I960)
that of the bloodstream forms, only the stumpy form develops in the
insect mid-gut. In this partially anaerobic and cooler environment
S
m
the stumpy forms multiply and elongate to give the epimastigote, or
t
midgut form, which is similar to the bloodstream organisms in so far
as the nucleus is still anterior to the kinetoplast. These flagellates
migrate across the alimentary tract of the tsetse fly, and eventually
attach to the walls of the salivary glands, where a transposition of
t
c
nucleus and kinetoplast occurs to produce the crithidial form. Further
+
multiplication and another reversal of the positions of nucleus and
kinetoplast, gives rise to the metacyclic trypomastigotes. This stage •
of development is slightly smaller than, but morphologically similar to,
the bloodstream stumpy form, and is the form which is infective to the






Morphological changes on in vitro cultivation.




to establish in culture. Where a successful growth has been obtained
1 9
4
(e.g. Ryley, 1962) it has been found that after inoculation of the cul¬
tures with the bloodstx*eam trypomastigotes, the flagellates take on the
morphological characteristics of the insect midgut form. This change
ft
ft
has usually been paralleled by a loss of infectivity to both the tsetse
fly and the mammalian host, but there are reports of infective organisms
ft
ft
being obtained from cultures (Trager, 1959 (T.vivax); Weinman, 1957) •
On the basis of the superficial resemblance between the culture forms
♦
and the tsetse fly midgut organisms, these cultured organisms have been
ft
used as the basis for biochemical investigations on that part of the life
s
cycle oecui'ring in the insect vector, to avoid the obvious difficulty in
ft








flies. However it is interesting to note that abort term cultivation
of the bloodstream forms has now been obtained, without the morphological
switch to the vector epimastigote form occurring (he Page, 1967)* and
i
this should allow a more detailed study of the factors influencing the
morphological changes in these organisms.
*
The maintenance of strains in the laboratory
Trypanosomal infections may be transmitted in the laboratory either
*
by cyclical passage through tsetse flies, or by direct syringe passage
from host to host, and, due to the difficulties involved in maintenance
S
of a tsetse colony the latter is the preferred method. However, after
several passages, the pleomorphism of the strain gradually disappears,
Q
resulting in a monomorphic infection, morphologically identical to the
slender form of the pleomorph (Pairbairn & Culwick, 1947, Ashcroft, I960).
These monoraorpbic strains no longer show the relapsing infections charac¬
teristic of the natural pleomorph, but produce a fulminating infection,
9
killing the host in 3 - 4 days. .At the same time the organisms can no
longer be established in culture, and are not infective to the insect
*
to
vector (Ashcroft,f1957), lending weight to the observation that it i3' r
the stumpy forms which complete the life cycle in the fly.
Thus the maintenance of pleomorphism is dependent upon the natural
9
transmission via the tsetse fly, although the factors involved in this
dependence are as yet unknown (Newton, 1968).
to
Mitochondrial changes associated with cyclical transmission.
Evaluation of the above stages in the life cycle of T.brucei, has
been based on various characteristics of the individual organisms,
including breadth, length, presence or absence of a free flagellum, and
*
the relative positions of the kinetoplast and nucleus. In this study,
for example, a combination of the first three of these characteristics
was used to determine the relative proportions of the different blood-
stream'forms in a sample of infected blood (see Chapter 3). However,
much work has been done, mainly by Vickerman (1962a,b, 1963, 1965) on
the u11rastruetural changes of the mitochondrion associated with cyclical
development, with a view to linking morphological to cytochemical changes
s
in the organism. The monomorphic bloodstream form of T.brueei has a
single mitochondrial tube, starting from the kinetoplast and running
to the anterior end of the organism, ?/ith a shorter tube extending to
the posterior. The epimastigote form has a much more highly developed
system, with a complex network of mitochondrial tubes extending anterior
9
to the kinetoplast, and a longer posterior chondriome. A further
difference between these extremes, is the possession by the epimastigote
9
of numerous well defined cristae in the intramitochondrial space, and
9
the apparent lack of crista! development in the bloodstream monomoi-ph.
Intermediate between these forms is the stumpy bloodstream form
which has an expanded mitochondrial tubule, the transformation from
slender to stumpy trypanosomes being also accompanied by the appearance
*
of numerous cristae in the mitochondrial lumen, and occasionally by a
4






Intermediate bloodstream forms in pleomorphic T.rhodesiense.




stream forms of this organism can be classified into discrete slender
(LS) and stumpy (SS) groups. Many authors have included a third class,
the intermediate or intermediate stumpy (ISS) with various definitions
*
of the characteristics of this ISS form. Newton (1968) used length to
differentiate, the bloodstream forms, whereas Bishop (196?) defines the
ISS form as having a free flagellum of "intermediate length." Wijers,
ft
ft
(1559) further divided the pleomorphic organisms into long and short
ft
intermediate forms because of differences between his data and the
i
original drawings of Lady Bruce (Bruce, 191l).
The variations in the length and breadth of T.rhodestsnse blood¬
stream forms, have in fact been shown to be continuous (Swellengrebel,
1911) and the concept of the existence of several discrete morphological
ft




ISS forms appear to be more closely related to the stumpy end of the
*




For the purposes of this investigation, a simple" morphological
4
ft
division into slender and stumpy forms was used. Any organism lacking
a free flagellum and conforming to a subjective estimation of increased
ft
nuclear width was classified as stumpy; all other organisms as slender.
There appears to be a significant correlation between the increased
width and the lack of the flagellum (see Figure 4). Also, this defin¬
ition of the stumpy organism has a biochemical significance, (see Figure 6).
ft
ft






2) CARBOHYDRATE METABOLISM OF BRUCEI-GROUP TRYPANOSOMAS.
ft
Studies on the metabolism of the bloodstream trypanosomes have been
ft
4
confined almost entirely to strains maintained for long periods in




appear to differ biochemically as well as morphologically from the epirnas-
tigote form. As the intermediary metabolism of the epimastigotes
(exemplified by the cultured organisms) has been fairly well documented,
it seemed desirable to investigate the respiration of the stumpy form of
the natural pleomorph, to determine the extent to which any changes have
%
U
occurred prior to infection of the fly.
6
Metabolism of glucose by slender bloodstream forms
% *
i
Tho motility of slander bloodstream forms of T.brucsi and
9
QVrfaoftesiense depends upon a continuous supply of exogenous carbohydrate
#
(von Brand, 1933) which is metabolised at an exceptionally high rate.
It has been calculated (Christophers & Fulton, 1938) that these organisms
consume glucose equivalent to 50 ~ 10C$ of their own dry weight per hour,
utilising 0^ in equimolar amounts, and producing very little CO^ (Ryley,
9
1962). A radioactive carbon balance showed that glucose is metabolised
9
9
by a classical glycolytic sequence without the intervention of the pentose
9
phosphate shunt pathway (Grant & Fulton, 1957) and in the absence of a
t
functional tricarboxylic acid cycle, (Marshall, 1948; Ryley, 1956) pyra-
9
vate is excreted, accounting for at least 83$ of the glucose carbon util-
4
%
ised aerobically (Grant & Fulton, 1957). Earlier measurements of the end
products of glucose raetabolsira by monomorphic trypanosomes, led to some
9
confusion on this point. Grant and Fulton found 10$ glycerol and a trace
of succinate along with the large pyruvate yield, and Ryley(1956) again
*
found pyruvate to be the major end-product (78$) with 19$ glycerol, 2$
C02 and a trace of succinate. Shaw et al., (1964) found 60$ alanine
and 40$ lactate as the products of glucose metabolism, but these data
are based solely on recovered radio-activity. No pyruvate was estimated
and their organisms were contaminated with WBCs, making these figures
♦
totally unreliable. Fulton and Stevens (1945) found, in addition to
these products, acetate, formate and ethanol in a qualitative experiment,
and Glowazky (1937) found oxalate to be produced. However, with the
demonstration by Dixon (1966) that platelet contamination of trypanosome
preparations is entirely responsible for the apparent LDK activity of
these cells, previous work showing or implying lactate as an end-product
appears to be in some doubt (Shaw jat al., 1963; Fulton & Stevens, 1945?
^9
Ryley, 1962). Present opinion seems to be that the only significant
products of aerobic metabolism of glucose are pyruvate and glycerol with
7
a trace of succinate, although von Brand (1952), differentiating between
t
%
T.brueei and T.rhodesiense, states that glycerol is only produced
anaerobically in T.bruoei.
The mechanism of* Op utilisation by slender bloodstream forms.
No detectable cytochromes have ever been shown to be present in
these organisms (Grant et al., 1961; Hyley, 1956,1962; lYslton & Spooner,
0 «
1959) and their glucose metabolism is insensitive tc.cyanide and aside
A
(Ryley 9 and carbon monoxide (Pult 1959). Despite
pigments, T.bruc letabolising glucose
supports a very high rate of oxygen uptake, must
be involved in reoxidation of glycolytic NADH, in the absence of LDH.
Molecular oxygen is used as a terminal oxidant without the inter¬
vention of a conventional electron transport chain, by an L. <*. glycero¬
phosphate (L. oC.GP) oxidase system (Grant & Sargent, i960) containing
iron, thiol groups and possibly PAD (Bide and Grant, 1964; Grant and
Sargent, 1961). The complex therefore differs from the oxidases present
#
in brain mitochondria (Ringler and Singer, 1959) and in insect muscle
ss (Sstabrook and Sacktor, 1958a,b) which use the cytochromes
mediate electron transfer from L- <*-GP to oxygen. The trypanosome
system is extra-mitochondrial but particulate (Bide, 1963), and consists
of a coupled aerobic dehydrogenase and peroxidase (Bide 1963). This
system, in the presence of a soluble NAD-linked o<-GP dehydrogenase
0
allows reoxidation of glycolytic NADH according to the following schemes
(Grant & Sargent, i960)
H
.+
+ DHAP + NADH L-°<-GP + NAD
L-<*GP + hQ̂2 DIIAP
+ H„0
.+




The particulate oxidase is insensitive to inhibitors of electron
4
transport in higher organisms, such as cyanide, aside, ar/iytal, and anti-
mycin A (Grant & Sargent, i960) and the data of these authors show that
this system is sufficiently active in vitro to account for at least 83%
t
of the C>2 consumption in vivo. However in their discussion of this
enzyme complex, they do assume that this is the only hydrogen transport
t 4
system present in the organism.
Metabolism of glucose by culture forms.
•
.
Whereas the slender bloodstream forms of T.brucei are characterised




of glycerol and pyruvate, the cultured epimastigote forms carry the
oxidation to completion, producing CO^ and little organic acid (Ryley,
i
1962). Spectroscopic examination of the culture forms by the same
author showed the presence of absorption bands characteristic of cyto¬
chromes a and b, but no evidence was found for the presence of cytochrome
9 4
4
c. Aerobic glucose oxidation by whole cells, was markedly sensitive
4




The oxidation of L.o^GP is much slower in hcmogenates of the epimas¬
tigote than in lysates of slender bloodstream forms (Grant at al.., 1961)
9
although no evidence was presented as to whether this substrate was
utilised by the cytoplasmic oxidase or by a mitochondrial system linked
to the cytochrome chain. However, the cyanide insensitive oxidation
9
of NADH by frozen and thawed cells (Grant et al., 1961) indicates that





of Lo^GP in the same system was cyanide sensitive. This anomaly cannot
9
be explained on the data presented by these authors.
$
Enzymes of the tricarboxylic acid cycle in bloodstream and culture forms.
Although the overall metabolism of glucose by these two forms differs
markedly, and the slender bloodstream forms appear to be incapable of
utilising the tricarboxylic acid cycle, several of the enzymes involved
in this cycle are common to both stages of the life cycle (Ryley 1962).
Malic dehydrogenase (E.C. 1.1.1.37), aconitase (E.C. 4.2.1.3.), fumarase
«
(E.C. 4.2.1.2.) and isocitric dehydrogenase (E.C. 1.1.1.42), are all
found in the slender organisms, but in every case at a much lower
ft
activity than in the epimastigote (Ryley, 1962) although these results
I
may be due to the assay temperature being between the natural environ-
ment temperatures of these organisms (37°C and 25°C respectively), No
evidence has been presented for the presence of oxidative decarboxylation
systems in the slender forms (Ryley, 1962), nor has succinic dehydrogenase
activity been detected.




(l?62j), the presence of an active pyruvate oxidase in the culture organ¬
isms, and demonstrated that whole cells of this form can metabolise
succinate, this activity being more marked at slightly acid pH. Unfort-
ft
unately, although this work gives an excellent outline of the enzymic
competence of the bloodstream and culture organisms the quantitative
ft
ft
aspects are in some doubt since LDH was shown to be present in the enzyme
preparations. However, the apparently complete oxidation pf glucose
. to COg with an R.Q. approaching 1, indicates that in parallel with
r
T.gambiense culture forms, a fully functional tricarboxylic acid cycle
is operative at this stage of the life cycle.
f
Metabolism of glucose by stumpy bloodstream forms.
Despite the relatively large amount of data available on the ■
glucose metabolism of the artificially induced monomorphic trypanosoraes,
the amount of work done on a true pleomorphic strain has been minimal.
At soma point in the natural development of the trypanosoroe from
*
ft*
slender bloodstream to mid-gut epiraastigote form, the metabolic
complexity must change from the simple glycolytic system to the
# «
complete oxidative capacity of the tsetse mid-gut form. To what
extent these changes occur prior to infection of the insect vector
ft
was practically uninvestigated.
Grant and Pulton (1957)? investigating the metabolism of a newly
ft
isolated pleomorphic strain, found that pyruvate production and
ft
%
labelling from 1-^C glucose was identical with that of an old mono-
• >
'ft
morphic strain. However, whereas none of the tricarboxylic acid
cycle intermediates sustained respiration of the monomorpk (Hyley,
ft
ft*
1962), Balis (1964) showed that motility of the culture forms was
retained with <*-0G as an energy source. This observation became
'
more significant when Vickerman (1965) showed that in a pleomorphic
strain, the motility of the stumpy forms was preferentially supported
ft
by this substrate. This was the first evidence contrary to the
suggestion of Grant et al., (1961), that the respiratory switch from
aerobic glycolysis to classical aerobic respiration mediated by cyto-
ft
chromes and a tricarboxylic acid cycle, occurred only on transfer to
the lowered oxygen tension available in the insect mid-gut or in
culture. This induction of cytochrome synthesis and oxidative
ft
I
enzymes has been shown to occur with a decrease in available oxygen in
« t
Pseudomonas sp«(Lenhoff et al., 1956). Further evidence that the
0
switch may be partially effected on transformation to the stumpy blood¬
stream forms came from cytochemical studies (Vickerman, 1965) involv-
ft
ing the deposition of formazan when fixed trypanosomal smears were
ft
ft
incubated with a tetrazolium salt and NADH, as a cytochemical indicator
9
of the presence of "diaphorase" in the organism. In T.vivax and
T.congolense which are thought to have a complete oxidative metabolism
ft
%
in their bloodstream forms (Ryley, 195&)> deposition of the formazan
ft
was dense and was located in, the mitochondria. When a pleomorphic
ft
ft
strain of T.brucei was tested, the formazan deposits were confined to
the intermediate and stumpy forms, the slender trypanosomes showing no
mitochondrial formazan deposits. As further evidence that these
% *
ft
slender forms are analogous to the monomorphic syringe-passaged strains
#
tests on the latter also gave no mitochondrial formazan deposition.




specific term "diaphorase" with a specific enzyme title, "NADH -
ft
lipoamide oxido-reductase," ant extrapolation not justifiable from the
original results. This enzyme, catalysing the transfer of electrons
from the reduced coenzyme to a tetrazolium salt is probably best
#
ft
described as a "tetrazoiiura reductase," and one of these has been shown
ft
to be a flavoprotein which is probably autoxidisable (Nachlas et al.,
ft
1958)' I" view of the number of flavoproteins that catalyse the
9
ft
reduction of intermediary metabolites by NADH, and the ability of
reduced flavoproteins to reduce tetrazolium salts, it is obvious that
to ascribe the results of Vickerman to a particular enzyme is illogical





the author found extra-mitochondrial formazan deposits in the slender
ft
bloodstream form, which he attributed to the action of the L.oi.GP






It appeared that the metabolic switch must therefore be at least
ft
partly stimulated by some event occurring in the bloodstream of the
♦ 9
mammalian host. As suggested by Newton (1968), the assumption of an
12
% #
increased oxidative capacity by the stumpy form may explain the prefer-
ential survival of these organisms in the tsetse mid-gut, and the
m
apparent inability of the slender form to infect the insect vector.
As the only evidence for this diversity of metabolism in the blood-
4
stream forms was on the basis of a motility test and the qualitative,
non-specific tetrazolium reductase analyses, it seemed desirable to
C
investigate further the biochemical changes which have occurred before
4
4
infection of the tsetse fly, despite the negative results of Grant and
Pulton (1957). Previous reports on the aerobic metabolism of mono-
morphic T.bruoei have suffered from a degree of inconsistency, probably




erythrocytes and leuocytes from infected blood is relatively easy,
successful removal of platelets does not seem to have been achieved in
4




of monomorphic trypanosomes, in my hands yielded preparations with a
*
4




repeated centrifugation technique reported by Ryley (195^?1962), whilst
4
completely eliminating EEC's and WBC's, did not yield 'trypanosomss free
from LDII contamination. Other studies based on the comparison of
i
infected and uninfected blood (e.g. von Brand £t al., 1950) are suspect,
due to the altered blood element picture, obtained in infected animals,
« i
which show a marked polythrombocytaemia. As a result, the basic meta-
4
bolic studies carried out on the pleomorphic strains in this work, were
t
repeated both on an established monomorph, and on a pleomorphic strain
in which monomorphism was freshly induced by syringe passage. The
1
isolation method desci'ibed in Chapter III section/gave trypanosome
preparations completely free from blood elements.
3') THE ACTION OF ABSEKICAL5 ON METABOLISM.
ft
%
Compounds of arsenic have been used for hundreds of years, for
both medicinal and homicidal purposes, and as a result much work has
been done with a view to elucidating the mechanism of action of these
compounds. Early work was concentrated on the effects of inorganic
arsenite and arsenate, the interconversion of these forms, and their
♦
relative toxicities. It was not until 1905? more than 60 years after
ft
the discovery of the first organic arsenical, that Thomas and Breinl
realised the value of sodium arsanilate in murine trypanosomiasis, and
4
ft




sleeping sickness. These observations were contrary to the findings
of Ehrlich, who had previously shown that sodium arsanilate was inaot-
ft
ft
ive in vitro against trypanosomes, but they led to the introduction of
ft
many organic arsenicals as tiypanocides, and also as effective agents
against amoebiasis and syphilis.
By this time, the mid-nineteenth century concept that arsenicals
were "protoplasmic" poisons with a non-specific coagulating action, had
« ►
ft
been firmly replaced by the idea of their interfering with cellular
ft
ft




demonstrated that the arsenicals do not act by release of inorganic
ft
arsenite, and that the pentavalent arsenicals are probably reduced
»
in vivo prior to their activity against the cell, but the major import¬
ance of this work lay in his formulation of the concept of specific
arseno-receptors. These specific receptor groups within the cell were
ft
postulated to be thiol groups (Voegtlin et al., 1$23), and Barber (1929)
showed that condensation can occur between phenylarser.oxides and organic
thiols such as thiolacetic acid and thioglycollic acid.
From this demonstration, it was to he expected that in the presence
i
of a large excess of exogenous thiol, the toxicity of the arsenicals
« *
would he much reduced. This was experimentally proven by Eagle (1939)
4
who showed that the anti-spirochaetal activity of trivalent arsenicals
is abolished by free thiol compounds such as cysteine, but not by
fr
methionine. Unfortunately, although these data from protection experi-
0
ments were held for many years as circumstantial evidence for the
involvement of thiol groups in arsenical action, they are in fact
9
completely worthless in this respect. Such data only indicate the
relative binding affinities of the cellular receptor whatever its nature,
♦ ♦
and the exogenous thiol for the arsenical. '
. However, much work has accumulated since the postulate of Voegtlin
et al., (1923), to point to free thiol groups as the arseno-receptors
4
of Ehrlich. Krebs (l933a,b), by demonstrating the accumulation of
9
keto-acids such as pyruvate in kidney cells treated with arsenate, gave
the first indication of the primary metabolic target. It became
*
evident that the. oxidation of keto-acids is the key reaction in arsenate
C
inhibition, and intensive study of the organic trivalent arsenicals by
{(Peters et al., 19^5; Peters,. 1955)
Peters'] £ ■ -'and" o'tkir'a"'showed that pyruvate oxidase is specifi¬
cally and markedly inhibited by these compounds, presumably due to the
4
involvement of lipoic acid and dihydrolipoyl dehydrogenase in the
%
reaction mechanism. Kany other enzyme systems have, however,been shown
to be affected by the arsenicals, which are now used as common reagents
• * *
for inhibition of thiol dependent reactions.,
%
Despite the early introduction of the organic arsenicals, there is
relatively little information on their metabolic effects compared to
those of inorganic arsenite, although the inhibitions by these types of
compounds often differ maa'kedly. Although arsenite is trypanocidal,
Fig . |;
t

















Sodium Melarsen (Mel 5).
Melarsonyl Potassium (Mel w).
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work will therefore be devoted in the main to a consideration of the
aromatic arsenicals, especially as, to quote Webb (1966) "... there is
a paucity of good delineation of the overall effects of the (organic)
« .
arsenicals on the metabolism of any organism or tissue, and essentially






The terminology used in this v/ork v/iil be that of Doalc and Preec.man
%
(i960), although alternative names are available for most of the compounds
4
involved. The arsenicals used are shown in Fig.l$ for convenience the
-As=0 form is used in the text, but this is not intended to indicate the
















of pentavalent to trivalent arsenicals, was based entirely on indirect
evidence, with no demonstration having been given of this occurring in
9 9




ducts, when the two forms of the phenyl arsenical were injected into
V
rabbits (Crawford & Le\j/y, 1947). Surprisingly he found that the
4
expected reduction did not occur to any marked extent. Whereas over
4
4




product of the trivalent form was the oxidised compound. Frost (1967)
%
4
cites numerous examples of this same phenomenon although his dogmatic
0
» 9
statement that "Nature - apparently may not produce trivalent organic












Furthermore, the much lower toxicity of the pentavalent compounds
*
indicates that reduction is at best a very much slower reaction than
was thought, if it happens at all. The toxic side reactions of the
trivalent forms, such as liver dysfunction and dermatitis, are not
produced to the expected extent even in cases of chronic administration
of the pentavalent compounds. Instead the pentavalent arsenicals often
4
9
present a totally different clinical picture, causing optic nerve
atrophy and resultant blindness.
ft
The lack of knowledge of the selective permeability of cells to
the arsenicals in vivo and the systems involved in the redox changes
♦
of the compounds, leaves some doubt as to the exact state of the arsen-
9
icals in the body. The selective action of the pentavalent compounds
on the visual system may be due to differential permeability of the
*
tissue or to a specific action of the drug itself. However, the vast
• •
majority of enzymes which have been investigated show no affinity for
4
the pentavalent compounds. As will he shown in this work, there is a
definite preference for the trivalent form as an inhibitor of EC which




Development of melaminyl arsenieals
9
9
In the development of arsenical drugs, problems have been encoun-
m
tered with the onset of resistance to the drugs, and with permeability
*
• >
barriers. Aliphatic phenylarsenoxides and their reduced counterparts
such as tryparsamide and orsanine have been found to be ineffective
against T.rhodesiense although useful against the related T.gambiense.
The latter species has been shown to develop resistance to tryparsamide
ft
*
very effectively, and thu3 some other derivatives wer6 needed to replace
»
this drug. Friedheim (1940) introduced a new class of trypanocide in
17
which a 2*4*6 - triamino-S-triazinyl (melaminyl) residue was attached
in the para position in phenyl arsonate .This compound* known as
melarsen was found to be very effective in the treatment of tryparsamide
0
s
resistant strains (Williamson & Lourie, 1948), to be active as a
m
trypanocide against T.rhodesiense, and to be useful -in the treatment of
advanced cases of the disease, where central nervous system involvement
drug barrier."
The trivalent equivalent of melarsen, raelarsen oxide, was found to
following
the introduction of BAL (Peters et al., in detoxifying oxophenar-
sine (Petex-s & Stocken, 1947; Friedheim & Vogel,. j1947) • This combines
4
4
the trivalent As in a stable 5~®embered ring form with the two thiol
groups of BAL, producing the cyclic thiol derivative, Mel B. Thi s and
melarsen are the only drugs effective against the late stages of
0
T.rhodesiense infection (Hutchinson & Watson, 1965)* The preparation
of a water-soluble analogue of Mel B, Mel W, in which the As is coupled
0
to dithiosuccinate proved disappointing against this trypanosome -
0
4
(Hutchinson & Watson, 1965), and apart from easier administration, this
drug
It is generally accepted that these disulphide derivatives are
hydrolysed to the arsenoxide form prior to exerting their therapeutic
effect, and the parent arsenoxide melarsen oxide has therefore been
used in much of this present work.
Mechanism of trypanocidal action.




action are often considered to be the c*-keto-acid oxidases, but thex-e





references quoted by Webb (l966) on the inhibition of respiration and
*
* •
build up of keto-acids in the presence of arsenicals, 5 are studies.of
%
aromatic arsenicals and the rest are of lewisite and arsenite. Through-
i
out his monumental work on the arsenicals as a class, Webb is continually
and quite correctly lamenting the 3parsity of data on the more complex
aromatic arsenicals, compared to the volume of work on inorganic arsenite.
€
This is particularly relevant to the problem of trypanocidal activity
0
where the monomorphic bloodstream forms have no active <*-keto acid





arsenicals. In these organisms, then, some other focal point must be
0
the site of action of these drugs, and yet there has been little reliable
*
%
work carried out to determine the nature of this receptor site. Much
0
energy has been expended (Eagle, 19.45? Eagle & i)oak, 1951? Eagle et al.,
0
1942, 1943, 1944a,b) on evaluating the effects of substitution on
0 ♦




• ion of lethal and toxic doses of the drugs (Yorke et ad., 1931; Pulton
0
& Yorke, 1943; Kerr et ai., 1963) but the active receptor site remains
very much a mystery. Chen (1948) and Marshall (1948) produced some
m
evidence that in T.equiperdum and T.evansi respectively, hexokinase is
the most sensitive site in vivo. However, Cantrell (1951, 1953) came
to the conclusion that this was not the case, although he used a compar¬
ison between infected /mapharsan treated and infected/untreated blood,
with obvious difficulties of interpretation. Thirty minutes after
<
P
treatment of one of a pair of rats with mapharsen, glucose utilisation





were measured. Glucose utilisation rates were found to be identical
0
✓
in the treated and untreated samples, although pyruvate production was
0
9
lower in the drug-treated blood, implying a site of action between
glucose-6-phosphate and pyruvate.
19 .
Thus, from known actions of the arsenicals and the lack of pyruvate
oxidase in bloodstream monomorphic T.brucei and T.rhodesiensesr it is
4
4
unexpected that arsenicals inhibit their respiration at all, and the
mechanism of this inhibition was very obscure» It was therefore





in parallel with an examination of the metabolic properties of pleomorphic
t
Tprhodesiense. ■ ' "
CHAPTER 2




Chapter 4 of this work outlines the evidence leading to the
conclusion that, in vivo, one of the primary arsenical-sensitive sites
ft
in T.rhodesienae is pyruvate kinase. Some sensitivity of hex.oki.nase
was observed, and a third site of action of these drugs is known, viz.
ft
glycerokinase (E.G. 2.7.1.30.) (Fairiaaib, unpublished communication).
ft
The common denominator in the catabolism of glycerol and glucose by these
organisms is thus, with respect to arsenical action, pyruvate kinase.
The introduction to the enzymplogical part of this thesis will therefore
deal with the properties of the mammalian PK's, to enable a comparison
ft
between host and parasite enzymes to be made from a cheraotherapeutic
and a kinetic viewpoint
PK catalyses the transfer of a phosphoryl group from PEP to AJ)P,




ore stable keto form on release of the constraint imposed by the phos¬





0 0- + A2)P + H
1




CH-= C — C = 0 + AIT4








catalyses a COg-dependent phosphorylation of fluoride by ATP (Tietz and
Ochoa, 1962) and with the enzyme from the same source which phosphory-
lates hydroxylamine (Kupiecki and Coon, 1959). The physiological signif-
ft
ft
icance of these reactions is still doubtful.
21
ft
The existence of a new glycolytic intermediate between 3.PGA and
pyruvate was demonstrated by Lohmann and Meyerhof (1934) who simultan¬
eously' purified PEP and elucidated its properties and molecular structure.
ft
The role of the adenine nucleotides in the enzyme reaction was,
*
however, unclear at this stage. Lohmann and Meyerhof were of the opinion
*
that the reaction was one of dephosphorylation, with the coenzyme nucleo¬
tide acting as a catalyst for inorganic phosphate formation. Subsequently,
AMP was postulated as a phosphoryl acceptor in the PIC reaction (Heedham
and van Heyningen, 1935) but the presence of adenylate kinase in the
ft
ft
enzyme preparations complicated the conclusions. Later work by Boyer
ft
et al., (1942, 1943) confirmed the suggestion of Meyerhof and Junowicz-
ft
Kocholaty (1942) that the nucleoside diphosphate was the physiological








PIC has in common with other kinases, a requirement for a divalent
cation for activity, first demonstrated by. Lohmann and Meyerhof (1934)•
^ w
Melchior, (19^5) showed that MgADP*" is the specific coenzyme required
by PK, free ADP^~ not acting as a phosphoryl acceptor in the reaction.
ft
This requirement for a divalent metal ion may be met by various ions
other than Mg . Solvonuk and Collier (1955) showed that Mn" and Co*"
2+ 2+




Whereas a requirement for Mg ions or a similar divalent cation
is a general property of kinase enzymes, PIC also shows a strict require¬
ment for a monovalent cation. Boyer et al., (1942, 1943) demonstrated
enzymic dependence on IC+ ions, (the first known role of K+ ions as an
enzymic cofactor) and Rb+ or RH^+ ions have since been shown to replace













studies (MiIdvan & Cohn, 1964) and UV difference spectra of tryptophan
perturbation in the enzyme (Kayne & Suelter, 1965) have all been inter-
-
preted to mean that monovalent cations affect the conformation of the
protein, and hence modify the binding of substrates. One report, how-
A
ever, claims that the enzyme from E.coli is unaffected by K+ ions (Maeba
& Sanwal, 1968a). The last steps in the purification procedure employed
0
by these authors- are ammonium sulphate extractions, and no indication is
given that the NH^ ions were removed prior to assay of K activation,
+
It is therefore possible that a sufficient concentration of NH^ ions
was added to the assay system to saturate the enzyme, prior to addition
of excess K ions.
Purification and physical properties.
♦ ^
^
FK is now accepted as being an essential component of glycolysis,
and as such will occur in all tissues and organisms capable of utilising
this metabolic pathway. The enzyme has been identified in most animal
phyla, from protozoa to mammalia (see Boyer, 19.62) as well as in many
0
plant tissues (Miller and Evans, 1957) moulds, (Damodaran et al., 1955).
and yeasts (Washio & Mano, i960).
The first purification data, from rat muscle by Negelein (quoted
•1
Buchsr and
the first published purification is that of Kubowitz & Ott from human
4
muscle (1944). Crystallisation of the enzyme from various muscle
sources has now been effected, and the yeast PK has been obtained in a
0
■high degree of purity (Haeckel et al#> 1968; Eunsley & Suelter, 1969?
4
Washio & Mano, i960). Erythrocyte PK has been obtained in a highly
purified state (ibsen et al., 1968), and one hepatic isoenzyme (L) has
been crystallised (Tanaka et al,, 1967a).
23
The amino
reported (Hunsley & Suelter, 1969j Bischofberger et al., 1970)* find
the raolo wt enzyme 200.000
(Bischofberger et al., 1970) and 138,000 - 166,000 (Hunsley & SueIter,
1969)® Kuczenski and Suelter (1970) reported the molecular weight as
162,000 - 168,000 and further showed it to be a tetramer of four sub-
units of approx. equal molecular weight of 42,000 - 45,000. This last
tt
figure corresponds to Buchars estimate of the molecular weight of
11
muscle
obtained by a light scattering technique. The enzyme from rabbit
pascle has been reported as being of molecular weight 237,000 (Warner,
1958), dissociating into 2 sub-units in 6M-urea (Morawiecki, i960);
each sub-unit consists of 2 polypeptide chains of 57,000 (Steinmetz and
Deal, 1966).
Thus both yeast and muscle PK have been shown to consist of four
chains. The leucocyte and erythrocyte enzymes, under the ultra-
*
t ft




and two Mn binding sites (Mildvan and Cohn, 1965) per native muscle
enzyme molecule of weight 237,000. This and other evidence has led to
the now accepted model of FK being a tetramer containing two protomers
ft
or catalytic particles, each protomer being capable of'subdivision into
tv/o non-identical polypeptide chains.




been reported as inhibiting PK (Reynard et al., 19^1) and FDP acts as a




I6t fll • j1
in the control of glycolysis and gluconeogonesis (Weber^"l9o6a), There
ft
.
has also been a suggestion that PK may be under endocrinological control,
ft
as diethylstilbestrol, (and to a lesser extent certain steroid hormones)
ft
effects a change in the viscosity and electrophoretic properties of PK
m




PEP is the only known phosphoryl donor in the PK reaction according
to Woods et al., (1970) who synthesised seven homologies of this substrate
and tested their activity as substrates or inhibitors. This selectivity
is marked, as only phosphoenol- ix-oxobutyrate and phosphoenol- of-oxovalerate
had the capacity to inhibit the reaction with PEP as substrate.
The specificity of the enzyme for the nucleotide coenzyme is less
ft
ft




(Strominger & Lowry, 19555 Tietz & Ochoa, 1958) were questioned by
Davidson (1959) on the basis of the presence of nucleoside diphospho-
ft
kinase in the experimental system, which resulted in a transfer of phos-
ft
phoryl groups from, adenosine nucleotides. However, a closer examination
ft
of this problem by Plowman and Krall (19&5) confirmed the broad specificity
%
»









The first demonstration of PEP synthesis from ATP and pyruvate by
ft
ft
Lardy and Ziegler (l945)t refuted the previously held concept that PK
catalysed an essentially irreversible reaction between PEP and ADP.
2+
The K of the reaction is dependent upon the Jug ion concentration
app
4 4
(McQuate and Utter, 1959)s presumably because of the higher equilibrium
2+
constant for the binding of JJg to ATP than that for the binding of
ft
2+
Mg to either ADP or FEP. Under physiological conditions, however,
3
the K appears to be of the order of 6™7 x 10 , and the equilibrium
app
thus lies very much in favour of pyruvate. The apparent - AP for the
reaction is approximately 4700 cal., (McQuate & Utter, 1959), but
*
ft
despite this and the unfavourable K for PEP synthesis, the ratio
app
of the V values in the reverse to the forward reaction is onlyulo3£
approx. l/200 at pH 7®4. However, the K value for pyruvate estimateds
-2
by these same authors is 10 M, and thus in vivo the velocity will not
approach the V value.
insx
These facts combine to form a physiologically insurmountable block
against the participation of PK in the reversal of glycolysis, and
thus we are dealing with a virtually unidirectional process. Ho
ft
ft
evidence has been presented for the presence in T.rhodeslease of
gluconeogenesis or of the now generally accepted mechanism by which
ft
PK is bypassed in gluconeogenesis in higher organisms, viz. by the
*
combination of pyruvate carboxylase, and PEP carboxy-kinase (Utter,
Keech & Scrutton 1964). From an experimental viewpoint, the enzymic
ft
section of this work has therefore been limited to the utilisation of
ft
ft








In the absence of a control of FK in the organs of gluconeogenesis,
PEP regenerated for gluconeogenesis would be converted into pyruvate.
Two means by which this control may be exerted exist in the case cf
the mammalian liver enzyme. Firstly, the level of hepatic PK is under
dietary and hormonal control (Tanaka et al., 1965); in a primarily
glycolytic tissue such as muscle, these factors do not affect the
enzyme. Secondly, the liver isoenzymes are subject to allosteric
ft
control by intermediary metabolites.
ft
Zone electrophoresis of crude muscle and liver extracts by Tanaka




at least four bands from the liver extract. Only one of the four
9
liver isoenzymes was antigenic when immunological assays were carried
out with anti-muscle PK serum, and this isoenzyme was named type M,
6
The other three isoenzymes (L^ Lg and L^) were not precipitated by
this antibody. Of these three enzymes, only type 1^ has beon investi-
4
gated further, and has been shown to differ from muscle type M in the
response to ammonium sulphate precipitation, DEAE-cellulose elution,
and inhibition by .pCMB, as well as in crystal form and molecular weight
L® '
(Tanaka et al., 196"jj().
9
A danger inherent in the classification of FKs from other tissues
as type L or type M, on the basis of immunological or eiectrophoretic
properties, is the lack of correspondance between these properties of
the enzymes. Two isoenzymes exist in mammalian kidney, electrophoret-
A
ically classified as types L and M, but both are precipitated and
.ia-,b~
inhibited by anti-M serum (Tanaka et al., 1965s ly6lj)* The only other
known source of a type L isoenzyme is the erythrocyte, but whereas the
9 4
4
level of the liver L type PK is subject to dietary and hormonal control
the level of the erythrocyte enzyme is independent of these factors.
4
4
In this respect, then, the erythrocyte enzyme more closely resembles
4
4
the muscle and liver type M isoenzjnces. •
The existence of the two isoenzyme forms in the hepatic cell has
' •
led Tanaka et al., to postulate the presence of two glycolytic sequence
The diet-, hormone-, and effector-independent type M, in combination
with hexokinase (Walker et al., 1963), constitutes, with the rest of
the glycolytic enzymes, the basal pathway. When the balance between
glycolysis and gluconeogenesis is of special significance, the nutrit-
9
4
ional and hormonal state of the organism effects changes in the L type






kinetics, in so far as both substrates exhibit hyperbolic velocity
0
versus substrate concentration curves. (Kachmar & Boyer, 1953?
McQuate and Utter, 1959? Boyer, 1962; Reynard et al., 1961). This
9
property is reputedly shared by the type M isoenzyme of liver (Tanaka
i«,
et al., 1^6'ij), the leucocyte enzyme (Campos et al., 1965) and the
type L erythrocyte PK (Ibsen et al., 1968). The PKs from yeast
c
(Haeckel et al., 1968) and adipose tissue (Pogson, 1968), and the
ing 2nd order Lineweaver-Bu ric
plots with varying PEP concentration, The 1st order kinetic pattern
of the nucleotide acceptor is in all cases similar to that of the
muscle enzyme
Quantitative estimates of and values for the PK of different
tissues vary greatly, depending on the conditions used both for extract-
0
ion of the enzyme, and for assay. Further complications arise from
the use of crude tissue extracts, where kinetically different, isoenzymes
9
are present (Llorente al., 1970). Reported PEP values for the
—3
erythrocyte enzyme, for example, range from 1.5 x 10 M-PEP to 4.6 x 10
9
9
M-PEP (Campos et al., 19^55 Wiesmann et al., 1965; Boivin ijf_(
9
Ibsen et al., 1968), and whereas only one electrophoretic band of PK
— — .
,
appears under the experimental conditions of Tanaka et al (1967/)» there
nzyndc forms of this enzyme
et al., 1971? Rudiger et al., 1968). K^ ADP values reported for this
ADP
9
and Whigham, 1967? Campos et al., 1965)- The greater reproducibility
of this parameter may reflect the relative insensitivity of the KM ADP




The kinetic constants defining the binding of ADP and PEP to FK
are probably mutually independent In the cases of the liver L type
(a> '
nzyraes 9 enzyme
©t al., 1965) the muscle enzyme (Boyer, 1962; Reynard e_t al., 196l),
*
and the erythrocyte enzyme (Ibsen et al,, 1968), the Kj. value for each
substrate was found to be unaffected by the concentration of the other
substrate. However9 differences have been found, by Campos et al.,
erythrocyte and by McQuate and Utter (1959) for
tuscle PK.
Further definition of the K„ and S..,. values obtained for various
M 50
FKs would be of little worth at this point, as the reported experimental
assay conditions vary drastically with respect to temperature, cation
•
- •
concentration, and degree of enzyme purification.
Regulation of PK by metabolic activators and inhibitors
As a consequence of the high PK activity in gluconeogenic tissues,
some mechanism has been assumed to operate by which HC may be inhibited
in the gluconeogenic state and activated when a high rate of glycolysis
is required Hepatic PK is stimulated by FBF (Taylor & Bailey, 1967)
and inhibited by NADH (Weber etal., 1965), ATP (i7eb«r et al., 1966a),
2+
octanoic acid (Weber et al., 1966b) and Cu ions (Carminatti et al.,
1968). All these factors have, been postulated as exerting a regulatory
function in vivo
i. NADH
The concentration of NABH required for the inhibition of hepatic
PK, is much higher than that found under in vivo conditions of gluconeo
genesis However, the extent of this non-competitive inhibition was
shown to be dependent upon the preincubation time of the enzyme with
the inhibitor (Weber etal., 1965, 1966a) and a role for this coenzyme
ft




to be dependent upon the enzyme
source, and is still a matter of some controversy Muscle PK has
ATP
1949? Reynard et al., 1961; Mildvan & Cohn, 1966) Tanaka _st al.,
(19676) and Reynard et al., (1961) attributed this inhibition to a
ft
competitive effect for the enzyme active site, but McQuate & Utter




thereby decreasing the effective MgADP concentration, was the basis of
the inhibition. Wood (1968), investigated these effects under various
2*4*
conditions and showed that the addition of excess Mg ion totally
any inhibition muscle enzyme !UI •
However, the liver enzyme is inhibited by ATP under conditions




et al., 1966a), although the inhibition is potentiated at limiting Mg
ft
levels, due to the chelation effect. The significance of this inhib¬
ition in vivo may therefore be greater than that of NADH. The for
ATP in the hepatic enzyme system of Weber et al., (1966a) is 8.0 x 10 ^
.M-ATP, compared to the in vivo concentration quoted of 2 mM-ATP. ATP
also shows cooperative interactions with hepatic HC at acid pH values,
indicating rather more than a simple product inhibition.
A rise in the intracellular ATP concentration could therefore act
as a negative feed-back control on IK hence limiting its own production
energy Any fluctuations in the
concentration of ATP may therefore alter the glycolytic/gluconeogenic
balance, and small variations in pH within the physiological range
may also markedly alter the effect of this inhibitor (Hoz-engurt et al,,









iii. Free fatty acids
4
Since the observations by Krebs et al., (1965) and Hanes jst al.,
(1965) that free fatty acids (FFA) stimulate renal and hepatic gluccneo
9
#
genesis respectively, many key enzymes of the catabolic pathways of
*
glucose metabolism have been shown to be inhibited by FFA, viz, PK,
hexokinase, glucokinase and phosphofructokinase (v/ebsr et al., "1966a,b)
4
Glycolytic activity is therefore severely depressed by elevated coneen™
m
trations of both FFA and their coenzyme A derivatives, with a concomit-
♦
9
ant increase in the gluconeogenic rate. The effects of these inhib-
, • •
itors were not, however, investigated on the trypanosomal enzyme, on
the grounds of the non-specificity of the FFAs (fumarase and isocitrate
s
9
dehydrogenase are also inhibited)-and the fundamental lack of knowledge
9






The effects of FDP on the kinetics of FK have been investigated
on the enzyme from various sources, including liver (Hess & Haeckel,
1967), adipose tissue (Pogscn, 1968) yeast(Hess et al., 1966; Hunsley
& Suelter, 1969) and B.coli (Maebar& Sanwal)l968a,b) and again the
details of the activation differ from source to source.
*
p
With increasing concentrations of FDP, a progressive increase in
4
PK activity is observed, although the values for this activator
range from 3.8 x 10 ^ M for the liver L enzyme (Weber et al., 1966a)
0
—4
to 1.5 x 10 M for the yeast enzyme (Hess et al., 1966). Quantitative
0
discrepancies are again noted in this respect, as Llorente et al.,
0
rr
(1970) quote 5 x 10 M-FDP as producing "nearly full activation" in
liver. However the FDP effect is known to depend upon PEP concen¬
tration and also the last figure comes from a source which, despite
the publications of the last five years on isoenzymic forms of liver
*
4
PK, uses a crude extract of liver as an enzyme source. The ratio of
L to M type PK in their enzyme preparation is therefore dependent upon
4
the dietary history of their experimental animals, and interpretation
%
+
of their quantitative results becomes extremely hazardous.
The common qualitative effect of FDP on PK is to alter the shape
0
i
of the PEP saturation curve from a sigmoid to a hyperbola, increasing
0
4
the affinity of the enzyme for this substrate. The rat muscle enzyme
4 0
which displays hyperbolic saturation chaz*acteri sties to PEP in the
0
absence of FDP, shows virtually no response to this modifier (Llorente
0
et al., 1970)» a property shared by the enzyme from eight other tissues
0
tested by these authors. There remains some confusion as to the
0
position of the adipose tissue PK in this respect; Llorente et al.,
(.1970) report a negligible effect of FDP on their enzyme preparation,
0
|
whereas Pogson (1968) demonstrated a positive response to this modifier.
The results of the last author, however, again indicate how pretreat-
0
ment of the experimental material may alter the kinetic picture.
4
Extraction of adipose tissue with a medium containing EDTA produces a
form of PK designated PyK-A, in which form the enzyme is FDP-activated
2+ +
and shows cooperative kinetics towards PEP, % ions and K ions. In
0
the absence of EDTA, FyK-B is obtained, which shows normal Michaelis-
0
Menten kinetics with PEP and metal ions, and is FD? insensitive. The
0




been confirmed (Llorente et al., 1970), and it was further demonstrated
*
that preincubation conditions,-temperature, and the age of the experi-
* «
0
mental animal affect the enzyme characteristics. The latest work of
I
4
these authors (Marco et al., 1971) would appear to confirm the hypoth¬
esis of Pogson (1968) in that adipose tissue PK is FDP-sensitive in vivo
The yeast enzyme displays cooperative interactions with K ions,
the sigmoid nature of the response to increasing concentrations of this
cation being abolished by FDP (Hess & Haeckel, 19^7)* As a comparison,
2+ +
the cooperative effects of Mg and K in.the adipose tissue system are
ft
unaffected by FDP. Hess and Haeckel also found that the V of the* max
yeast enzyme v/as altered by FDP when K+ was the activating monovalent
ft
cation, but not when KH.+ was used.4
No report has yet been published in which a comprehensive investi-
♦
gation of the factors which affect FDP activation is made, namely
0
1) pH (Taylor & Bailey, 19^7).
2) Temperature (Llorente jet al., 1970).
s
3) PEP concentration (Taylor & Bailey, 1967)*
0
0
4) Cation specificity (Hess & Haeckel, 1967)-
0
m
5) The presence of FDPase in the enzyme preparation.
ft
6) Extraction procedure (Pogson, 1968).
I *
The effects of pH and temperature are liable to be of minimal
physiological significance, and a standard cation concentration has been
maintained throughout this work.
0
Taylor and Bailey (19^7) showed that whereas hepatic L type PK was
»
30$ activated at pH 6.0 by 5 x lO-^ M-FDP, over 20-fold activation
occurred at pH 8.0. Unfortunately it is impossible to conclude from
W
the data presented whether this simply reflects a protective effect by
0
FDP in alkaline solution. Desensitisation of this enzyme to FDP. has
33
been reported, by storage at 0-2 C (LIorente et al., 1970) or by
elevating the PEP assay concentration to (Taylor & Bailey, 1967).
Interestingly, the effect of cold storage is accompanied by an abolition
of the homotropic cooperative effects of PEP
9
These effects say account
for the difficulties encountered in obtaining reproducible results for
t
the allosteric behaviour of this enzyme.
Finally, one anomaly is shown in the case of the PK from E.coli





The postulated control of liver L type PIC by reciprocal Cu
2+
inhibition and FDP activation (Carminatti et al., 1968) is of doubtful
in vivo significance. The ncn-corapetitive nature of the inhibition




Similarly no significance can at present bo
2+
ascribed to the reported inhibition of liver PK by Zn ions (Solvonuk
& Collier, 1955) and the interesting nucleotide specificity of Cu
inhibition (Carminatti et al., 1968).
2+ .
ion
3) MODELS TO DESCRIBE THE ALLOSTERIC PROPERTIES OF PK
Extensive information about the interaction of PIC with the above
effectors has been obtained, especially for the liver L type enzyme,
*
and it is therefore possible to propose an allosteric model along the
jMonod et al. ,•
lines of the Monod hypothesis (£1965) • It must be noted, however, that
« •
whereas the model proposed below acts as a valuable working hypothesis,
4
it is based solely on kinetic data, which is rarely sufficient to
dist-ingui
enzymic sub-units and forms. This basic inadequacy of a purely kinetic
investigation sterns from the major assumption of the R-T classification
system of Monod et al., (1965), that molecular symmetry is at all times
conserved. This premise cannot be tested kinetically. Hov.-ever, as
the relatively simple model on the Konod hypothesis fits the available
9
data, it serves as a summation of the observed modifier and substrate
*
effects on PIC.
FDP, ATP and PEP all exhibit under certain conditions, a homotropic
W
4
cooperative interaction with liver L type FK, demonstrable by the
sigmoidal velocity - effector concentration relationships. The homo-
tropic interaction of PIC with PEP is abolished by FDP, and the activation
of the enzyme by the latter metabolite is eliminated by a high concen-
%
tration of PEP. Both these modifiers may then be said to combine
preferentially with the enzyme in the T state inducing a conformational
change to the catalytic R state. Reduction of the pll to a value less
%
than 7«0> eliminates the activating potential of FDP, and transforms
%
the sigmoidal PEP kinetics to a Michaelis-Menten type hyperbola. Hence
#
this treatment of the enzyme also favours the R state.
9
%
The effects of ATP mirror these'transformation as follows. At
acid pH values, ATP interacts cooperatively with L type PK, even at
4
low concentrations of PEP. At pH 7»5s however, the ATP inhibition
t
curve is hyperbolic, unless FDP is present, or a high concentration of
PEP is used. Thus the effects of pH change coincide with the. modifier
%
effects of FDP and ATP as follows:
* •
ATP OH""
The assumptions inherent in this model, l) that two intsrcon-
i
4
vertible forms of the enzyme exist and 2) that the nature of the
substrate saturation curve reflects, in the presence or absence of
% '
»
modifying agents, changes in the distribution of these forms, are in
this case probably justified. Recent work by Llorente et al., (1970)
indicates that L type FK may be desensitised to FDP activation, ATP
»
inhibition, and PEP homotropic cooperativity, by cold preincubation.
This marked desensitisation strongly supports the view that this PK
is typical of the allosteric enz3nr.es, and in this respect the enzymes
[& Suelterl t •
from rabbit (Kayne"] .j/', 1968) and Alaskan king crab muscles (Somero,
1969) have also been shown to undergo a temperature dependent configur-
>
ation transition. Unfortunately, as previously stated, the rabbit
muscle enzyme portrays no allosteric properties with reference to PEP
and FDP, having a hyperbolic response to PEP concentration, and being
virtually unaffected by FDP (Taylor & Bailey, 1967) • In these respect,
assuming that these non-regulatory properties are not artefacts of
• '
purification, the rabbit muscle enzyme resembles the PK,, state of theft
equilibrium postulated for the L type enzyme. If one accepts the
evidence of Wood (19°8) that muscle FK is ATP insensitive, this enzyme
behaves as a "fixed" type of the PKR mentioned above.
This simple model however does not account for all the data
presented to date, especially that of Bailey et al., (1968) who invest!
gated the extremely complex kinetic changes occurring on preincubation
J
of the liver L type enzyme. Without preincubation, the atypical shape
of the activity/substrate-concentration curve necessitated the postulate
that the enzyme as prepared consisted of a mixture of two PK's, named
I.A and Lg. ltype is akin to the M.type enzyme in exhibiting a
Michaelis-Menten hyperbolic response to substrate concentration and in
36
being insensitive to FDP. This form is converted into Lg on prein-
o
cubation at 25 C, producing a conformation which shows a cooperative
response to PEP and is FDP sensitive. The effect, noted by Carminatti
et al., (1968), that FDP effectiveness is markedly enhanced by
preincubation at 37 C, confirms these observations Although Bailey
et al., (1968) present some evidence to show that their is not
r
identical with the M type enzyme of Tanaka et al., (1965), they ignore
i
the possible mixture of types Lg (nomenclature of Tanaka et al.,
1967) which their abbreviated purification procedure may produce. Iso¬
enzymes Lg and were named purely on the bases of their neutralisation
with anti-L antibody and their insensitivity to anti-M antibody. The
9
rigorous purification procedure of Tanaka et al., (1967) produced a
crystalline, ultracentrifugally pure type PK. No kinetic analyses
have been reported on types Lg and L^; one of these isoenzymes
conceivable obtain to hyperbolic kinetics, and could be identical with
the enzyme of Bailey jet al.
The potentiation of sigmoidicity FDP
sensitivity, on preincubation at 25 C is thus the reverse of the cold
desensitisation observed by Llorente et al. (1970), and the temperature
dependent conversion appears to be repeatable many times.
Two potential amended models may now be built for the liver L type
PK.


















At present, insufficient evidence is available to decide whether
the temperature sensitivity is a property of the previously described
W
4
R-T equilibrium, or whether the preincubation at low temperatures shifts
configura
enzyme

















Fig. 2. The derivation of T.brucei TREU 277.
The rodent hosts used for passage are as indicated
The number of passages is unknown.
1) BIOLOGICAL METHODS
0
Strain maintenance and characteristics.
In the course of this work, several strains of T.rhodesiense and
4
T.brucei were used, the strains varying in their degree of pleomorphism,
9 ft
and in their history, as follows.
v
#




in 1923 from an infected human patient, and has been maintained subse-
0
quently by syringe-passage in rodent hosts. This strain is completely
%
4
monomorphic, producing a rapidly fulminating infection in rats, which
*
results in the death of the host animals 3-4 day3 after inoculation.
4
T.brucei TREU 277 strain (Trypanosomiasis Research, Edinburgh
*
•
University) originally showed a pleomorphic type of infection, with the
« • »
second peak of the relapsing parasitaemia resulting in death of the
o
host 9-12 days after infection. On storage at -70 C this strain lost
d
%
its pleomorphic character over a period of 1-2 years and new yields an
4
W
infective pattern similar to that of the "L" strain. Figure 2. shows
|
the derivation of TREU 277 and the following two strains, since the
original isolation of the organisms. The number of passages to which
4
these strains have been subjected is uncertain.
In the search for a truly pleomorphic strain of trypanosome TREU 55
9
and TREU 87 T.brucei strains were investigated, to determine whether ,
4
\
they .would produce a higher yield of short stumpy forms than the TREU 277
strain. Despite the fact that TREU 55 and TREU 87 had been subjected
to fewer passages than the final TREU 277 strain, neither of these
0
infections possessed an increased pleomorphic character.
EATRO 165a (East African Trypanosomiasis Research Organisation)
9
is a strain of T.rhodesiense whose history since isolation is again
































Figure3.Threlationshipbetw entl^Lghtofparasitaemia compositionfT.rhodesie seEATRO173.Dailytail-bloodmears
andthepleomorphic weretakenfromth
ratandstainedwi hLeishmanstai .T ehe ghtof(SS)formswereestimatedade crib dinthxt.
theparasitaemiandt%th ck
sf
undergoing a slow change in character on storage at -70°C. After a
*
period of approximately 5 months, the yields of SS type organisms at
any stage of the parasitaemia had markedly decreased, and the infection
I 0
became gradually more virulent in character* When first obtained,
0
death of the host occurred after about 13-18 days on the third peak of
4
the parasitaemia. After storage for 5 months, more than two phases
A
of the relapsing infection were rarely obtained and some rats succumbed
i
on the first parasitaemic peak after only ^-6 days. However, in the
early stages of storage, this strain was used for some of the metabolic











This strain was isolated from a human patient in 1962. Unfort¬
unately no record exists of its subsequent history, but it is known
that it has been maintained in the frozen state for the majority of
4




This strain showed a satisfactory pleomorphism and has been used
0
throughout the majority of this work. The infection is still of a
relapsing nature, although some of the biochemical properties, e.g.
4
the RQ values, have altered slightly since these studies were initiated.
The percentage of short stumpy forms present at the various stages of
the parasitaemia is now rather lower than the yields obtained originally
•
•
but infections of ; 10-80% SS forms are still obtainable.
i
Characteristics of T.rhodesiense EATRO 173 and identification of SS form
0
The levels of parasitaemia and the percentage of the trypanosomes
in the SS form at different times after infection are shown in Figure '.'3
Parasitaemias were estimated from microscopic inspection of a wet blood
film obtained from the tail of a rat, using the following system:
Plate 1. The morphological appearance of the SS and LS forms of
T. rhodesiense EATRO 173.
Stained blood smears taken from the relapse (above) and the
remission (below) phases of the parasitaemia. L - 3ong slender (LS)

















0 s No trypanosomes visible in 20 fields.
ft
- s 1 trypanosorae every 3-4 fields or fewer.
ft
+ s Approx. 1 trypanosome per field.
ft
-H- s 9-1° trypanosoraes per field? easily countable.
+++• s Difficult to estimate the trypanosome count/field.
t
s Very heavy infection only obtained in the 6-12 hour
period prior to death.
» •
ft
The SS to IB ratio of the trypanosomal forms was again estimated
* i
by microscopic inspection, but in this case a dried blood smear, stained,




SS form under these conditions were ; lack of a free flagellum, greatly
increased width through the nucleus and slightly reduced length. Some
I
organisms inevitably did not fit all these requirements and the deciding
factor for classification as SS or LS in these case3 was taken as the
. - »
• « •
absence or presence of a free flagellum.
ft
This subjective estimation of the forms of the trypanosorae present
*
ft
in a stained smear, was checked on representative samples such as those
ft
ft
shown in Figure 4. These data show the measured width through the
• ^




flagellum. It appears, then, that at different stages of the infection
a preponderance of the SS or 15 forms is: found. The correlation of
ft
these measurements with the visual, estimation of the percentage of short
ft
W ft
stumpy forms present in a blood smear, showed that the two methods gave
comparable results (Fig.5). As a routine method, the simple microscopic
examination and subjective estimation on a stained smear was utilised
to gauge the type of infection present in. the experimental animals.
ft
Photographs of two stained samples, pertaining to different stages of
0
the infection, may be seen in Plate 1.
ft
From seven days after infection, tail blood smears from batches of
ft













7 9 II 13 15 17
Days after Infection.
9
Comparison of subjective and objective
technigues in defining the pleomorphic composition of a
A
trypanosome population. Daily tail-blood smears were
taken from an infected rat after the onset of the
parasitaemia. The nuclear width of 200 organisms per diem
was measured on stained smears and those cells having a width
of greater than 1.8|i were classified as SS. Visual estimation
of the composition of the samples was carried out on unstained




of a reasonably high parasitaemia with a high percentage of the SS
%
forms were utilised for experimentation.
0 9
Staining method.
A drop of infected blood was taken from the tail of the rat onto a
ft
♦
microscope slide, spread into a thin film, and stained with Leishmans
0
stain (predissolved, BDH Chemicals, Ltd., Poole). Stained smears were
0
stable for at least a week before the stain faded and the slide became
4
unusable. Where a permanent record of the infection was required, to
facilitate measurement at a later date the smears were mounted in neutral
XAM obtained from G. Gurrs Ltd. London.
*
A variation of the Romanowsky type eosin-methylene blue stains,
t
namely Giemsa's stain, was tried in an attempt to produce a clearer




However, Leishman's stain gave the most consistent results and was adhered
%











The monomorphic strains were maintained by continual syring/ passage.
Infected tail blood from a parasitized animal was diluted with three
times the volume of citrated saline (0.9$ w/v) NaCl containing 1.5$ O'/v)
0
sodium citrate) and 0.5 ml was inoculated intraperitoneally into fresh
0
« *
rats. No restriction was placed on the number of trypanosomes used
to infect a host animal in this way, as variation of the infective dose
was found only to alter the time of death within the range 3-5 days.
Wistar strain white rats w©re used as host animals throughout this work.
9
No attempt v/as made to restrict the host animals to a certain weight







Syringe-passage could obviously not be used to maintain the pleo-
4
raorphic strains of T.rhodesiense, as this treatment is known to lead
6
4
to loss of pleomorphism (Pairbairn & Culwick, 1947? Asheroft, tl957j).
The strains were originally obtained in the form of infected mice or
rats and the following method was found to be suitable for the mainten¬
ance of the pleomorphic forms in the frozen state.
Three mice were infected with the organism, and the parasites allowed
*
to increase for 3 days. At this time, the parasitaemia was too low to
*
be detected microscopically. The blood from these animals was used to
infect a batch of six mice, which were then checked daily until the
4
blood count was of the order of + to ++ on the first peak of parasitaemia.
4
(This process of "blind passage" had the effect of minimising the
4
circulating antibody level of the blood at the time of storage, as the
*
presence of high levels of anti-trypanosome antibody was thought to
ft
damage the organisms on prolonged storage). At this stage, the infected
0
4
mouse blood was collected from the cavernous venous sinus, followed by.
*
cardiac puncture, and taken into heparinised Krebs saline (5 l.U.
#
4
heparin/ml). The pooled infected blood was made 7.5$ (V/v) with
*
9
glycerol, thoroughly mixed and dispensed into glass capillaries, ID
approximately 1 mm., and approximately 10 cms in length. Thus about
0.05 ml of infected blood was contained in each capillary. The ends
4
of the glass capillaries were sealed in a flame and the capillaries
immersed in ice-cold methanol. The ampoules were slowly cooled to
f
-70°C in solid carbon dioxide, the process being slowed by the packing
of the capillaries in polystyrene to increase the time required for
complete cooling. After two days, the ampoules were removed from the




batch of rats, the contents of two such ampoules were diluted in 4 ml
4










The regression of strains TREU 277 and EATRO 165a is thought to
have been caused by the use of rat blood for storage, as opposed to
mouse blood. Other workers, however, have reported that rat blood
I
may be used with impunity in this respect (Evans D. personal communi¬
cation). No other explanation for the loss of pleomorphism by these
strains has been found.
Preparation of parasites free from blood elements.
The first requirement for this work v?as the production of a method
which completely eliminated erythrocytes, leucocytes and thrombocytes
from the trypanosome preparations. The methods available in the
*
literature v/ere in most cases unreliable, as since the work, of Dixon
(1966) any method of purification'which yields trypanosoraes having
lactate dehydrogenase activity, must be suspect. The following
ft
ft
procedure was, however, found to give reasonable yields of apparently




assumed to be free of blood cell contamination.
• ft
Infected blood was withdrawn from the rat by cardiac puncture and
ft
diluted with citrate-saline containing 200 mg$ (W/v) glucose at 10 ml
per ml of blood. CaC^ (lml 0.2M) was added for each 10 ml of citrated
blood, with continuous shaking in the presence of glass beads, and the
shaking continued until the fibrin clot had separated. After filtration
ft
ft
through glass wool the blood was centrifuged for 10 minutes at lOOOg
and the trypanosome layer removed and resuspended in Krebs-saline
glucose (vide infra). Rabbit anti-rat erythrocyte serum, was added
(l drop per 10 ml) and the infected'saline allowed to stand for 10 minutes
J
I
at room temperature. The agglutinated red cells were packed by a brief
(10 second) spin at lOOOg and the trypanosome containing supernatant
f





the leucocyte contaminants by filtration of the material through a no,3
%
9
sintered glass funnel previously roughened by immersion in a 1:1 (v/v)
%
mixture of HHO^ and ethanol. (This process made the sintered disc much
more effective in the removal of the white cells.) A further centri-
fugation at lOOOg for 10 min. usually showed a few contaminating red
cells in the preparation. By sacrificing the lowest layers of the
packed trypanosome mass, completely pure organisms could be collected.
9
Resuspension was normally finally in Krebs saline-glucose unless glucose
*
free organisms were required, when Krebs saline itself was used. In
♦
this latter case, the organisms were viable if kept in ice for no














Per the metabolic studies the trypanosomes were washed twice in




packed cells and homogenised by hand with an ice cold teflon pestle in
o
a glass homogeniser at 0 C. This material was used directly and will
be referred to as the standard water lysed preparation. Several other
►
methods of lysis were used for investigation of trypanosomai suecin-
1




Attempted separation of SS and LS forms of pleomorphic T. rhodesienso.
Ideally a sepax*aticn technique yielding a 100$ SS form trypanosome
9
suspension was required, and to this end much effort was expended in
attempts to separate the bloodstream forms of the organism by use of
density gradient centrifugation. Step, linear, and exponential
gradients of sucrose and of Fieoll (a synthetic sucrose polymer,
*
Pharmacia Ltd.,) in Krebs saline glucose were employed with no success
ft
in the separation of the LS and SS trypanosomes.
ft
Trypanosomes could readily be separated from erythrocytes and
ft
leucocytes, (on e.g. a three-step sucrose gradient of 9$, 13$ and 15$
(V? y i Q »/v) sucrose, after eight minutes centrifugation at 400g, and 2 C),
but the thrombocytes were found to have an identical density to the
0
trypanosomes. In the gradient described above, the trypanosomes and
ft
I
platelets are retained in the 9$ sucrose hand, the erythrocytes in the
ft
13$ sucrose band, and the leucocytes distributed between the 13$ and
15$ sucrose band.




abandoned, and whole trypan©some preparations used as the source of
f
material. For the metabolic studies detailed in this work, preparations
0
which had a SS s LS cell ratio of 75$ plus were routinely used. It
*
ft
may be seen from Figure 3 that parasitaemias having a SS cell count of
» ft
« ft
greater than 80$ were rarely obtained, although figures as high as 92$ •
ft




three rats was routinely used per diem,the final trypanosome preparation
v/as never higher than 84$ SS nor lower than 78$ SS, unless a "thin"
9
4
preparation was especially required. For this reason, no attempt was
ft
made to adjust the metabolic figures obtained to account for the minimal
variation in SS-LS cell ratios. Where metabolic differences between
ft
the morphological types became apparent (e.g. in the oxidation of cC-OG),
these differences have been correlated with the percentage of thick forms
present in the material.





A rabbit was subjected to a course of six injections over a period
• ft
ft ft
of three weeks, each dose consisting of 2 ml of a 50% ( /v) suspension
ft
of washed rat erythrocytes in Krebs saline. The injections were given
ft
via a marginal ear vein and when a sample of the animals' serum obtained
4
from the same source showed an adequate antibody titre to normal rat
ft
ft





The blood was allowed to clot at room temperature for 5 hours and
I
the retracted clot removed by centrifugation. The clear serum was
ft
o
dispensed in approximately 2 ml aliquots and stored at +2 C, The
9
activity of this stabilate was not markedly decreased over the longest












Oxygen utilisation and carbon dioxide evolution were measured in
ft
♦ ft
a conventional Warburg apparatus at 37°C with air as the gas phase.
t
9
The fluid volume was in all cases 3.0 ml with 0.1 ml of 40!$ (W/v) KOH
ft
ft
or 0.1 ml of Krebs saline in the centre wells of the flasks, absorbed
ft




was carried out for 10 minutes prior to the start of the experiments,
ft
and the measurements were terminated by the addition of 0.5 ml 0.33
M-PCA from the side arm. Single side arm flasks were used unless
ft
otherwise stated in the text. For the investigation of the effect of
• •
cyanide, centre well mixtures of KOH and KCN and reaction concentrations
of cyanide were calculated according to the method of Robbie (1946).
>
ft
The flasks were continually mixed by agitation at 110 rpm through an
arc of 26 degrees.
TABLE 1
Effect of supplementation on oxygen utilisation by lyssd cells
Standard water-lysed preparations (approx. 1.0 tag N) of
T.rhodesiense EATRO 173 were suspended in 1.0 ral saline with the
4
constituents as shown below in a final volume of 3.0 ml. Oxygen
uptakes were measured manometrically over a period of 30 minutes in
t
the presence of 25/umoles glucose. Utilisations expressed on the












As 1 + ATP (5yumol)
As 2 + EDTA l( 3 yumol) ,,
As 3 + BSA (10 mg)
As 4 + llg2nf (20yarao1)
As 5 + K+ (200yuniol)
(5yumol)
(5yumol)
As 6 + ADP
As 7 + NAD













Careful washing of the organisms in glucose free saline ensured
ft
that no endogenous gas exchange occurred, and occasional checks on the
lack s.substrate were
carried out.
Experiments using whole organisms necessitated the solution of all
substrates and inhibitors in isotonic saline to avoid cell rupture.
The use of the standard water-lysed preparation led to problems of
fortification to correct for the dilution of coenzymes and intracellular
salts occurring on lysis. The minimal supplementation used was .based
on preliminary tests, some of the results of which are shown in Table 1.
Nicotinamide is included to inhibit the activity of NADase, and the two
cations are known to be specific requirements for glycolytic kinases.
ft
Bovine serum albumin (BSA) stabilises the L.<*GP oxidase system (Grant
& Sargent i960) and markedly increases the time over which the oxygen
utilisation rate is linear. Ethylene diamine tetracetate (EDTA),
presumably acting in its normal role as a trace metal chelating agent,
had a similar effect to BSA. The
ft
concentrations of the supplements. For all subsequent experiments
using the standard water-lysed material, the following buffer system was




KC1 0.05 M )
)
MgSC. 0.1 M < .
Nicotinamide 8xlO~3 k titrated to PH 7.4
EDTA 10-3 M ] with 0.1 IHffil-
BSA " 10 mg ml""1 )
Na„HP0. 0.02 M )2nrvj^ Jlfl )
48
Where ADP and NAD were added as supplementation, 5yumole of each
♦ ' »
♦ •
coenzyme was added to each flask.. Throughout the text, the combination
+
of the standard Warburg buffer and ADP + NAD will be referred to as
s
minimally fortified medium (MFM).
* ft
For the estimation of the very low succinoxidase activity, and the
further
acid oxidases, a polarographic system was used. Oxygen uptake was
°C with a Clark oxygen iV.
The electrode was fitted to a perspex reaction vessel of 3 ml capacity,
equipped with a thermostatically regulated v/ater-jacket and connected
to a Servoscribe Model RE5H graphic recorder. Ten minutes were
allowed for temperature equilibration, and the reactions started by
ft




At the end of the period of incubation in the Warburg apparatus, the
ft
ft
reactions were terminated by addition of 0.5 ml of 0,33 M-PCA from the
ft
%
flask side-arm. Absorption of gaseous COg by the centre-well KOH was
ft
complete 20 minutes after acidification, at which time the gas exchange
was centrifug
utes at 2000g, and the supernatants were separated. A part (2,5 ml) of
4
#
the supernatants was neutralised by addition of 0.6 H-KgHPO^, and the
o *
neutralised fractions were stored at +2 C for at least six hours to
*
precipitate the perchlorate as the potassium salt. After centrifugal
ft
removal of the precipitate, aliquots of the supernatants were used for
the determination of intermediary metabolites. For- studies on carbon
%
balances from glucose, pyruvate or oc -0G, sample flasks were treated
• in an identical fashion, with the addition of perchloric acid from
»
t
the side-arms immediately after the closure of the taps at the start
P
of the experiments. The analyses from these flasks were used as "To"
samples, to enable the definition of substrate utilisation and product













Glucose was determined by use of commercially produced "Glucostat"
kits (Worthington Biochemical Corporation, Freehold, New J.) in which
the hydrogen peroxide produced by glucose oxidase action is used to
9
oxidise a colourless chromogen to a coloured product as followss
glucose








The colour absorbing at 400 nra is stable for at least two hours if
the enzymic reaction is terminated with 4M-HC1, Standard glucose
solutions were taken through the deproteinisation procedure prior to use
as standards for the assay. As the glucose oxidase is specific for
-D-glucose, freshly prepared standard solutions were allowed to stand
for several hours before use, to allow the mutarotation process to reach
£
equilibrium. Standard curves obtained were linear up to 200^ig glucose/
9
assay; by inspection of the oxygen uptakes obtained manometrically, a
■
ro\*gh estimate of the glucose utilisations could be formed, and the
|
aliquots of the deproteinates chosen to contain from 50-150yug glucose.
All estimates were carried out in duplicate.
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ii. Pyruvate and phosphoenolpyruvate
+
Deproteinised samples (50yul) were incubated in 0.2 M-K phosphate
pH 7.0 (2.0 ml) with 0.45 yuraole NADH in a total volume of 2.98 ml^
0
After measurement of the extinction at 340 nm, 20yul lactate dehydro-
» «
genase (approx. 50 I.U.) were added and the reaction mixtures left for
0
30 minutes at room temperature. The pyruvate concentrations in the
experimental aliquots could then be calculated from the decrease in
using
3
for NADH. Blank estimations containing no LDH were used to correct for
autoxidation of the reduced coenzyme.
Phosphoenolpyruvate
final pyruvate estimation solutions, of 20yul of a solution containing
20 yuraoles MgSO^, 5 I.U. of rabbit muscle pyruvate kinase, and 2yumole
ADP.
The reactions occurring:
PEP + ADP — t> Pyruvate +' ATP
.+
Pyruvate + NADH + H Lactate + NAD
f
enable the PEP concentration to' be obtained from the further decrease
in absorbance at 340 nm after correction for the dilution factor.
iii. Acetate.
utilising
sulphanilaraide acetylating enzyme of pigeon.liver. In the range 0.025
4
to 0.20 yumole of acetate, a linear response is obtained to the concen-
tration of acetate present, measured as a disappearance of free sulphan
0
ilamide. Estimations were carried out in duplicate, and each run
contained four standard acetate solutions, from 0.03 - 0.20 /umole
W






The determination of succinate was carried out enzymically, using
the succinoxidase of rat liver mitochondria to reduce ferricyanide
(Singer ot al. , [3.962]). Mitochondria were prepared by the method of
Weinbach (1961).
V/ith the low concentrations of succinate produced in the Warburg
flasks, direct estimations of the reduction of ferricyanide at 410 nm
gave very low spectrophotometry values and hence a low accuracy. A
.
much higher accuracy was obtained by estimation of the ferrocyand.de
produced, by coupling to a ferric salt to give ferric ferrocyanide
(Prussian blue) and estimating this compound at 620 nm.
4
After incubation of the samples with washed mitochondria (0.1 ml
containign 5-10 mg protein) for 40 minutes in the presence of fsrri-
cyanide (0.2 ml, 0.01 M), 5*0 ml of ferric reagent (vide infra) were
4
added and the mixture allowed to stand at room temperature. Approxi-
mately 2-3 hours were required for full development of the blue
colour, but linearity of colour versus succinate concentration is
obtained after 15 minutes. Ferric reagent was prepared as follows:
*
t |
Recrystallised ferric nitrate (5 gm) was dissolved in 500 ml of double
distilled water, mixed thoroughly with 75 ml of "Analar" orthophosphoric
acid and diluted to one litre. This reagent normally required filtrat-
>




As with all other analytical procedures estimations were carried out in
duplicate, and standard succinate samples were taken through the
• ♦




The standard reaction mixture for the spectrophotometry estimation
i
%
of glycerol v/as made up as follows, in a final volume of 2.0 ml:
52





















mately 0.1yumole glycerol was added, and the system allowed to come to
equilibrium At this point,, most or all of the pyruvate present in
the sample will have been converted to lactate with the concomitant
utilisation of NADH. Simultaneously any ADP contaminating the ATP,
*
or present in the sample will have been phcsphorylated at the expense




ole NADH, until the extinction at 340 nm was stable
at between 0,8 and 0.9, and the volume of the assay mixture then diluted
tb 2.95 ml* This dilution decreased the measured extinction at 340 ni
%
to approximately 0.8 units. Addition at this, point of $0of glycero
kinase (5 I. units) resulted in the following reactions:
Glycerol + ATP Glycerophosphate + ADP
ADP + PEP ATP
9
Pyruvate
Pyruvat e + NADH Lactate + NAD




correction for the dilution factor, enabled the concentration of glycerol
present in the sample to be estimated.
53
vi, oC -oxogiutarate
Total keto-acicls were estimated in the deproteinised samples by
#
the method of Friedemann and Haugen (1943), utilising the extinction
band at 500 nm of the 2,4 dinitrophenylhydrazone. The concentration
♦
*
of ot-OG in a sample is estimable by subtraction of the pyruvate
estimate from the total iceto-acid figure
Samples (lOOyul) were warmed for 10 minutes at 25°C, mixed with
hydrazine reagent (1,0 ml; see below) and allowed to stand for 5 minutes
prior to addition of 2.5 K-NaOH. Ten minutes after addition of the
alkali, the extinction at 500 nm was measured. Standard curves were
prepared both with «*-0G and with oC-OG/pyruvate mi.xtu.res.
Hydrazine reagent
2,4 dinitrophenylhydrazine (100 mg) is ground in a mortar with
small volumes of 2N-HC1 and made up to 100 ml in this reagent. This
o
solution was filtered and stored at +2 C.
vii. Citrate
Citrate was estimated by the spectrophotoraetric estimation of NADPII
%
formation in the presence of aconitase and iso-citrate dehydrogenase.
(Siebert, 19^5)•
viii. Hexose monophosphate.
Glucose- 6-phosphate and fructose-6 -phosphate were estimated by
9
NADPII





Estimation of haem pigments.
♦ *
S pect rophot oraetric estimation of cytochromes was carried out on a
Unicarn SP 800 recording spectrophotometer in 1 cm path length quartz
g






spectrophotometer to either a .Servoscribe R.E. 512. potentiometric slave
%
recorder, or to a Unicam SP 20 recorder. At the maximum range of
t
I
scale expansion (x20) a scale width of 0 - 0.1 extinction units is
t «
4
obtained on this instrumentation.
The more sensitive chemical estimation involving the production
A
9
and estimation of pyridine haemochromes was carried out essentially by
«




















■ Reagents A 2$ (W/v) NagCO^ in 0.1 N-NaOH
B 0.5$ (W/v) CuS04. 5H20
C 1.0$ (W/v) Sodium citrate
D . Folin-Ciocalteau reagent (BDH biocheaicals)
0
4
diluted 1 : 1 with water.
* •
Reagents A, B and C are mixed in the ratio 100 : 1 s 1 by volume,
to produce reagent E. The sample (l.O ml, approx. 0 - 250yugm protein)
is added to reagent E (5.0 ml), thoroughly mixed, and allowed to stand
4 0
at room temperature for 10 minutes. Reagent I) (0.5 ml) is added, the
mixture is thoroughly agitated, and after a further 30 minutes at room
4







The concentration of protein is estimated by comparison with a
|
4
standard curve of extinction at 660 run versus yug
standard solution of BSA, This standard graph is linear
250/ug protein/
nra
is that of Warburg and Christian (1942).
Estimation of total nitrogen.
0
Lyophilised trypanosomes (approx. 20 mg) were digested in a
0
:Kjeldahl flask with catalyst (25O mg, CuSO^ / Na^SeO^) and conc. HgSO^
(2.0 ml). After digestion, the flask contents were diluted to 20.0 ml
and 4.0 ml aliquots were steam-distilled on a Markkam still into 5 ml
ethanolic 1$ C/v) boric acid / mixed indicator (vide infra). The
%
NHj content was determined by back titration with standardised approx.
0.01 M-HC1. Ammonium sulphate solutions of known strength were used
to calibrate the standard acid.
Mixed indicator.
Methyl red (70 mg) and bromocresol green (40 nig) were dissolved
in 50 ml ethanol, and 3 drops of this indicator were used per assay.
Krebs-Binger Phosphate Saline (Krebs saline).
This isotonic saline has the following constituents!




1.15$(w/v) KC1 4 parts
0.1-M-phosphate (Na+) buffer 20 parts
pH 7.4
3.82/, C/v) MgS04. -7H20 1 part
56
Where Krebs saline glucose is referred to in the text, glucose
issolved in this saline to a final concentration of 2 rag/ml.
Estimation of protein
*
The method of Ellman (1959) was used as follows. An aliquot
(.02 ml) of Ellmans reagent (39.6 mg 5*5 dithio bis - (2 rdtrobensoic
fc
acid) in 10 ml 0.05 M-KgHPO^ pH 7»0) was added to a mixture of 0.05
M-K^HPO, pH 8.0 (0.6 ml), resuspended lyophilised trypanosomes (0.5 ml
c. 4
3 mg /ml), various concentrations of melarsen oxide, and water, in a









after correction for the blank solutions, this absorbance was taken as
proportional to the thiol concentration in solution.
9
Estimation of inorganic phosphate
Inorganic phosphate was estimated by the method of Bartlett (1959)
57
Chemicals.
Ail chemicals used were of the highest available purity, and were
purchased from the following suppliers.
V
LDH GDP NADH Coenzyme A MDH
ADP UDP FDP od-oxoglutarate PK (Rabbit muscle)
ATP CDP F6P Glutathione G6PDH
PEP HADH G6P ICDH Hexose isomerase
Malic acid Pyruvic acid Aspartic acid Citric acid
Boeringer & Sohne (London) Ltd., London W.5. U.K.
#
Dithlothreitol ; Koch Light Laboratories, Colnbrook, Bucks,
England.
DL- c4-glycerophosphate s Sigma Chemical Company
DL-isocitric acid, tri.30dium salt )
L-proline,










The trivalent and pentavalent. arsenicals used in this work were a gift
from May & Baker Ltd., and this gift is gratefully acknowledged.






Preparation of the arsenicals for use.
0
0
Both melarsen oxide and phenylarsenoxide are insoluble in water.
The standard preparative method employed with these drugs was to
%
dissolve them in 40$ (W/v) KOH soln., dilute to approximately the
required volume with water, and titrate to the required pH with
5N - HC1 immediately. If these compounds are allowed to stand in
alkaline (pE ^ 9»0) solution for longer than ten minutes, a clouds'
solution is obtained on back-titration to neutral pH values. This
may be due to the relative instability of the S-triazine ring in strong
0
alkali.
Immediate titration produces clear solutions, but after approxi-




reason, no solution older than two hours was used for any purpose.
0 •
0
Assay method for pyruvate kinase.
*
Assay of PE activity is usually carried out by estimation of the
rate of production of pyruvate. Two methods are available for this
✓
estimation, a sampling technique in which the pyruvate is measured
. chemically by estimation of the 2.4 dinitrophenylhydrazone(Kachmar et al.,
1953) and an enzymic technique. The latter method, based on the
decrease in the 340 nm absorbance of NADH, depends on the coupling of
%
the pyruvate to lactate dehydrogenase producing lactate at the expense
0
of NADH (Bucher & Pfleiderer, 1962). This assay has the advantage of
0
r
continuously removing pyruvate, eliminating any possible product inter-
ference with the enzyme activity. .
0




product formation. The PEP remaining in the assay mixture may be
• *
cleaved to produce inorganic orthophosphate, by mercuric salts or












entails sampling and cannot be used for continuous monitoring of
activity. In 1967, Pon & Bondar suggested that the VK reaction may be
0
followed directly by recording the change in optical density of the




a direct, sensitive and continuous assay method. Unfortunately, it
has two disadvantages. Firstly, pyruvate is not removed from the
system and may interfere to produce non-linear rates. And secondly,
standard
wavelength, especially in the presence of high concentrations of protein
which necessitateslln many cases a base line shift due to the protein
absorbing strong]y in this range
FK
of- continuity and removal of product, was carried out by the compound
.. t( 1962)


















light path) and pre-equilibrated in the spectrophotometer for ^ 3 minutes
at 25 C. The nodel S.P. 800, fitted
with a scale expansion unit and coupled to a slave recorder, Servoscribe
model RE.211. Earlier experiments were made on the Unicam spectrophoto-
ng
|
read-out slave recorder, and in this case, reading;





speed of 600 mm hr ' were used unless otherwise stated. The cell
ft
compartment in the SP 800 was maintained at 25°C - 0,6°C by means of a
9
circulating water bath and pump. The reaction was started by additio:
4
of enzyme* again unless otherwise stated* and initial velocities were
estimated bv tangential measurement to the recorded curve with crude
enzyme, or by the gradient of the rate line using purified preparations.
The variation in cation and coenzyme requirements between PK's of
vai'ious tissues and species necessitated the investigation of the special
trypanosomal enzyme. The
.+ _ _ 2+
ADP
found in Chapter 5. Theoretically, ^saturating concentrations of all
reactants should have been used for assay of the enzyme, but to avoid
9
wastage of ADP and PEP, the following assay system was utilised for
routine analysis
Reagent. Volume. Final Concentration
4
1.0 ml - • 33.3 mM
0,1 ml 6.67 mM
0.1 ml 66.7 mM
0.1 ml 1.33 mM
9
9
0.05 ml 5 I.U.
0.0125 M ADP • 0.1 ml 0.41 mM























kinetics may "be described by the two constants Vma-x- and Km. However,
any enzymes are now known to show a sigmoid response of initial
velocity to increasing substrate' concentration and in these cases two
parameters are inadequate to describe the enzyme reaction.- The substrate
concentration required to produce an initial velocity equal to gVmax in
'
such a system will therefore be designated S50 in accordance with the
suggestion of Koshland (l966). This parameter will have the dimensions
of a Km value but will be a function of more than one equilibria
1
»
constant. The Vmax in a sigmoid system retains its usual significance
and the third parameter "n" (see below) defines the degree of
sigmoidicity of the initial velocity versus substrate concentration plot.
An obvious extension of this nomenclature is the use in this work
of the terms A^q, to designate the concentration of a modifying compound
required to give half maximal activation and 1^ denoting the concen-
tration of inhibitor giving 50% inhibition under a given set of experi-
nental conditions.
Treatment of kinetic data
v
In all cases, kinetic data were converted to a linear form prior
to analysis. Where the reaction order with respect to a substrate or






has been used to determine the kinetic constants,
the assumptions of Hill (1913) that in the reaction
This plot, based on
E + nA EA
n
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product) step is rate-limiting is based on the kinetic equation
v 1
K\nV 1 + (T)max SA'
Obviously, as a log/log plot, the Hill plot will be relatively insens-
«




of v. However, more rigid analysis on the model of Monod et al., (19^5)
in terms of L (the conformational equilibrium constant) and c (the
$




in the present case. Interpretation of kinetic data in terms of these
4
descriptive parameters relies heavily on the regions of activity 'where
10* * of the maximum
g
et al., 1966). At present, the properties of trypanosome PK in the
purified state make analysis in these regions comparatively unreliable.
0




Hill plot, and the three parameters V , Sc_ and n have been used toe ' max 50
describe the enzyme. Estimates of V were obtained from double^
max
9
reciprocal plots and used to calculate the ordinate values in the plot
V
of log V -v vs log (s). The values are taken as the interceptsin yU
of these plots on the abscissa, and the slopes at this point are^taken as
the values of n. This analysis does not therefore allow any quantit-
# 0
ative significance to be attached to the value of the "interaction
coefficient" in terms of the number of substrate binding sites. ■ Values
of n > 1.0 have therefore been taken only as indicative of the existence
of multiple PEP-binding sites whose degree of interaction and co-operat-
*
ivity is dependent upon the presence or absence of a modifier (FDP),
*
and no quantitation of these interactions has been attempted.
63
All linear dat.a were subjected to regression analysis, -the
gradient and intercepts being obtained with an Olivetti desk computer
4
model "Programma-101." My thanks are due to Dr. I.A, Nimmo of the
4




EXPERIMENTAL AND RESULTS -
METABOLIC STUDIES
1.) METABOLITE UTILISATION BY T.BRUCBI AND T.RBODBSIENSE
Utilisation of extracellular substrates by whole cells
The observation pf Vickerman (1962) that the S3 forms of
T.rhodesiense retain their motility in solutions of of. -oxoglutarate
(oi-OS) whereas the IS forms become immotile, indicated that the pleo-
morphic types differed in their abilities to utilise this substrate as
an energy source. The capacities of a pleomorphic and a monomorphic
W
i
strain to utilise various substrates, are shown in Table 2,■
In the absence of a readily utilisable substrate, the tr3"panosomes
4
rapidly lost their motility and lysed. This sensitivity of the isolated
organisms was noted by Ryley (1962), and casts some doubt on experimental
9
results obtained over a longer incubation period e.g. Grant & Pulton
9
(1957) - 2 hours. The minimal utilisations obtained with all substrates
except glucose, glycerol and U-0G with EATRO 173, and glucose and
P
glycerol with TREU 277> are similarly ascribable to cell lysis prior to
A
utilisation, rather than signifying a capacity of the intact organisms
to metabolise these compounds.
6
*
Inspection of a suspension of the pleomorphic strain supplied with
06-OG as substrate, confirmed the preferential survival of the SS forms,
the LS forms rapidly becoming immotile and disintegrating. The ability
of the pleomorphic strain to oxidase oC-OG and the significant carbon
#
dioxide evolution from the utilisation of glucose or glycerol, are the
outstanding differences between the strains found on this preliminary
survey. Individual estimates of the R.Q. values ranged from O.48 - 0.62
' •
.
for the utilisation of glucose by EATRO 173, and from I.58 - I.69 for
the utilisation of <-0G by the same strain. After storage of the
organisms at -70 C for approx. 2 years, the glucose dependent R.Q.
TABLE 2
gen utilisation by whole cells in.the presence of various substrates
^ 1
Whole cells (approx. 0,2 rng K) were suspended in saline with 20/uvnoles
substrate per flask under the standard manometric conditions described
in Chapter 3. Where oxygen utilisation was at a rate greater than
1.0 Ail/min/mg E", the exchange over, a period of 30 minutes was measui*ed.
t a+m/nvi A«tcAe i mi + ^ ei maH'aa vjawa A«+4i*»»s+A^ Pleomorphic coni'oos*"In fell other cases, initial rates were estimated.
ition of EATRO'173 » 78 -.81$ S3.
T. rhodesiense T.brucei
. f EATRO 173 . TREU 277
V •
ft









(yul / min / mg N) (yul / min/ mg N)
Glucose
t 4 i







0.51 21.3(2 0.1(2) 0.01
ot -Oxoglutarate 8.4(6) 13.9(5) 1.64 0.2(2 0.1(2) -
Succinate 0.5(2) 0.5(2) ft 0.2(2 0.1(2) —
Fumarate
ft








0.4(2) 0.3(2) — 0.2(2 0.1(2) —
Is'o-citrate ■ ■ ♦ 0.3(2) - 0.3(2)
ft
0.2(2 0.1(2) —
Proline 0.4(3) 0.7(2) — 0.2(2 0.1(2) —
Figures in parentheses denote the number o:
analyses, of which the mean value is given
65
decreased to 0.39 - 0.46 measured under identical incubation conditions *
4
This coincided with the gradual deterioration of the pleomorphism of
the EATRO 173 strain, described in Chapter 2.
The
very similar to 'that of the culture form
1962), with the exception that the pleomorphic bloodstream forms cannot
utilise exogenous succinate. The rate of oxygen uptake by the culture
forms utilising succinate is stimulated 6-7 fold by incubation in an
acidic
this substrate by the bloodstream organisms occurred at pH 5*6, and the
• |
glucose supported respiration was markedly decreased, as follows The




























Absolute data not reported«
Although the incubation conditions employed by Ryley differ slightly
9
from those employed in this work, (the figures for the culture forms
9
were obtained at 30°C with a gas phase of COg + air (5 : 95)5 as opposed
to the standard conditions of 37°C and a gas phase of air used for the
bloodstream een that the capacity for succinate
utilisation is not present in the SS forms.
41






" • •« •
Oxygen utilisation by standard water-lysed preparations in the
presence of various substrates
i
P
Standard water-lysed material (approx. 1.0 rag N) was suspended in MPT?
with the substrates as indicated, at 20yumoles/flask. Manometric
details as described in Chapter 3 and Table 2. Where a substrate is
#
»
marked with an asterisk', NADP (5yunoles) was included in the incub¬
ation media. . All values are corrected for control values obtained
in the absence of exogenous substrate. Pleomorphic c.omposition of
*
* ~














i °2 C02 • « °2 co2
»





(yul / rain / rag 3?) (yul / min / mg K)
Glucose
• *
4.49(7) 2.29(7) 0.51 4.91(3)
•
0.4(3) 0.1
<<-0xoglutarat e 2.12(11) 4.18(10) 1.97 0.3 (6) 0.2(4) -
Pyruvate
0
1.67(9) 3.09(7) 1.85 0.3 (6) 0.2(3) 0
L-r ©CrGP. ...
a













0.3 (2) 0.5 (2) - 0.3 (2) 0.2(2)
<
*
Iso-citrate 0.6 (2) 0.5 (2) - 0,3 (2) 0.2(2) -
*
Fumarate 0.2 (2) 0.1 (2) - 0.3 (2) 0.2(2) 9
Aspartate 0.2 (2) 0.1 (2) — 0.3 (2) 0.2(2)
•
Proline 0.6 (2) 0.3 (2) — 0.3 (2) 0.2(2) -
Maiate 0.2 (2) 0.1 (2)
0
0.3 (2) 0.2(2)
* Figures in parentheses denote the number of







Utilisation of metabolites by lysed cell preparations.
0
0
While experiments using whole organisms give some indication of
4
the cellular properties iji vivo, the selective permeability of the
organisms to substrates may obscure the ability of the cells to utilise
the- endogenous ly produced compounds. The standard V7atsr-lysed prepar-
ation was therefore used to investigate the capacity of the organisms
to utilise various energy sources (Table 3).
*
The rate of oxygen uptake by the water-iysed preparation utilising
L-oC-GP is about half the rates obtained by Grant et al., (l96l). However,
♦ •
these authors used a partially purified system, consisting of the resus-
4
0
pended pellet from a repeatedly water-washed lysate, and much nitro-
V
0
.. genous material was presumably lost in the discarded supernatants.









the process of cell lysis. As a lowering of the efficiency of the
system is unavoidable on disrupting' the co-ordinated intracellular
9
0









173, appears to be due to a permeability barrier preventing access of
this metabolite to the pyruvate oxidase system. The development of
this system is confined to the pleomorphic strain in the same manner as
0
• f>
the oC -oxoglutarate oxidase system and the R.Q. values for pyruvate and
t
• •
o£-0G suggest that their catabolism is confined to one step oxidative
*
decarboxylation reactions.





of the tricarboxylic acid cycle intermediates succinate, citrate, iso-
0









Fig. 6. The rate of oxygen utilisation by T. rhodesiense
EATRO 173 as a function of the pleomorphic composition.
Whole cells (approx. 0.2mg N) were suspended in Krebs saline
with 20 pmoles glucose (□) or *-oxoglutarate (El) and incubated
under the standard manometric conditions as described in
Chapter 3. Standard water-lysed preparations (approx. l.Omg N)
were suspended in MFM with 20 pmoles pyruvate (A) and
incubated under the same conditions. The utilisation of
oxygen was measured from 10 to 40 minutes after the start.of
the experiments. All data are corrected for the oxygen uptake
obtained in the absence of exogenous substrate, and each point
represents the mean of three determinations.
I
»
cycle activity under the conditions employed, No R.Q. figures are
• 0
4
given for these substrates as the total gas exchanges are of the order
%
of 3 - 15^/ul over the experimental period. At this level of estimation,
rnanometric measurement is accurate to not more than i lyul, or 6 - 30$.
A small error of reading thus introduces a discrepancy which is large
♦ 4
enough to make a calculated R.Q. meaningless.
Dependence of the substrate utilisation upon the proportions of cell types
The simple motility test indicated the preferential utilisation of
o{~0G by the SS forms of EATRO 173, and this was borne out by manometric
observation, as shown in Figure 6. Organisms were harvested at different
9
0
stages of the parasitaeraia, corresponding to different SS/LS ratios and
the rate of oxygen uptake in the presence of o4-0G or glucose was measured
The utilisation of. o£-0G may be concluded from these data to be a specific
property of the SS forms. When similar experiments were carried out
9
with standard water-lysed preparations, it was found that the presence
b
0




The mechanism of pyruvate and o^-oxoglutarate utilisation by cell lysates.
In an attempt to demonstrate whether the utilisations of pyruvate
and oi-OG are by classical oxidase systems, further supplementation of
9
the MFM was carried out, with the results as shown in Table 4. Standard
0
r
water lysed preparations (approx. 1.0 mg N) were suspended in the media
indicated and the gas exchanges were measured over a period of 30 minutes,
0
after addition of 20 ^umoles pyruvate. None of the cofactors was found
to significantly stimulate utilisation, but this does not preclude the
TABLE 4
Effect of supplementation on gas exchange by standard water-
♦ 4
lysed preparations utilising pyruvate
^ «
ft
Experimental conditions as described in Table 3. Results are corrected
9
for the gas exchange in the absence of exogenous pyruvate, in the
presence of the relevant cofactors. Values are calculated on a basis
standard
xons
Organism: T.rhodesiense EATRO 173. Pleomorphic composition 79-81$ SS.
°2 C02
Cofactor additions uptake evolution
4
i
1) 13FM ,100 100
2) MFM, IJADP (5/umoles),
Coenzyme A, TPP, Lipoic 105 - 3 (5) 101 ~ 3 (5)
acid (reduced), (l/umole
ea,ch) '
3) As 2) + Fe S04 (3yumoles) lo6 + 3 (3) ^ + 4 (3)
+ GDP (5yumoles)
' 4) As 3) + aspartate (5yumoles) 93.--4 (3) 96-4 (3)
ft
5) As 3) + oxaloacetate 100 + 3 (3) 1Q6 + 4 (3)
ft
6) As 3) + malate (2yumoles) 104 - 3 (4) 107 - 4 (4)
Figures in parentheses indicate the number of estimations
operation of oxidase systems similar in nature to those found in
%
mammalian systems. Even after the final 48-fold dilution of the cell
lysate, sufficient coenzyme A may be present to prevent stimulation
✓
by further addition of the eofactor. Hydrolysis of acetyl coenzyme A,
or. the absence of citrate synthase (E.G. 4.1.3.7«)j similarly would
J »
abolish any stimulation of the gas exchange rates.
M
»
Removal of endogenous cofactors by dialysis of v/ater-lysed prepar-
a * «
ations for 2-4 hours against two changes of 0.01 M-tris buffer pH 7*1
%
led to extremely low yields of activity of both the pyruvate and ci -03 .
%
♦
oxidase systems. After complete refortification with MFM plus NADP,
coenzyme A, thiamine pyrophosphate and lipoate, activity of these
systems ranged from 0-14$ of the rates obtained with untreated lysates.
ft





organisms is the L-*-GP oxidase complex, 2 yumoles of FD? (as a source








The use of G.25 Sephadex was mere successful in the removal of
endogenous cofactors, although the glutinous nature of the lysates
limited the yields from gel filtration (c.f. purification of pyruvate
kinase, Chapter 5)« Standard water-lysed preparations were applied to
ft
a column of G.25 Sephadex (10 cm x 1.5 cm diameter) pre-equilibrated in
physiological saline, and fractions (2 ml) were collected on elution
with saline. It was necessary to stir the top of the column of gel
with a glass rod to avoid complete agglutination of the material; even
with this treatment the yield of total protein through the column was
ft
less than 25$ of the application. The rates of oxygen utilisation
0
obtained with totally augmented preparations of this nature, using
pyruvate, were extremely variable9 and ranged from 18 80 nmol





Cell lysates were desalted as described in the text. Aliquots (2,0 ml
approx. 1.0 wg N) were incubated in the oxygen electrode system with
l.'O ml of 11PM containing 20yumole substrate. Cofactors were added
sequentially as indicated (in a volume of 10 Ail). All rates are
corrected for control values obtained in the absence of substrate.

















































































02/l0 min/mg N i.e. never greater than approximately 10$ of the rates
obtainable with whole lysates. The Clark oxygen electrode, having a
higher sensitivity, was therefore used to measure the. rates of oxygen
*
%
utilisation. ~The effects of further fortification, estimated bjr
sequential addition of cofactors, are shown in Table 5. It must be
# »
• *
, " • *





oxygen is occurring under conditions where the L-o£-GP oxidase system
is expected-to be inactive i.e. in the absence of DHAP as a hydrogen
carrier. The positive utilisations obtained could imply incomplete
removal of DHAP, or the presence of an alternative oxygen-utilising
NADH oxidase. The reproducible stimulation of oxygen uptake by ADP
9
supports the latter possibility, as the L-t^-GP oxidase system is
9 '
reported as being ADP-independent and non-phosphorylating (Bide, .1963).
I
»
On the other hand, the partial stimulation by coenzyme A in the absence
/
%
of exogenous MD+ and ADP may indicate incomplete removal of these two




of DHAP may also still be present. The complete removal of coenzyme A
.however, appears to be achieved by the gel filtration.
NAD , ADP and coenzyme A are the only cofactors which stimulate
4
oxidation of pyruvate (Table !?)• The failure of TPP and lipoate to
increase the rates of oxygen uptake, corresponds with the known proper¬
ties of mammalian c^-keto acid oxidases in which these cofactors are
prosthetically bound, thus making Sephadex treatment ineffectual for
their removal. The lack of stimulation by. malate and NADP is probably
due to the extremely low levels of citrate synthase activity in the
extracts, as malate dehydrogenase is very active in these preparations.




The interpretation of the above results, while subject to a number
of reservations, suggested the existence of a terminal oxidase system
alternative to the L-o^-GP oxidase, in the pleomorphic organisms.
ft
Monomorphic trypanosoraes have repeatedly been examined for the presence
of cytochromes, and for cyanide and carbon monoxide sensitivity, with
negative results (Ryley, 1956; von Brand, 1951? Pulton and Spoon.er-J.959)•
|
Yfith the development of the ©£-keto acid oxidase systems in the pleo-
ft
ft
morph, the possibility of the presence of the cytochrome system in the
ft
SS forms had to be considered.
4
*
Y/hole cell preparations and lysates of the pleomorph were subjected
4
to spectrophotometry analysis with NADH, glucose and dithionite as
ft
reducing agents. Reduced versus oxidised spectra cf these preparations
ft
did not show the presence of cytochrome pigments.
ft
The more sensitive chemical estimation of haem pigments by pyridine
ft
haemochromogen formation was attempted on lysed material and on lyophil™
ised preparations, again with negative results. Some early samples of
ft
lyophilised T.rhodesiense showed the presence of trace amounts of a
ft
ft




(V 423 nm; 558 nm) but these traces are eliminated by rapid removal
of the erythrocytes from infected blood samples, ensuring minimal red
ft
cell lysis during the preparation of the trypanosomes. Presumably
ft
these traces are therefore due to contaminating haemoglobin.
ft
In agreement with Ryley (1962), the conclusion is that if cytochrome
ft
ft
pigments are present in the blood stream organisms, they are to be
4
found only in exceptionally small concentrations. Assuming a molar
extinction coefficient of 2 x 10^ for the Soret bands of the pigments
I
(Y/illiarns 1964), the estimation method used should have detected the
presence of absorbing pigments at amounts ^ 0.2 nmole per 10 rag protein.
0
This compares with the figure of 1.14 nmole protoheme per 10 rag protein
• found to be present in C.fasciculata (Hill & White' 1968).
i
9
The preparation of trypanosomal material free from haem complexes
4
4
does, however, demonstrate the purity of the organisms from blood elements.
Succinate dehydrogenase and citrate synthase in T.rhodeslense.
Several enzymes of the tricarboxylic acid cycle have been demonstrated
4 4
4 4
in monomorphic T.rhodesiense, as described in Chapter 1. This work adds
%
the two oxidative decarboxylase systems of the cycle in isomorphic
i
infections. Hence, the only cycle enzymes which have not been demonstrated
9
9
are citrate synthase and the succinoxidase system. Repeated attempts to
demonstrate the synthesis of citrate by lysed cell preparations in which
the oxidation of pyruvate was supplemented by aspartate, oxaloacetate
4
or malate gave negative results, when citrate was estimated by the method
#
of Siebert (1965). When the direct assay for activity of this enzyme
P
was employed, however, low levels of activity were estimable.
m
i






graphic estimation of oxygen utilisation with succinate as the substrate.
9
The rates obtained for oxygen utilisation in the presence of 20 yumoles
succinate were approx. 5 nraol Og/min/rag N, i.e. about 5$ of the rate of
oC.oxoglutarate oxidation. Apart from the demonstration that this
enzyme is competitively inhibited by malonic acid, no further invest!-
9
gation of the system was carried out. Sonication or freeze-thawing as
0






Wholecel s(appr x.0.2mgN)orstandardw ter-lysedprepa ations(a ox.1.0r g)w reincubateds li en
ft
MFMrespectively,inthpresenceofvaryingconc n rat onsfthi ibi ors.Oxyg nuptakewme sur do r









Inhibitor Rotenone Amytal Cyanide Azide Antimycin Kalonate
1 1

















1.9-0.8x10(4) 5.oio.6xio"4(7) * N.I N.I
Pyruvate Lysate 5.1^1.1x10( ) 1.1-0.2xlO~3(3) N.I. N.I. N.I. N.I.
04-GP Lysate N.I. N.I, N.I. N.I. N.I. «.x.


















3) THE EFFECT OF METABOLIC INHIBITORS ON PLEOMORPHIC T„RHODESIENSE.
«.
%




the standard Warburg system in the presence of varying concentrations
of the inhibitors shown in Table 6. The fragility of the whole organ-
i
t
isms precluded preincubation of the cells with, inhibitors in the absence
of substrate, and for comparative purposes substrate was also included
9 % ^
in the lysate systems during preincubation. In the presence of higher
► 4






and in these cases, the initial rates of oxygen uptake were estimated.
The general lack of inhibition by cyanide indicates the absence of
0 ,
a
a functional cyanide-binding cytochrome oxidase in these organisms, and
* 9
the inability of azide and antimycin A to inhibit oxygen uptake, similarly
lb—»c





transfer step respectively. Azide was also tested at pH 6.5, since it
• «




transport chain at pH > 7 (Keilin 1936). At pH 6.5, the utilisation
of glucose was depressed, but azide was still ineffective.
0
0
The inhibition by cyanide in the case of cell lysates utilising
|
oC-OG is somewhat anomalous. Cyanide complexes v;ith o4-keto acids, but
in the concentrations used (cyanide: oC ~0G approx. 1: 14) this( should
9
4
not have decreased the-available substrate significantly, and this
removal of substrate would not account for' the differential susceptibil-
itieS of whole cells and lysates to the inhibitor. If this inhibition
is via a specific action of cyanide on the electron transport system
between «<-0G and oxygen, the implications are that two routes for
oxygen utilisation are present, that these routes are utilised prefer-
** * *
entially by different substrates, and that in vivo a permeability
TABLE 7
Effect of rotenone on NADH utilisation by Sephadex G-25
treated cell lysates
s




rates are corrected for oxygen utilisation in the absence of exogen-
4
4
ous substrate, and are expressed as nmol O^/lOrriin/mg F. Rate
obtained in the presence of PDF are corrected for the oxygen utilis
>
ation in the presence of this metabolite .alone. Rotenone was added
-5 .
to a final concentration of 10 ^ M, in lOyul ethanol.
Substrate
KADH (5yumoles)
FADH (5yumoles) + ethanol













NADH (5yumoles) + PDP (2yumoles)
i
NADH (5 /utaoles)_+_ PDP (2 /araoles)/ ?+ Pfliannl /
NADH (5yumoles) + PDP (2yumoles)






barrier to cyanide exists. Alternatively, the in vivo reoxidation of
4
t





Amytal and rotenone were thought to be specific inhibitors of the
4
flavoprotein /.non-haem ferroprotein electron transfer step in the
f
4
cytochrome chain, oxidising NADH. ' Recent reports, however, have
4
4
extended .the effects of fotenone to include."focal points other than
f -V'
site I of the electron transport system. Butow (1966), showed
L . -bi »
beef liver, glutamate dehydrogenase to be rotenone sensitive, and
[& Mattoon1 ^
Baleavage^( I.967) demonstrated rotenone inhibition of yeast mitochondrial
alcohol dehydrogenase. In the absence of demonstrable cytochrome
• 4
1
pigments in pleomorphic T.rhodesiense, the rotenone/amytal sensitive
4
4

















NADH oxidation by desalted cell lysates.
4





treated as described previously in an attempt to remove endogenous DHAP
•
,
and thus render the L-oi-GP oxidase system inactive.. Such preparations
still utilised NADH at the expense of molecular oxygen, although readdit-




This stimulation was remarkably constant in the preparations used,
4
(ranging only between 9'2-fold and 11,1-fol'd in seven 3ephadex-treated
t
samples), which may indicate the presence of two separate systems. If
this is the case, however, both, systems are rotenone sensitive. As
%
L-ot-GP oxidase is not sensitive to rotenone (Table 6), the NAD -linked
4
L-oC-GF dehydrogenase appeared to be a possible site for the action of
%
4
this inhibitor. This was supported by the similarity of inhibitor
■M *TABLE 8
Prelimj balance studies on the metabolism of
glucose by whole cells.
Whole organisms (0.3 mg N) were suspended in saline with 25yumoles
glucose per flask, and incubated under the standard manometric
conditions Aliquots of the deproteinised flask contents were
analysed for glucose and pyruvate. Results are expressed on the
basis of the net experimental metabolism after consideration of the
*
sero time samples (see Chapter 3). The experimental periods varied
9
from 35 to 60 minutes as indicated.
% glucose carbon found
Strain
Pleomorphic





Monomorph 0.1 ■ 89.O 89.I 45
T.brucei
TREU 277




Monomorph 2.3 74.0 76.3 40
T.rhodesiense
EATRO 165a.
80$ thick 6.5 44.1 50.6 60
T.rhodesiense
EATRO 165a
22% thici 1.5 52.1 53.6 60
concentrations required for 50$ inhibition of oxygen utilisation with
+
*




action independent of the NADH source. Unfortunately, a final check
4*
on this hypothesis, in which the NAD -dependent dehydrogenase was
assayed spectrophotometrically, showed it to be .untenable. Lyophilised
trypanosomes desalted on G-25 Sephadex, were resuspended in 0.01 M-tris
* P
buffer pH 7*3 at 20 mg/ral, and the rate of NADH reoxidation by the
preparation wa3 measured at 340 nm. In this system, oxidation of NADH
»
alone was extremely slow, but was rotenone sensitive, whereas on addition
♦
of PDP the oxidation rate was stimulated 20-fold and was rotenone
4
insensitive.
At this point it was found that concentrations of rotenone and
amytal in the same range as those used with the pleomorphic organisms,
were as effective in inhibiting oxygen uptake by the moncmorphic strain
*
utilising glucose. The action of these inhibitors is not therefore
indicative of a developmental change in the slender to stumpy transform-
< 4
♦







4) CARBON BALANCE STUDIES ON PLEOMORPHIC T.RH0DE5IBNSB.
ft
The lack of detectable cytochrome pigments in the pleomorphic strains
< « «
» t •
of T.rhodesiense, indicated that mitochondrial differentiation in these
4
organisms is not complete. However, the presence of pyruvate and e^-OG
% •
oxidase systems, and the production of significant amounts of carbon
9
dioxide from the metabolism of glucose, suggested that the tricarboxylic




Preliminary estimates of the end-products of glucose metabolism
are shown in Table 8. Whereas the recovery of glucose carbon as pyru-
ft
vate is approaching quantitative levels in the "L" strain, between
TABLE10
Carbonb lancestudiesoT.rh desiense'SATRO173:ff ctfthincubationp ri d

















































Carbon balance studies on T.rhodesiense EATRO 173s range of products
Experimental details regarding whole cells, as in Table 8. Standard
v/ater-lysed material (10 mg If) was suspended in MFM with 25yumoles
pyruvate. Substrate utilisation and metabolite formation were esti-
mated on deproteinised samples as in Chapter 3.
as percentages of the glucose carbon utilised.
Yields are expressed
Figures in parentheses








































N.E. denotes not estimated.
26% and 36% is unaccounted for in the other strains used. The carbon
*
0
dioxide yield appears to b© related to the percentage of SS forms and
.ft
t *
continual passage leads to decreased carbon dioxide production and an
0
J
increased yield of pyruvate.
*
The pyruvate yield from the EATRO 165a strain was consistently
lower than that obtained from the major pleomorphic strain used in this
work, EATRO 1'73, a],though the carbon dioxide yield was also slightly
lower (cf. Table 9)» No significance other than natural biological
0 '
variation can be attached to these differences.
In*an attempt to elucidate the pathways involved in the metabolism
*
of glucose, further balance studies were carried out, involving a more
comprehensive series of possible end-products (Table 9)•
0
Catabolism of glucose, whilst partially terminating1 at pyruvate,
does produce significant although relatively minor quantities of
0
acetate, glycerol and succinate. Although the total recovery of glucose
carbon was relatively constant at 91 ~ 95%i in the five analyses where
%
all metabolites were estimated on a single incubation.(Table 10), there
was considerable scatter in the percentage accumulation of the various
•
.
products. These variations did not correspond to the minimal differ-
m
ences in pleomorphic composition of the preparations used, and the only









Effect of incubation time on metabolite production from glucose.
4
4
At the time these experiments were carried out, T.rhodesiense
o
EATRO 173 had been stored in stabilate form at -70 C for between 7 and
12 months. Some deterioration of the pleomorphism appeared to have
A
occurred as previously described, reflected in relatively higher yields
0
of pyruvate than those obtained with the newly acquired material. The
COg production and R.Q. values obtained were also lower after storage.










































































































































































































































































































10 20 30 40 50 60
Incubation time {mins [
70
7. The effect of incubation time on the glucose
metabolism of whole cells.
4
d). The production of succinate.
*
♦
The data of Table 11 expressed as molar ratios with respect















10 20 30 40 50 60 70
Incubation time
{minsj
The effect of incubation time on the glucose
metabolism of whole cells.
4
c). The production of acetate and glycerol.
The data of Table 11 expressed as molar ratios with





























The effect of incubation time on the glucose
tetabolism of whole cells.
a). The R.Q. value and the utilisation of oxygen.
The utilisation data of Table 11 are expressed as molar











times, are given in Table 11, and are plotted in terms of yurnole
metabolite/yuraole glucose utilised, in Figure 7 (a-d). Over-.a period
9
of 70 minutes, pyruvate production and oxygen utilisation per glucose
utilised steadily decrease, whereas % yields of glycerol, succinate and




The decrease in oxygen consumption may be qualitatively accounted
for by the parallel increase in glycerol production. Dephosphorylation
of L-<^-GP to produce glycerol will enable the reoxidation of N.ADH by
DHAP to occur, without a concomitant utilisation of oxygen. The
*
increase in production of carbon dioxide and succinate at the expense
9
of a decreased yield of pyruvate, may reflect an effect of the increasing
9
pool size of pyruvate during incubation and its further catabolisrn by
decarboxylation. After one hour, the in vitro concentration of pyruvate
9
is approximately 3 mM, whereas the normal uninfected range of blood
pyruvate concentrations in vivo is 0.2 - 0.4 mM (von Brand & Coleman,
• 4
1957)• The same authors report that even in heavily infected experi-
9
mental animals, no significant change in the blood pyruvate level occurs
9
until the immense terminal parasitaemia is reached.
Effect of carbon dioxide on metabolite production from glucose.
9
9
Throughout the work reported above, the msnometric technique used
involved the inclusion of incubation flasks in pairs (i.e. with and
without KOH in the centre well) in order to measure oxygen uptake and
*
carbon dioxide production simultaneously. In some cases the contents





volume available for duplication of estimation; the question therefore

































































































































































incubation also affected the course of metabolism. Any differences
0
• 4
between such a pair of flasks would produce anomalous values for the
4
gas exchange occuring, as the evolution of carbon dioxide in the flaslc
0
without KOH is measured on the basis of the oxygen utilisation in the
t m
other member of the pair. To clarify this possibility, flasks were
obtained with two side-arms, one of which is connected to a trough-
t
shaped centre vessel. It is possible in these systems to measure
%
oxygen utilisation and carbon dioxide evolution on the same experimental
♦ W
4 •




at the end of the incubation period as follows. At the termination
of the experiment the gross gas exchange is directly measurable after
*
addition of perchloric acid from the sidearm to the incubation medium,
*
to release dissolved carbon dioxide. This corresponds to the (02 - CO^)
volume. Potassium ferricyanide from the second side-arm is thon tipped
9
4
into the centre well which contains potassium permanganate; the reaction
produces potassium hydroxide which absorbs the gaseous carbon dioxide
0 ♦
♦






KMn04 + 3K4 Fe(CN)6 + 2H20 1- Mn02 + 3K^ Pe(CNg) + 4KCH.
• •
The difference between the nett and gross figures therefore is equal
|
»
to the evolution of carbon dioxide (see Warburg & Krippahl,1960), Two
sets of data from this system, with analyses from the conventional centre
*
well flasks which contained samples of the same trypanosome preparations,
.
are shown in Table 12, No significant differences between the two
0
single side-arm flasks - KOH and the double side-arm flasks are apparent.
However, this alone does not signify that carbon dioxide fixation is
not involved in trypanosomal metabolism. When perchloric acid is added


































T.rhodesiense(Melarsen EATRO173 7780$ thick(oxide ( ( ^Phenylarsenoxide (
4
3.1-0.8xlO"5(4)2.0-0.8xl0"5(4)2.2±0.2xlO~5(5)5. - .9 l 6(9)1.1^0.2xl0~5 4 4.1-0.7xlO-6(3)3.2^0.6xlO"6(6)4.0-0.8xlO-6(5)5.2-0.8xl0"7(8)8.8^1 6 1 . (3)
T.brucei TP.EU277 Konomorph












zero time concentrations of metabolites to be estimated, a considerable
*
evolution of carbon dioxide occurs from the flasks containing TCOH in
the centre well. After approximately 8-10 minutes the gas is absorbed
*
by the alkali, but this evolution does imply the presence of dissolved
carbon dioxide in all the flasks during the experimental period. Hence
4
9
the presence of KOH in the centre-wells of tho respirometers does not
« ♦
remove all the available COp, due to the relatively slow evolution of
the gas from neutral solution. The use of the standard.inanometric








5) THE EFFECT OF TRIVALENT ARSENICALS OK THE METABOLISM OF T.RHODESIENSE.
«
4
The rapidity with which trypanosomes lost their motility and stopped
9
utilising oxygen when suspended in high concentrations of raelaminyl
arsenicals, indicated that the action of these drugs is closely assoc-
4
4 •
iated with the mechanism of energy production in the organism. The
relative efficiencies of such a series of drugs may therefore be defined
9
4
in terms of their respective abilities to inhibit the oxygen uptake of
the organism, and the differential effects of a given drug on the oxygen
utilisation from a series of substrates, may indicate the reaction involved
*
9
in the inhibition. As will be seen in the following section on carbon
I
m
balance studies with the arsenical drugs, an inhibition derived from
#
experiments using only one concentration of inhibitor may be misleading,
in so far as different reactions may be arrested by different drug
concentrations. The I^q values for oxygen utilisation, as reported
4
in Table 13, therefore are a measure of the overall effectiveness of
the drugs, irrespective of the actual point of inhibition.
Phenylarsenoxide inhibits oxygen utilisation in all the systems
I 0
investigated at concentrations an order of magnitude lower than those
(>'
♦
required for equivalent effect by the me1aminy1 derivative. The I^q
#
value for plienylarsenoxide in a whole cell system using glucose is
about half that reported by Marshall (1948) who used a whole blood
suspension of T.evansi. However, as differences in sensitivity occur
even between strains of T.rhodesiense, this discrepancy is hardly
surprising. Marshall also used a whole blood preparation of the
trypanosomes, and although he showed that the blood elements contri¬
buted a negligible part to the oxygen uptake of his experimental material,
no account was taken of arsenical uptake by the erythrocytes, a process
which would have decreased the effective free concentration of inhibitor.
In all cases, a higher concentration of drug is required to produce
50$ inhibition of the oxygen utilisation rate with a cell lysate, than
that required with whole cell preparations. These differences were
not as great as may have been' expected on the basis of the data of
Hawking (1937»1938), which showed a selective uptake of phenylarsenoxide
by trypanosomes to give a cell to medium partition ratio of 5-lCs x 10^.
This figure for arsenical accumulation, however, will be dependent upon
the initial extracellular concentration of arsenical, and the free
4
concentration of inhibitor in the glycolytic compartment of the cell may
be much lower than the total intracellular concentration, The variation
found between whole cells and lysates is also probably due in part to
the liberation on lysis of non-specific arsenical binding sites, which
will effectively lower the free drug concentration.
The melaminyl drug and its parent arsenoxide are powerful inhibitors
of glucose supported oxygen uptake, and of the oxidative decarboxylations
of pyruvate and oC-OG. The similarity of the Icn values for the various
substrates, appeared to indicate a substx-ate-independent point of action
' of the arsenicals. However the utilisation ef oxygen with L-o^-GP as
—5 —6
the substrate, was uninhibited at 2 x. 10 M-melarsen oxide and 3 x 10
M-phenylarsenoxide. When the NAD -dependent L-oC




less than 15$ inhibition was obtained at the above inhibitor concen¬
trations. The two common steps in the pathway of electrons to oxygen,
from glucose, and the *x?-keto acids, i.e.
ft
NADH + DKAP + II ■*» L- oC -glycerophosphate + NAD+
and L- oL-glycerophosphate + -gO,, ——DHAP -i- HgO
ft
appear therefore to be relatively insensitive to the arsenicals. Fro
ft
the data presented in Table 9 it may be seen that the utilisations of
pyruvate and oC-OG are confined to one-step oxidative decarboxylations,
producing acetate and succinate respectively. As the reactions from
NADH to oxygen are not markedly sensitive to the drugs, it would there¬
fore appear that the oxidative decarboxylases themselves are target
enzymes for the arsenicals. However, the monomorphic strain of T.brucel
ft
is sensitive to the arsenicals at the same drug levels as the pleom
organisms, indicating that these enzymes are not the primary trypano
cidal targets.
ft
Effects of melarsen oxide on the products of glucose metabolism
by cell lysates.
ft
The susceptibility of monomorphic T, rhodesiense to melarsen oxide,
es that any major therapeutic effect exerted by the drug on the
catabolism of glucose by these organisms, is directed at some point
prior to pyruvate in the degradative sequence. The productions of
acetate and succinate from pyruvate, (reactions which the monomorphic
%
strains have lost the capacity to carry out), are therefore not primar-
tryp elarsen oxide, and
7



































































































































































Melarsen oxide inhibition of glucose metabolism
by standard water-lysed preparations. The substrate
utilisation and metabolite production data of Table 14
expressed as % inhibitions / stimulations.
using
inhibitory
from glucose by standard water-lysed T.rhodesiense EATRO 173, are shown
in Table 14 and the same data are presented graphically in Figure 8.
♦
At the lowest concentration of meiarsen oxide (1.15 * 10~' M
Table 14) the gas exchange of the lysates is inhibited, whilst the
nett amount of glucose utilised is not significantly altered. Accoro
4
panying this differential effect of the drug, is a stimulation of
«
«
pyruvate production. The first point of action of the arsenical,
therefore, is the pyruvate oxidase system. The decrease in oxygen
over¬
all utilisation of glucose and the further metabolism of pyruvate. As
previously stated, the oxygen uptake of cell lysates using L~c£-GP is
uninhibited at this concentration of arsenical. . The decrease in glucose
utilisation from Table 14 may be seen to be 0.55 yumole in experiment I,
equivalent to a decrease in oxygen utilisation of 0.55 /"mole in pro
ducing pyruvate. The gross decrease in oxygen uptake is I.85 yumoie,
pyru.vat e 0.55)
- 1.30 /urncle oxygen. The parallel decrease in CO^ production is
2.63 /amoles, giving an R.Q. of 2.02 for the decrease in gas exchange
in the presence of the drug. Whereas this figure agrees well with the
ft
R.Q. obtained from lysates utilising exogenous pyruvate, the theoretical
accompanying
dioxide production is 2.63 yumoles, as opposed to the 1.08 yumoles
obtained experimentally. This "loss" of pyruvate carbon indicates
that the drug is, in fact, partially inhibiting one of the reactions
producing pyruvate, at the same time as it inhibits pyruvate utilisatio:
The inhibited reaction involved in the formation of pyruvate must be in
the part of the glycolytic sequence subsequent to the oxygon utilising
step (i.e. the production of NADH by triose phosphate dehydrogenase),
4
as otherwise the R.Q. of the "lost" gas exchange would be less than 2.0.
4
4
A similar analysis of the second set of data from Table 14 shows an R.Q»
*
of 1.86 for the nett decrease in pyruvate utilisation, and again a loss
4
of approximately 40$ in the theoretical increase in pyruvate formation.
Doubling the concentration of rnelarsen oxide further inhibits the
carbon dioxide - oxygen exchange and a marked inhibition of glucose
*
9
utilisation now accompanies the effects on gas exchange. Pyruvate
4
production is still essentially unaffected. At this point, analysis
/
of the arsenical effects along the lines indicated above does not give
a clear-cut definition of the inhibitions. In both cases, the decrease
%
I
in oxygen utilisation may be totally accounted for on the basis of the
decrease in glucose uptake, and the basic weakness of these analyses
4
4




of glycerol in the presence or absence of the inhibitor.
• ■
The production of 8.85 yumoles pyruvate (Expt.I, 2.30 x 10 ^ M~
melarsen oxide) requires the utilisation of 4.43 yumoles oxygen.
Assuming that all the COg production is from the decarboxylation of
pyruvate to produce acetate, another 1.25 yumoles, of 0^ are required
at this step, giving a maximal total requirement of 5*68 yumoles oxygen,
compared to the observed utilisation of 7>24 yumoles. Again, assuming
that no other routes of glucose metabolism are being used in these
lysates, a buildup of carbon between 3-phosphoglycerate and phosphoenol-
pyruvate is indicated.
Further increase in the drug concentration produces a multipoint
4 9
4
inhibition. Hexokinase becomes inhibited markedly as seen from the
drop in utilisation of substrate, and the data become uninterpretable
in terms of specific inhibitory effects. This inhibition of hexokinase
Effects of melarsen oxide on glucose metabolism by-
whole cells; l) Inhibitor titration
ft
Whole cells cf T.rhodesiense EATRO 173 (approx. 0.3 mg N) were suspended
in saline and incubated under the same conditions as those described in
Table 14• All other experimental conditions are as described in Chapter
































































































Fig. 9. Melarsen oxide inhibition of glucose metabolis
by whole cell preparations.
b). The production of pyruvate and CC^.
































a). The utilisation of glucose and oxygen.
The data of Table 15 expressed as % inhibitions.
ATP. The
pattern of metabolic changes obtained by incubation of whole cells of
the pleomorphic trypanosomes with melarsen oxide was found to be oriite
different to the lysate effects, indicating that extrapolation of the
results obtained with, cell lysates to account for the in vivo effects
leads to difficulties in interpretation. No further experimentation
% V
was therefore carried out on the lysed material.
Effects of mslarsen oxide on the products of glucose metabolism
by whole cells.
The oxidative decarboxylation of glycolytic pyruvate appears to
be the primary enzyme point of attack of melarsen oxide in the water-
9
9
lysed system, in which all semblance of compart.mentation will have been
lost. No indication of a similar preference for- this system could be
found, hov/ever, in the intact organisms
J
Table 15 contains the results of four series of experiments, the
experi
and these data are plotted in terms of percentage inhibition versus drug
9
9
concentration in Figure 9 (a and b). These figures may be compared
with Figure 8 which contains the analogous data pertaining to the lys
9
cell preparations; in this present case, the coincidence of the inhib
9
9
itions of glucose and oxygen utilisation, and of the production of
carbon dioxide, necessitates the separation of the graphical represen
tations for reasons of clarity. All three of these parameters have
I
^ values in the region of 5 ~ 6 x 10 ^ M-melarsen oxides The product
ion of pyruvate is more sensitive to this drug, with an value in
the range 1 - 2 x 10 ^ M-melarsen oxide, No inflections are to be
found in any of these experiments, analogous to that obtained for
Melarsen oxide inhibition of glucose metabolism
by whole cell preparations. The data of Table 15 expressed
as molar ratios with respect to the utilisation of glucos.e.
a = oxygen utilisation. A = pyruvate production.




pyruvate production by cell lysate3 at different arsenical concentrat¬
ions • Stimulation of the production of this end-product, theoretically
r
obtained by a specific inhibition of the pyruvate oxidase system, could
not be demonstrated in the intact cells at any concentration of melarsen
oxide. The lowest concentration of inhibitor used experimentally,
—7
(10 M), produced an inhibition of 15$ of the production of pyruvate,
simultaneously having a negligible effect (^ 4$ inhibition) on the
utilisation of glucose and oxygen or the production of carbon dioxide.
Under in vivo conditions the primary inhibition by this arsenical would
appear to be prior to the formation of pyruvate, in the glycolytic chain
By a similar logic to that used in the interpretation of the results
*
obtained with lysed cell preparations, this inhibition cannot be between
glucose-6~phosphate and the triose phosphates, or a decrease in the
ratio of oxygen utilised to glucose utilised would be apparent5 Figure
10, which contains the data of Table 15 expressed in this manner, shows
this ratio to be more or less constant over the range of inhibitor
concentrations used. A build up of an intermediate of the glycolytic
9
pathway between 1:3 diphosphoglyceric acid and PEP is therefore expected
At low levels of inhibitor (lO ^ M,y the utilisation of glucose is itself
f
inhibited, indicating that hexokinase is sensitive to melarsen oxide.
(This inhibition may again be due to a decrease in the availability of
9
ATP due to the primary inhibition of pyruvate kinase.) This is borne
out by the parallel nature of the inhibitions of glucose and oxygen
consumption and carbon dioxide production; assuming that the evolution
of carbon dioxide is at least in part due to the production of acetate,
it would appear that either this system is uninhibited by melarsen oxide
in vivo or the drug cannot permeate into the cellular compartment con-
i
taining the oxidase system. The highest concentration of drug utilised
•in the whole cell experiments is 6 x 10 ^ M. At this concentration,
TABLE16
• •
Effectsofmelarseaxideonglucosemetabolismbywh leel ; 2)'PEPaccumulation -6•^
ExperimentaldetailsasinT ble15>w hlarsenoxidet20M#Pleomorphiccomposit on78$SS i Metaboliteestimationscarr edouts,iChap r3.Experim ntaldu ion45m nutes. Glucoseutilisation Oxygenutilisation Pyruvateproduc ionoles 8.61. 8.95 10.85Standard $Glucose carbon 100 63
+Melarsenoxide moles 534 5.77 4.97
$Glucose carbon 100 47
*
V















the utilisation of pyruvate by cell lysates as measured by the
»
.
utilisation of oxygen in the presence c-f pyruvate as substrate, is 18$
»
W ^ ^
sensitive to melarsen oxide, and hence the latter ot those alternatives
t
is preferable. When the concentration of the drug by the trypanosomal
cell is taken into consideration, this argument is reinforced.
■ By analogy with the inhibition of hexokinase by melarsen oxide,
two enzymes in the second half of the glycolytic sequence appeared as
P
possible alternatives for the primary inhibitory point by which a
decrease in pyruvate yield is possible,, without, a concomitant decrease
4
in oxygen uptake or glucose utilisation; These are the two kinases,
*
catalysing the production of 3-phospnoglyceric acid from 1,3-diphospho-
1%
glycerate and of pyruvate from PEP. Of these enzymes, the latter
« •
4
appeared the most promising alternative, as a buildup of l,3-diphospho~
glycerate accompanying an inhibition of phosphoglyceric acid kinase,
I









Accordingly, estimations of PEP were carried out on normal and
P
9
inhibited whole cell preparations, the results of which may he found
0
in Table 16. Approximately 60$ of the glucose carbon no longer found
*
*»
as pyruvate in the presence of the drug, is accounted for as a buildup
4
of PEP, leading to the conclusion that pyruvate kinase is the focal point
ft
|
of arsenical action in this part of the glycolytic sequence. •
, -
The second part of this work is accordingly devoted to a comparative
study of the pyruvate kinases of trypanosomal and of mammalian systems,
ft
















1) CHOICE OF MATERIAL AND ASSAY CONSTITUENTS.
*
If
The preferred assay system for pyruvate kinase, that of Bucher
ft
and Pfleiderer (1962), is dependent upon the utilisation of NAM by
LDH in the presence of pyruvate produced by the kinase, and is followed
spectrophotometrically by the decrease in absorbance at 340 run. The
use of freshly lysed trypancsoraal material was investigated as a
ft












rate between different lysed samples, the time entailed in the prepar-
ft
$
ation of the organisms free from blood elements, and the finding that












experimental source of the enzyme, as recoveries of activity from such
powders were exceptionally low. Lyophilisation, however, yielded the
ft












Effects of lyophilisation on pyruvate kinase.
ft
f




obtained after correction for the endogenous rate of oxidation of NADH,
although the instability of the enzyme made these estimates to a certain
extent unreliable. Comparison of this activity with the rates obtained
I
from lyophilised material, showed that from 55$ to 75$ of the total
ft
activity was retained on freeze-drying. Apart from subjecting the
trypanosomal material to lyophilisation as soon as possible after lysis
9
of the cells, no attempts were made to improve these yields. Any
TABLE17
T.
Pyruvatekinasactivityndphysico-chemicalpropertiesfT. odesi n end.bru give














































batch of material with a specific activity of less than 0#5 /umole /
I
linut.e /as protein was discarded.
In the lyophilised state, the pyruvate kinase activity found
to decrease gradually on storage at 2 C, but this deterioration was
practically eliminated by storage in vacuo at this temperature. Batches
• 4
of material stored in this fashion for up to two years' have been found
80$ Prior to use, each individual
* «
batch of lyophilised material was assayed for lactate dehydrogenase
enzyme
*
(indicating purity from blood element contamination) were used for
investigation of the trypanosomal pyruvate kinase.
Table 17 indicates the relationship between the activity of this
1
1
enzyme .and the characteristics of the gsyophilised material from pleo





from 0.74 to 1,04 yumole/min/mg protein, whereas the in vivo rate of
4
glucose utilisation is of the order of 1*0 yumole/min/mg protein i.e.
equivalent to 2 /umole PSP/min/mg protein. The losses of activity on
freeze-drying only raise the total activity to approximately 1.4-1.9
0
mole/min/mg protein assuming the maximum lo3s of 45$ of the activity,
which still does not account for the observed in vivo turnover rate.
However, two aspects of the properties of this enzyme, namely the
activation by thiol compounds and by fructose 1,6 diphosphate, indicate
that the in vivo activity is in fact sufficient to account for the total
netabolisrn of glucose to pyruvate




Early experiments using "the phosphate buffer system of Bucher
««•
very

























pmoles Mg* per assay.
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The effect of cation concentration on the
activity of unpurified pyruvate kinase. The enzyme source
was lyophilised T. rhodesiense'EATRO 173 resuspended in
water at 2.0 mg/ml. Aliquots (0.1 ml) were assayed at the
indicated cation concentrations with A) 200 pmoles KC1 per
assay and B) 20 pmoles MgSO^ per assay. All other assay
'
conditions were standard, as described in Chapter 3.
Reactions were initiated by addition of enzyme.
inhibitory to this enzyme, and a five-fold increase in activity at
*
*






The effects of varying K or Hg ion concentration at a
fixed concentration of the other cation are shown in Figure 11. These
%
data are from the last in a series of experiments in which the concen¬
trations of both cations were varied both independently and together to
find the optimum conditions. As the sole purpose of these experiments
was to define the optimal conditions of assay, no account of the potass-
♦
ium ion content of the buffer has been taken.
With the exception of these two parameters, the assay system used
|
ft 4






2) STABILITY AKD STABILISATION OF TRYPAN05QMS PYRUVATE KINAS3.
ft
ft
After resuspension of freeze-dried trypanosoroes in water, a large
decrease in activity is found in the first 24 hours storage, either at
ft
17°C or at 2°C. The extent of the loss in activity is dependent upon
*
ft
the concentration of the resuspended material, but is very variable
ft
between batches of lyophilised material. The enzyme, in simple aqueous
solution, was also found to possess a negative temperature coefficient
*
of activity, a property known to be associated with hydrophobic enzyme
proteins.
The results of experiments aimed at the stabilisation of FK are
ft
found in Table 18. AI>P and PEP were used due to their function as
cosubstrates of the reaction, Kg and K ions as activating cofactors,
ft
BSA in an attempt to mimic a further increase in the concentration of
*
the lyophilised material and glycerol to provide a more hydrophobic
4
environment. Ammonium sulphate, EDTA, and the thiol compound DTT are
.TABLE18
Stabilisationoftrypanosomepyruvatekin s
























































































three known enzyme stabilising agents. The contamination of the
4
incubations was minimised either by the inclusion of a crystal of
0
ft
thymol, or by use of a toluene overlay. No inhibition of activity
was found with either of these bacteriostatic agents.
Of the above reagents, only glycerol and DTT gave any protection
«
against inactivation, and both these agents were more effective under
9
refrigerated conditions than at room temperature. Throughout subse-
*
quent work on the purification of the kinase, a solvent system of 25$
ft
(V/v) glycerol / 10 ^ M-DTT was used, with 0.1 M-tris titrated to
9
pH 1.2 with K0H/HC1. Since these conditions were defined, it is of
interest to note that two authors have recommended similar protective
4
media for stabilisation of the highly unstable liver type L pyruvate
kinase isoenzyme: Tanaka et al., (1967a) reported that addition of
0.5 mM-ADP, 0.5 raM-PSP and 10 ^ M-DTT stabilised this enzyme, and
Rozengurt et al. (1969) utilised 10 ^ M-DTT, 0.25 M-sucrose and 0,15
0
M-KCl to effect stabilisation at 4°C. In the case of the trypancsome
m




stability of the enzyme on storage, as do EDTA and dilution of the
resuspended lyophilised material* The effect of glycerol is analogous
*
4
to that of sucrose in the system of P.ozengurt et al,, (1969) in decreas¬
ing solvent interaction -with the hydrophobic protein in aqueous solution.
0
These similarities are of note in so far as the trypanosoine enzyme has
been shown to have many kinetic properties in common with this isoenzyme
9
4
of mammalian (host) liver.
ft




for enzyme assay, this material was found to interfere markedly with
the estimation of protein by the method of Lowry et al., (1959) giving
0
t
a very intense blue colour with the reagent. A tris buffer system
was therefore used during any experiments in which protein determination
^ This interference is probably due to the formation of a complex •
'between Cu++ ions and triethan'olamine in the alkaline assay solution.;
















































Thiol activation of unpurified pyruvate kinase.
Lyophilised, resuspended T. brucei TREU 277 (0.16 mg/assay)
was preincubated in the standard assay medium with and
without the thiol compounds as indicated, for 3 minutes at
25°C. Reactions were initiated by addition of ADP (1.25
pmol/assay.) and PEP (5.00 pmol/assay). Results are
expressed as % of the rates obtained in the absence of
exogenous thiol.
90
. was required. Tris itself interferes with this determinative method
-
, . . Nishimura, • ,
(Gellgrt et al.f 1959) as does glycerol (Zishkaj j • r 1970) but
%
these interferences were found to behave in a reproducible manners and
%
could be controlled.
Effects of thiols on unpurifled pyruvate kinase.
»
During the attempts at stabilisation of the trypanosomal PK it
was found that DT'T,as well as stabilising the enzymes had a marked
stimulatory effect. This effect, along with the actions of two other
0
reduced thiols, glutathione and cysteine, is illustrated in Figure 12.
The oxidised form of one of these thiols, cystine, is included to show
9
that this is an effect attributable to the reduced -3H group. Oxidised
glutathione similarly produced no activation. Variable results are
m
obtained unless the thiols, after dissolution in degassed distilled
water, are kept under a layer of petroleum ether. The total activat-
ion by PTT (10 M) observed with different batches of lyophilised
0
material, ranged from 84$ to 128$, presumably due to variation in the
0
oxidation of the samples during lysis and the freeze—drying process.
Although no experiments were performed on the variation of stimulation
with duration of storage, the increased stability of the preparations
• *
when stored in vacuo may be ascribed to elimination of the oxidation
%
process. In a similar fashion the instability of resuspended lyophil¬
ised material is probably in part due to oxidation.
0
The thiol concentration required for 50$ maximal stimulation was
very much lower in the case of the dithiol, DTT (1.5 x 10 ^ M) than
with the monothiols (GSH : 3 x 10 ^ M; CySH : 3 x 10 ^ M) and the total
extent of activation v/as also higher with the dithiol reagent. Increas-
0
ing the concentration of cysteine to 0.1 M, and prolonging the incubation
time did not increase the activation above 70$: this marked preference
*
9
of the enzyme for DTT appears also in ether enzyme systems (Threonine
%
A
deaminase. Burns & Zarlengo, 1968; Pyruvate kinase of E.coli» Maeba &
Sanv/al, 1968a). The work of the latter authors showed that E.co'li FK
is inactivated by dialysis and reactivated by DTT. Ultracentrifugal
studies showed that, dependent upon the induction of thiol groupings,
this reversible inactivation appears to be an association/dissociation
phenomenon. It has not been possible to determine whether an.analogous
dimerisation occurs on treatment of the trypanosorne enzyme with the
* •
dithiol, due to the low yield and nature of the purified enzyme. How-
t •
ever, that the enzyme requires at least one thiol group in the reduced
hypo
of this action of the thiol reagents; as such PK appeared as a suitable
target for inactivation by the arsenical drugs which (as far as is known)
are specific thiol inactivating agents.
3) PROPERTIES OF TRYPAMOSOKE PK III UNPURIFISD LYOPHILISED' MATERIAL
Characterisation of an enzyme in an unpurified state is obviously
desirable in so far as any purification procedure is liable to
the protein even further from its natural environment, and may induce
ft
properties which are normally absent. In the case of trypanosome PK,
may purification does not markedly
affect its kinetic properties, and so only a few properties of the
unfractionated enzyme will be described in this section, as purification
*
*
in this instance was later found to be obligatory for kinetic analysis.
It was found that prolonged storage of resuspended material in
glycerol /DTT resulted in a gradual and variable decline in the
sensitivity of the PK to melarsen oxide. The use of DTT in this
fashion is also impractical, as the presence of the thiol would effect¬






























the enzymes by formation of the cyclic thioarsinite. To avoid these
*
*
complications all results obtained on the crude material were produced
*
with lyophilised trypanosomes resuspended in double-distilled water,
0
and all preparations were discarded not more than four hours after
resuspension, during which time they were routinely stored in ice.
Over this period, whereas the decrease in activity was measurable
0
(12-20$) and was in all cases corrected for, the kinetic and inhibition
characteristics of the enzyme which were reliably estimable, appeared
0^
to be unchanged. For purposes of correction, the standard activity
with 5 yumoles PEP and 1.25 yumoles ADP was measured at least every
4
fifteen minutes and all results were adjusted to allow for the percen-
"
«
tage decrease in activity of this standard system.
Effect of ADP concentration.
The kinetic data of Melchior (19^5) Ibsen et al., (1968)
3-
suggested that the monomagnesium salt of ADP , and not the free
0 m
1 0
coenzyme, is the specific cofactor in the pyruvate kinase reaction,
2+
although evidence is to be found (Mildvan & Cohn, 1966) that free lAn
and free ADP^~ do bind to the enzyme. Under the conditions of assay
used in this work, effectively all the ADP present is in the form of
MgADP . Using the value of 2 x 10 (O'Sullivan & Perrin, 19S4) for
the estimated affinity constant for MgADP , it is possible to calculate




concentrations of Kg . The range of concentrations of ADP used to
*
determine the K„ value for this coenzyme are such that at all times theM
3-
concentration of free ADP is negligible, and the kinetic constant
• •
derived is descriptive of the MgADP complex,
%
0
Figure 13 illustrates double reciprocal plots of the enzymic rate
*
versus ADP (MgADP~)• concentration, at two concentrations of PEP.
+ -A
Calculation of the extrapolated IC, values gave 1.31 - 0,04 x 10 T M-ADPM
%
at loO /umcle PEP per assay and 1.30 i .03 x icf^ M-ADP at 5°0 /umole/ /
PEP per assay. The range of figures for this parameter obtained from
many estimations on different batches of lyophilised material was from
1.21 - 1.39 x 10 ^ M-ADP, with a mean of 1.30 i 0,16 x 10™^ M-ADP,
(Eleven determinations).
As a check on the methodology and for comparative purposes, the K,^,
ft
value for ADP was estimated under identical conditions using a commercial
ft
preparation of rabbit muscle PK. Three separate estimations gave a
%
mean value for ADP as 2.06 - 0.07 x 10 M-ADP, a figure close to
that of Reynard et al., (1961) of 2.1 x 10 ^ M-ADP.
Thus in a highly impure enzyme source, it may be seen that the
affinity of the trypanosome enzyme for ADP in the MgADP form is
slightly higher than that of the muscle enzyme, and is independent of
*
the concentration of PEP over the range 0.33 ~ I.67 mM.




Whereas the effect of ADP concentration on the reaction rate v/as
ft
reproducible from batch to batch of the lyophilised material, completely
irreproducible results were obtained when the effect of variation of the
concentration of PEP was studied. Double reciprocal graphical represen¬
tations of velocity versus PEP concentration gave curves which varied
0
from an approach to linearity to a marked upward concavity. Hill plots
ft
of these data varied in slope from n = 1.3 to n = 1.8, and at the time
ft
ft
no explanation of this variability was found. Later investigations on
ft
the purified enzyme led to the conclusion that the presence of varying
amounts of PDF in the lyophilised material may account for these anomal¬
ous results (vide infra). Due to these inconsistencies inherent in the
♦
«
use of the crude enzyme, no data will be presented for kinetic parameters
relating to PEP utilisation, and the description of other work carried
out on unpurified enzyme preparations will be confined to some prelimin¬
ary investigations of inhibitor action, the interaction of the arsenicals
with the lyophilised material, and the presence of .interfering enzymes.
Interference by contaminating enzymes, a) enzymes utilising PEP
The most likely source of error as far as the utilisation of PEP
is concerned,, is by reversal of part of the glycolytic sequence which
produces PEP. The presence of both phosphopyruvate hydratase (E.G.
4.2.1.11) and of phosphoglycerate 2,3 phosphoinutase (E.C., 5.4.2.1) was
demonstrated in the lyophilised material, by the oxidation of ITAM in
the presence of LDH and 2-PGA or 3-PGA respectively When quantitative
carbon-balance studies were carried out on the utilisation of PEP by
lyophilised material, the following data were obtained;















With a measure of inter-batch variation, PEP of the order of 5-15$
is being utilised by some pathway other than in the formation of pyruvate.
When these enzyme preparations were incubated with pyruvate under iden-
tical conditions, recoveries of between 98$ and 101$ were obtained.
Thus the loss of PEP carbon is not by further utilisation of the product
b) Other enzymes
Qualitative estimation of phosphate production on incubation of
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denotesotd termined.Oden t s17$inhibi iona5
denotesresultsvariable,betw en19$inhib tionnd4s imulationmM-iodoac tate
s>
95
material. Unpublished experiments of Fairlamb (1970) indicate that
« »
the level of ATPase activity is approximately 0,2yumol /rain/'mg protein.
Obviously any investigation of the effects of these modifiers on
0
the trypanosome FK would be severely hindered by the presence of these
*
enzymes, and a programme for purification of the enzyme was prepared.
It may, however, be noted that the consistency of the results obtained
fc
0
for the KjjADP in the crude system, is probably in part due to the high





vie »vV/ of the previously stated inaccuracies inherent in the use
enzyme
confined to a brief survey. By comparison of these data (Table 19)
9
with the inhibition characteristics of the purified enzyme (Table 24),
4
it may be seen that the purification procedure does not alter the prop-
erties of the enzyme to any large extent.
nhibition
by FK will be found following the analysis of the purified enzyme system,
eccune the data shown in Table 19, in
which the properties of the mammalian muscle FK are included for compar¬
ative purposes. n »
An obvious specificity for the arsenical drugs may be seen, in that
f
3
the trypanosomal systems are preferentially inhibited, and the muscle
enzyme is unaffected by these substances On the other hand, p.chloro-
ercuribenzoate (pCMB), a classical thiol inhibitor, affects all three
4
i
systems to the same extent. Of interest also is the total lack of
t
4
effect of arsenite, although here, as in the case of sodium melarsen,
correction had to be made for the presence of sodium ions which are
fc
J
inhibitory to the enzyme. The inability of melamine to inhibit the
0
enzymes supports the hypothesis that it is the -As=0 grouping of
melarsen oxide which is the active part of the molecule. At this point
%
%
it was thought that the preferential inhibition of the trypanosome
enzyme was due to the involvement of a dithiol group in this protein,
«
9
as opposed to a raonothiol in the muscle enzyme, accounting for the
t
♦
inhibition of the latter by pCftlB. Later data from the purified enzyme
(
system cast some doubt on this interpretation.
4
Further discussion of these data at this point would be of little
t *
value, as most of this work was repeated on the purified material, and
*
this table has been included solely for comparative purposes. However,
9 9
as well as establishing a differential effect between host and parasite
• • •
enzymes with regard to the arsenicals, it also shows that the monoraorpli-
and pleomcrph- derived enzymes are affected in an identical manner.
All six of the active inhibitors from this tabulation have 1-^ values
5U
♦
which, within the range of experimental error, are equal for the two
%
9
types of infection. The value of this identity lies in the following
9
section of this thesis, on the purification of trypanosome FJC. On the
0
basis of these results, it was decided that lyophilised T.brucei TREU 277
would be used as the starting material for the purification process, as
f
it is very much more rapid and simple to produce (relatively) large
»







Reaction with melarsen oxide
0
4
The I™ values quoted in Table 19 are subject to criticism on the
50
grounds that the arsenicals will react with protein thiol groups other






















Concn. of melarsen oxide (pM).
FigI 14. Interaction of melarsen oxide with the thiol
groups;of lyophilised trypanosomes. Resuspended,
lyophilised T. rhodesiense EATRO 173 was incubated in aqueous
solution with melarsen oxide for 20 minutes prior to the
estimation of free thiol groups by Ellmans reagent as
described in Chapter 3.. The concentration of thiol groups is
represented as the absorbance at 412nm of the final solution.
free in solution, and giving artificially high IKn values. One
critical experiment which should have been carried out on the purified
enzyme, was to show that on reaction with an arsenical, the free thiol
content of the protein decreased. As will be discussed, technical
difficulties have so far made this experiment impossible, and despite
the objection mentioned in this paragraph, the interaction of raelarsen
oxide with the protein thiols was investigated using the crude enzyme
laterial as an inferior alternative.




after incubation with low concentrations of the arsenical"for 20 minutes.
The maximal coupling of the thiol groupings with raelarsen oxide appears
Jt
at approx. 10 M-inhibitor, at which concentration roughly 5$$ of the
free thiol groups appear to be coraplexed. As the arsenicals were
thought to be specific for dithiol groups, this figure appeared rather
high, although reaction of a molecule of raelarsen oxide with two
monothiol-containing protein molecules is of course possible. The
increase in free thiol concentration at higher inhibitor concentrations,
4
while unexpected, may be accounted for by either of two hypotheses. At
these high melarsen oxide concentrations, thiol groups which are not
readily coraplexed with the arsenoxide group (e.g. monothiols) may react
and thus cause a conformation change in the protein molecules thereby
exposing previously "hidden" unreactive thiols. On the other hand,
whereas at low concentrations of the inhibitor- one arsenical molecule
may be forming strong bonds with two thiol groups to produce a cyclic
thioarsinite, in the higher range two arsenical molecules may be react¬
ing with the same thiols to produce much weaker links between the arsenic
atom and one sulphur atom. These bonds would be much more readily .
broken in competition with the Ellinan's reagent and would thus increase
the apparent concentration of free thiol.
Suffice to say, then, that reactions do occur between the
trivalent arsenical trypanocide and thiol groups in the trypanosornal
material, and between melarsen oxide and PK. The remainder of this
work is devoted to the purification and characterisation of PIC from





4) PURIFICATION OF TRYPANOSOMA PYRUVATE KINASE
0
#
The published methods for purification of PK are without exception
0
0
based on materials which are readily obtained in large quantities
(e.g. Tanaka et al., 1967a, la - 5 kilos rat liver). This allows the
utilisation of methods of purification giving good increases in specific
activity but low total recovery of activity - in the paper cited above
ft
ft
6.1$ M type and 1.6$ L type-PK were the final yields. In the case
•
ft
of trypanosomal material, the lyophilised starting material was avail¬
able in milligram as opposed to kilogram quantities, and hence a
different approach was necessary.
ft
This lack of material probably accounts for the fact that at the
commencement of this work, no report had been produced on the purifi-
%
cation of an enzyme from T.rhodesiense or T.brucei. Seed and Baquero
(1965), had centrifugally separated a T.rhodesiense lysate into sediment
and supernatant to demonstrate the particulate nature of hexokinase,
0
but no further purification was undertaken. Their preparation of




To date, only one further purification of an enzyme from this
organism has been described# Risby et al#, (19&9) obtained a 60-fold
4 ft 0
increase in the specific activity of phosphohexose isomerase (E.C.
0
5.3.1.9) by ammonium sulphate fractionation and BEAE-sephadex chromato-
0
graphy. In the context of the present work, it is noteworthy that
these authors state as their primary reason for choosing this enzyme
t •




Many of the purification techniques which were tried and found
to yield low recoveries of activity in this work, will only be dealt
with in brief. To avoid the cataloguing of an excess of data, the
*
quantitative results of these experiments will be confined to one set
0
*











The use of 25$ (V/v) glycerol solutions for many trial experiments
complicated manipulation of the material due to the high viscosity of
m
%
the resuspension. Aqueous resuspensions of the freeze-dried material
0
were therefore used despite the relatively low stability of the enzyme
in this solution, as most preliminary experiments could be rapidly
0
»
completed. An untreated aliquot of the lyophilised material resuspended
0 %
0









Solubilisation of pyruvate kinase.
0
The particulate nature of the resuspended freeze-dried material
necessitated the inclusion of a solubilisation process as the primary
9
0
step in .the purification. At this stage, the desired combination of
0
results from any treatment was a high recovery, with a high percentage
♦ 9
9
of activity in the supernatant after centrifugation (3000g for 10 minutes).
The method of solubilisation which best met these requirements was found
*
to be Teflon homogenisation in the presence of deoxycholate as a solub.il-
4
4
ising agent. Triton-X 100, which gave slightly higher yields, interfered
<
strongly with the estimation of protein spectrophotometrically at
9
4
260/280 nm and had to be replaced routinely with deoxj'cholate. When
TABLE20
Non-polarsolventextractionflyophilisedT.bru iREU277 'J
Lyophilisedmaterialwasresuspendedint r,25$/vglycerol,ordir ctlyit olv nt,tCc n n- t .»• trationof3rag/ml.Aque usndglycerolsolutionswe ema90$/vths lv nt,nds lu i nsw re *K
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this procedure was carried out in TGD, the supernatant yield v/as from
I «
87$ - 96$ of the activity. This supernatant, however, was exceptionally
• •
glutinous and was totally unsuitable for further purifications involving
column separation of protein fractions. A primary treatment of the
0
lyophilised material was therefore necessary, to decrease the viscidity
of the preparation which is probably due to the presence of large amounts
I






Treatment with non-polar solvents.
Application of Teflon/deoxycholate homogenised samples to columns
of DEAE-cellulose, Sephadex or Biogel, repeatedly resulted in obstruction
9
of the columns, and elution of the small amount of activity which was
0
recoverable, in one peak at the solvent front. It was found that a




prior extraction with a non-polar solvent. The results of extractions
• 0
with acetone, diethyl ether and benzene may be seen in Table 20.
ft
Prom inspection of these results, it appears that solvent extract¬
ion in aqueous solution is unproductive, and direct ether extraction of
%
lyophilised material was incorporated as the first step in all subsequent
I
«
procedures. The yield of activity at this step varied from 89$ to 9&$
r
and was maintained in the higher part of this range by previous drying
of the ether over anhydrous sodium sulphate. The sedimentation of
protein material after ether extraction was found to be complete after











PK from acetone- or ether-water mixtures (Table 20), the loss of
Saturation with (NH4) SO4
Fig. 15. Ammonium sulphate fractionation of lyophilised
T. rhodesiense EATRO 173. Lyophilised material was ether-
extracted and resuspended in water at 2.0 mg/ml. Finely ground
solid ammonium sulphate was added to aliquots of the pre-
cooled suspension in ice, to concentrations up to 80%
saturation. After standing for 20 minutes in ice, with
occasional stirring, the incubations were sedimented for 10
minutes at lOOOg and the supernatants removed for assay.
Sediments were resuspended in a volume of water equal to that
of the original solution. All assays were carried out in the
standard assay medium witjh 1.25 pmol ADP and 5.00 pmol PEP, and
were initiated by addition of enzyme. Rates are plotted as %





activity accompanying dilution of the resuspended material with ethanol
4 0
was too great for the method to be of use in this work. A differential
precipitation of protein could be obtained between 25$ (V/v) and 50$
4
(v/v) ethanol at-10oC, using a 25$ (V/v) glycerol resuspensipn of ether
. •






Fractional denaturation by heat.
ft
4
Purification of rabbit muscle FK by Tietz and Ochoa (1962) involved
I
ft
denaturation and insolubilisation of contaminating proteins by heating
of the material at 60 - 65 C. After one minutes incubation at this
temperature, ^ 16$ of the activity was recoverable from aqueous or
ft
glycerol solutions of the trypanosome enzyme. Heating at lower
ft
temperatures similarly destroyed the enzyme without removing significant








The response of trypanosomal FK to ammonium sulphate fractionation
is described in Figure 15• The minimum in the total recovery curve
is still of doubtful cause. Ammonium ions are known to be able to
ft
replace potassium ions as activators of FK, but as the volume of enzyme
used per assay was 0,10 ml, the final concentration of ammonium ion
V




with 3$ ammonium sulphate present in the assay cuvette, showed no
«
significant effect at this salt concentration.
I
ft
Later experiments on ammonium sulphate fractionation using a
40 - 60$ or a 40 - 70$ cut, gave higher yields of activity in the
t
4
precipitated fractions, varying from 80 - 90$ of the total activity
\
in a 40 - 70$ fraction, and from 60 - 80$ in the 40 - 60$ sediment.
102
The primary objective of these purification procedures, namely high
e •
. yields of activity, was therefore met to a satisfactory degree by this
technique. The activity of the above sediments was therefore corre-
i
lated to the protein content, and the results of two representative
experiments are tabulated below.
Protein was estimated by the standard procedure on the original
material, and on the fractions, after the latter were dialysed for one
hour against water (2 changes) to remove interference from ammonium
sulphate.
. Fraction ' ' Units activity Protein Yield Specific activity
^units/mg protein)
Total resuspension 9*32 ■ 16.08 -- O.58
40 - 60$ 6.41 3.75 69$ 1»72
40 - 70$ 7.65 8.14 82$ O.94
Total resuspension 9*35 11.42 - 0,82
%
40 - 60$ 6.90 2.56 74$ 2.74
4
40 - 70$ 8.22 5.10 88$ 1.61
&
Activity measured at the same time as the dialysed fractions.
When a similar fractionation was attempted on a 25$ (v/v) glycerol
enzyme, very The
ammonium presence of
glycerol, and at salt concentrations approaching saturation in this
I
solvent, the majority of enzyme activity remained in the supernatant
and practically no protein precipitate was obtained. When higher
centrifugal forces (up to 10,000g for 10 minutes) were employed to
|
separate the fractions, enzymic activity was sedimented in parallel
9
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The elutlon of pyruvate kinase from DEAE-cellulose.
Ether extracted, lyophilised T. rhodesiense EATRO 173 was
resuspended in 25% (v/v) glycerol at 2.5 mg/ml. To aliquots of
this material was added DEAE-cellulose (Igm wet wt./5.0 ml soln.)
pre-swollen in the same solvent, and the mixture was allowed to
equilibrate for 20 minutes in ice after adjustment of the pH to
7.3 with 0.1M-K0H/HC1. KCI (1.0M) was added to give the final
concentrations indicated after equalisation of the volumes with
25% (v/v) - glycerol. After a further 20 minutes the samples were
centrifuged briefly at 200g to remove the DEAE-cellulose and the
supernatants were assayed for activity in the standard assay
system. The protein content of the supematants is represented
as the extinction at 280nm.
10.5
4
Aqueous ammonium sulphate fractionation therefore appeared to be a
0
%
possible method of purifications' under controlled conditions. However,
4
experiment showed that the extraneous protein removed by this technique
was eliminated on a Biogel column at a later stage of the purification,
V












chromatography, has been reported from various enzyme sources (e.g-.
4
Washio & Mano, 1960$ yeast). Despite the use of ether extraction as
4
the primary step in the purification procedure, permanent adhesion of
. -
the enzyme to a column of DEAE-cellulose still occurred, unless a
4





. out. Some indication of the elution properties of the enzyme by a
salt gradient was obtained from the use of a batch addition technique,
4
4
the results of which are plotted in Figure 16. The release of activity
%
is very much less sharp using this technique, than that obtained by use
of a column procedure after CM-csllulose and Biogsl-A treatment. Attempts
4
were made to improve this process by alteration of equilibration time,
the enzyme/cellulose ratio and by elption by changes in pH. Neither
the yield of activity- nor the sharpness of the elution profile was









The blockage of DEAE-cellulose columns by the resuspended ether-
$
extracted material was not thought to be entirely due to the viscosity
of the applied samples. It appeared that an interaction between the
protein solution and the column material was causing a denaturation
9
ft
and precipitation of the protein, thereby producing the gelatinous
"plug" at the top of the columns. It was thought possible that this
ft
0
non-specific precipitation was inhibiting the release of the absorbed
ft
PK, and CM-cellulose columns were therefore used to allow this precipi¬
tation to occur under conditions where the kinase itself will not be
ft
ft
absorbed to the column.
ft
Application of the resuspended ether-extracted material to a CM-
ft
ft
cellulose column, and elution with TC-D gave yields of activity in the
range of 80 - 90$ and a purification factor of approximately three-fold.
The active eluate from such a column was found to be diluted by a factor





To concentrate this material, unswollen Sephadex 0-10 was added to
« •
the solution and allowed to swell, before centrifugation and removal of
the gel. However large losses of activity occurred on contact, with the
♦
Sephadex, and this technique was abandoned in favour of the use of poly¬








Sephadex, Biogel ct DEAE-cellulose columns to effect further purification
Dilution of the application to the CM-cellulose column by a factor of
five- or ten-fold, to simulate the eluate dilution, did not improve the
ft
ft
activity yields and slightly decreased the purification factor. Simple
dilution of the resuspended ether-extracted material and subsequent re-
concentration did not yield any diminution of the gelatinous properties
of the material, so the removal of extraneous protein on the column
ft
appears to be the critical factor.
The ion-exchange properties of the CM-cellulose column appear to
be involved in a normal fashion in the absorption of unwanted protein,
0
as replacement of the column by one of finely powdered cellulose did
0
not give a useful separation or purification. However, the shape of
%
the elution profile from the CM-cellulose column (Fig.17) leads the
0












ii'i. / Gel filtration
. «
Many variations of conditions were employed in attempts to effect
0
a purification using Sephadex G-150, Sephadex G-200, and the spherical
J
agarose gel, Biogel-A, in various mesh sizes. On samples not previously
*
treated with CM-cellulose, yields were consistently very low ( < 20$),
0
and elution profiles were with one exception confined to a single protein
0
0





from an ammonium sulphate" fractionation as the column application. This
0
produced three peaks on the elution pattern, but the activity yield was
only 18$.
0
After treatment with a CM-cellulose column, however, a very satis-
0 *
0 0




yields of activity. Sephadex G-200 gave rather poorer separations and
lower yields with the result that this method was discarded.
0
$
Ho benefit would accrue from further extended description at this
0
point of variations in elution procedure and profiles obtained with












Fig.' 17. The elution of pyruvate kinase from CM-cellulose.
The column of^ CM-cellulose was pre-eqilibrated and eluted
with TGD. Pretreatment of the material and chromatographic
details are described in the adjacent text. Enzyme activity





Purification procedure adopted for trypanosome pyruvate kinase.
%
On the basis of the trial procedures described in the previous
0
section, and many others, the following routine was chosen as a
P
standard method for purification of the enzyme*
Lyophilised material (100 - 150 mg) was resuspended in peroxide-
free, sodium sulphate dried, precooled ether, at a concentration of
1 mg/ral, After homogenisation in a cooled glass mortar with a Teflon
0
pestle, the material was allowed to stand for ten minutes in ice before
9
rehomogenisation, and centrifugation at 3000g for five minutes. The
0
ether layer was removed by suction and the extracted material dried in
c
a current of air. The dried residue was resuspended at a concentration
0




length 30 cms and total volume approximately 240 ml. Elution was
0
carried out with TOD, the column being pumped at a rate of 40 ml/hour,
and 100-drop fractions were collected on an 1KB "Ultrorac" fraction
collector fitted with a "Uvicord" ultraviolet 260 nm scannex'. As the
0 m
material in this state contained a large amount of nucleic acid, the
0
fractions were reassayed manually on a Unicam SP5OO or SP&OO spectre™
9
photometer to obtain their absorbances at 280 nm, and so detect more
accurately the fractions containing protein. As TOD interferes with
the absorbance at 280 nm due to the presence of unknown quantities of
*
oxidised DTT, fraction 1 or fraction 80 from the column was used as a
blank, zero value. Aliquots of selected fractions were assayed for
enzymic activity in the standard assay system, and a typical elution
profile is shown in Figure 17• The abscissa is plotted in terms of
the fraction number as opposed to elution volume, due to the variability
found between individual fraction volumes as a result of variation, in
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Fig. 18. The elution of pyruvate kinase from Biogel-A
(150-200 mesh). The column of Biogel-A was pre-equilibrated
and eluted with TGD. Pretreatment of the material and
chromatographic details are described in the adjacent text.
Enzyme activity was measured in the standard assay system.
The active fractions from the CM-cellulose column were combined.
i
Although a greater purification is obtained at this stage if the second
0
protein "peak" is omitted, it was found that increasing the specific
0
activity.in this manner at the expense of the yield of enzyme, did not
*
0
significantly alter the purification obtained overall; the extraneous
%




Ho amount of care in the preparation, loading or elution of the
*
column decreased the spreading and tailing of the protein peak, and
it is suspected that precipitation and resolubilisation are occurring
on the column. Elution of the column, after removal of the primary
A
4
peak, with a KC1 gradient from zero - 1 M-KC1 in TGD, produced varying
✓




enzymically active. The position and number-of these peaks were
irreproducible, and they are not included in Figure 17 as a result.
The total amount of protein eluted in this fashion was never in excess
0
of 25$ of that applied, and was in most cases between 10 - 15$.
The combined active fractions were placed in a preboiled dialysis
ft
sac, and immersed in "Carbowax" for 12 - 24 hours in a cold room, the
time in any individual case being that required to reduce the volume
*
to 20 - 30 ml. After assay, this material was applied to a column cf
0
Biogel A, (150 - 200 mesh, 50 cm in length, approximately 400 ml in
volume), which had been previously equilibrated in TGD. Elution from
w
such a column with TGD gives a profile such as that shown in Figure 18,
which was obtained at a controlled flow rate of 40 ml/hour. In some
fractionations, a small amount of activity ( ^ 10$) appeared as a peak
coincident with the first protein peak shown on this diagram. On one
i
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properties as the major enzymic fraction."- Although the properties
of this minor and variable fraction were not investigated in such4 w
• «
detail as those of the major activity peak, sufficient evidence was
4
* *
obtained to suggest that this minor peak is due to binding of the PK
to some other protein element in solution, rather than to the existence
4
♦ • •
of an isoenzymic form of the enzyme. This enzyme had the same Kj^ADP,
Sj.qPEP and FDP-activation characteristics as the enzyme from the major
peak. •
■The combined active fractions of the major activity peak were
4
routinely subjected to treatment with "Carbowax" as described for the
CM-cellulose fractions, as the enzyme was found to be more stable in
the concentrated form. The final purified material was optically
clear, and unfortunately did not contain adequate amounts of protein




products with the spectrophotometry estimation of protein at 280 n
4
made this method unreliable. However,■an approximation to the protein
content could be obtained by the method previously described for the
CM-cellulose fractions. The purification data for a representative
run, (shown in Figures
Comments on the purification scheme.
The graphical representation of the Bicgel-A elution profile shown
in Figure 18 is of one of the later purification processes. Previous
attempts, in which the elution rate of the column and the ionic strength
medium
+
enzyme peak varying from about' 2 - 5 mg protein, as estimated from th
nm
absorbance at. 280 nm of the application. For the kinetic studies
%
reported below, a satisfactory minumura purification factor of sixty-
ft
fold was set as the final requirement.
Variation of the conditions employed in running the Biogel-A
column did not increase the enzymic yield, and as mentioned above,
s
ft
occasionally altered the protein elution profile. The inclusion in
✓
the TGD system of 0,007 H-MgSO. and 0,07 M-KC1, for examnle, shifted
4
« •
approximately 60$ of the 280 nm-absorbing material from the first to
*
v




minor peak in the region of the pyruvate kinase active fractions. This
information, similar to that obtained on ammonium sulphate fractionation
of the lyophilised material, may be of use in the preparation and




ii. Application of the active fraction from a Biogel A column to a
ft
ft
column of DEAB-cellulose was found in later purifications such as that
ft
ft ft
described here, to be unnecessary. In earlier purifications, where
ft
ft





purification of the enzyme on DEAE-cellulose was successfully carried
out, the enzyme eluting at approximately 0,1 M on a KC1 gradient. Yields
• • «
4
from such a procedure were low ( < 50$) and this step was avoided when¬





iii. The final preparations from Biogel A, from three batches of
lyophilised material, were found to be free from the following enzymes:
hexokinase, enolase, fructose 1;6 diphosphatase, aldolase, ATPase and
any other enzymes utilising PEP. Carbon balances carried out with the
ft *
purified material gave the following results, the method being identical
9
to that described previously in this chapter.
110










Kinetic studies involving variation of PEP concentration using
the purified material appear therefore to be valid.
Preparation of the purified enzyme for kinetic investigation
The final enzyme preparations produced by the procedure developed
0
above, is in a buffered 25$ (V/v) glycerol solution containing 10 " M-DTT
and to produce a conveniently measurable rate of approximately 0.1/umole
per minute, up to 50fxl of this freshly prepared solution is required
per assay. In an assay volume of 3.0 ml, the final concentration of
DTT will therefore be of the order of 2 x 10 ■5 „M. As conoentrations
of the arsenicals in the region of 10-5 10
-4 .
M were necessary to
0
produce 50$ inhibition, removal of the stabilising thiol reagent- prior
B
*
to assay of the enzyme was essential, to avoid complexing significant
quantities of the arsenical with this reagent in ccmpetiti with the
enzyme thiol groups.
The enzyme was found to be very much more unstable in the purified
4
form, especially in the absence of DTT, than in the crude material under
similar conditions. following
removal of the thiol.
A column of Sephadex G-25 was prepared, the gel being swollen in
0.1 M tris pH 7,2/25$ ( /v) glycerol and thoroughly degassed by boiling
under reduced pressure prior to preparation of the column. The degass
ing
( ^ - 0.83 - O.87) and the column (l8 cm long; volume 50 rajl)
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Preincubation period inutes
The stabilisation of purified pyruvate
kinase in the assay medium. .Aliquots of enzyme (50 pi)
were added to the standard assay medium in the presence
of the stabilising agents as indicated. After
preincubation the reactions were initiated by addition
of ADP (1.25 pmol) and PEP (5.00 pmol), except in the
case of the zero-time figure which was obtained by
starting the reactions by addition of enzyme. . -
I




Biogel-A eluate (2 - 3 ml) was applied to this column, eluted with
|
ft
deoxygenated Tris/glycerol and fractions were collected under paraffin.
Under these conditions, the enzymic yield was from 40 - 60$, and th9
enzyme in the final solution had a half-life of approximately four hours
ft
compared to the half-life of about 3 days in the concentrated Biogel-A
ft
ft
eluate containing DTT. Where a column of this type was used more than
*
once, thorough washing with a solution of sodium dithionite after use,
followed by re-equilibration in degassed Tris/glycerol markedly increased
0




Removal of DTT did not affect the kinetic properties of FK, and this
4
m
procedure was therefore only followed for investigation of the action of





























large errors. This was found to be due to the fact that despite the
•ft
ft
relative stability of the enzyme on storage in TGD, the enzyme was
4
exceptionally unstable on dilution in the assay medium. This instability
could be diminished by a number of substances, most of which interfered
with the inhibition of the enzyme by melarsen' oxide, and were therefore
of little use. The effects of four stabilising agents are shown in
ft
Figure 19 •
The activity of the unprotected enzyme is almost totally lost, in this
case, after approximately 7-8 minutes preincubation in the absence of
s
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Total ^monovalent cationj (VnM x 10"2^).
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The effect of monovalent cation concentration on
the activity of purified pyruvate kinase. Aliquots of enzyme
(100 pi) were assayed at the indicated cation concentrations in
the presence of 6.67mM-MgS0^. All other assay conditions were
standard and reactions were initiated by addition of enzyme.
Monovalent cations were added as the chloride salts.
112
0
of purified enzyme, and extended from 12-15 minutes with fresh material
to 4™6 minutes after storage for 3 days.
Glycerol, PEP, BSA and EDTA all significantly stabilised the enzyme
in the assay medium, but EDTA alone had the property of stabilising
without protecting against the inhibition by melarsen oxide. The other
three reagents all showed a protective effect .against the arsenical.
Following these results, EDTA (final concentration 10 M) was included
in all assay media.
After storage of the enzyme in TOD for 3 days, the cooperative
ft
kinetic effects of PEP and FDP decreased markedly. Up to this time,
the properties of the enzyme with respect to these effectors appeared to
be stable, although the sensitivity to melarsen oxide decreased over the
whole period of storage. Wherever possible, the enzyme preparations
were therefore used within 48 hours of purification, and samples were
routinely discarded after 72 hours.
Effect of monovalent cations.
Prior to investigation of the cation requirements of the enzyme, it
was necessary to remove the cation contaminants from the enzyme solution,
again by treatment on a Sephadex G-25 column. Elution from the column
in this case was carried out with 25$ 0/v) glycerol/.05 M-tris pH 7,2 .
and the substrate, coenzyme and buffer in each case were neutralised with
the appropriate base. The LDH solution used was dialysed for six hours
against three changes of distilled water to remove ammonium ions, the
commercial preparation being stabilised in 2.2 M-ammonium sulphate.
Despite these precautions, the apparent residual activity in the
absence of exogenous monovalent cation probably indicates some contamin¬
ation with potassium ions rather than the ability of the enzyme to
%
A Mn
i i A A A J
0 to 20
Total [divalent cat ionJ m M).
Fig. 21. The effect of divalent cation concentration on
the activity of purified pyruvate kinase. Aliquots of enzyme
(100 pi) were assayed at the indicated cation concentrations in
the presence of 66.7mM-KCl. All other assay conditions were
All reagents were titrated to the assay pH with 0
Divalent cations were added as the sulphate salts
enzyme
li.
function in the complete absence of the ions (Figure 20), To prove a




waters and further use of an inactive base for reagent titration (c.f,
Kayne & Suelter, 19651 (^H-j)^ N+ CI ). As, however, the major function
of these tests was to determine optimal conditions for assay, 67 raM-KCl
ay
investigation of the monovalent cation requirement was carried out-
Effect of divalent cations
The PK of muscle and erythrocytes has been shown to be partially
2+ 2+
activated by Mn ions as a replacement for the more commonly used Mg
salts (Boyer, 1962; Solvonulc & Collier, 1955) • Figure 21 shows the
P
relationship between added cation (in the form of the sulphate salt) and
P
reaction rate, in the presence of 67 raM-XCl. On the basis of these
2-|.
figures, 6.7 mM-Mg was retained as the optimal divalent cation concen¬
tration.
From data of this nature, it should be possible to determine the
2+ 3-
predilection of the enzyme for free Kg , fi'ee ADP , and the MgADP
complex, but two factors make this analysis impracticable. Firstly, in
S
the absence of exogenous divalent cation, the activity of the preparation
does not decrease to the expected zero rate. Although extrapolation of
the data enables an approximation to be made- of the levels of contaminat
ing cations, the errors involved contribute greatly to the inaccuracy of
the estimation of final MgADP complex concentrations at low cation
concentrations. Secondly, the significant part of these data for purpose
of establishing the concentration of free ADP^ lies at these very low
2+
levels of Mg" ion, and the error in estimation of these slow enzymic rates









































































At the Mg concentration used routinely for enzyme
assay, (6.7 raM) all the ADP present is in the form of MgAI)F~;
Both cations inhibit the kinase in high concentration, although the
tolerable level of free Mg exceeds that of free Mn . Apparent half-
, ~4 ">+
saturation values are approximately 6.7 x 10 M-2%" and approximately
» I
~4 2+
1 x 10 4 M-Mn .
f
Effect of nucleotide coenzymes
Two double reciprocal plots describing the effects of ADP concen
tration on the enzyme activity are shown in Figure 22, The weighted
regression lines fitted to these data give extrapolated K^ADP values of
8.3 - 0.4 x 10"5 M-ADP (1.67 mM-FEP) and 8.0 £ 0.3 x 10 5 M-ADP (0.67
M-PEP). The mean value, obtained in the presence of 1.67 mM-PE'P, from
"




dean of 0.5 x 10 M, These figures, as discussed in the
section pertaining to the crude enzyme system, are in reality the K, J
JVi
values for the MgADP complex, and., they appear slightly lower than those
obtained with the unpurified system.
The independence of the value for the coenzyme of the concentration
9
of substrate over the range 0.33 - 2.5 mK-PEP is shown in Fig, 23. as
basic pattern for a bireactant system indicates a sequential mechanism in
enzyme
no irreversible step intervening between the combination of the first and
second cosubstrates.
*
Further discussion on the mechanism of this enzyme
will be found in Chapter 6, the only other point to be made here being
inhibition was found by ADP
4.5 x 10™4 M.
TABLE 22
Nucleotide specificity of purified trypanosome pyruvate kinase
Apparent K' and V values were determined as in Figure 22, the dataM rftctx
being treated as described in Chapter 3. app. values are quoted as
the mean of six determinations on a total of four enzyme batches, with'
the exception of ALP which is from seven determinations on seven enzyme
batches. V values are from one representative sample, on which three
max ,
estimations were carried out. Both parameters are mean values -- SEM.
s














GDP 0.098 0,010 1.40 0.16
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Nucleotide specificity
The specificity of the purified enzjnne for the nucleoside diphos
phate phosphoryl acceptor was investigated, and comparative apparent
ft
KL, and V values are shown in Table 22. The preferential bindingM Rlqjb
of ADP and GDP by this enzy
*
enzyme (Plowman & Krall, 1965), although the binding of GD? by the try™
panosomal enzyme is relatively stronger with respect to ADP. The primary
A
conclusion from the data on CDP and probably on UDP, is that the apparent
K„ values are higher than those of ADP and GDP. The large standardM
t
deviation values of the extrapolated K.„ and V values cast some doubt* M max
on the validity of the absolute values in the cases of UDP and CDP,
chiefly due to the difference between the available range of coenzyme
coenzyme) and the apparent IC„ values.
pH dependence of the apparent Mchaelis constant for ADP.
Direct involvement of thiol groups in the action of PK is difficult
to demonstrate. It was hoped that the ionisation of one or more of these
groups could be shown to affect the kinetic parameters of the enzyme, but
unfortunately the extremely low yields obtained from the pux-ification and
the low rates of activity in the normal ionisation range of thiol groups
precluded this demonstration. To avoid the discontinuities often shown
in enzyme responses to change in pH where different buffers are used in
« ♦
different regions of the pH range, the ne Figure
w0*
shown. The strict interpretation of these data in terms of the ionisation
of groups on the enzyme, ADP or enzyme-ADP complex is limited due to the
unfeasibility of using saturating concentrations of PEP for every asi
PEP








prohibitively high substrate levels. Despite this difficulty, the
4
inflection in the pK^ versus pH graph is interpretable qualitatively in
0
the following manner.
The graph of pTCg versus pH theoretically consists of straight-line
• sections of integral slope, joined by short, curved, corners. Each
inflection in the graph indicates the ionisation of a group in one of
0
\
the reaction components, the pK being derived by extrapolation of theSL
0
linear segments to their intersection. The ionisation of a group in
the EX complex (where X is a substrate or cosubstrate) produces a unit
increase in the slope; that of a group in either the free enzyme or
4
substrate produces a unit decrease in the slope. Quantitatively, the
distance between the linear intersections and the curvature of the graph
is equal to a (vertical) distance of log 2 = 0.3; if two groups ionise at




imposed upon these data by the use of a non-saturating concentration of
0
PEP this quantitation is not permissible in this case.
V/hen the ionising group on the enzyme or the free substrate is
directly involved in the binding of enzyme and substrate, the ionisation
is normally entirely suppressed and results in a discrete kink in the
♦
graph (cholinesterase, Dixon, 1953: alkaline phosphatase, ibid.,). The
wave-like form as seen in the case of this trypanosome enzyme, has been
interpreted as the ionisation of a group not actively involved in the
» 0
complexing of enzyme and substrate, but one whose pK is altered by this
zA
combination (Dixon & V/ebb 1958); this case the pK shift is from
approximately 6.6 in the free enzyme or substrate to 6.1 in the EhlgADP
4
complex. The titration curve of ADP in the presence of the assay concen-
2+
tration of ?.?g ions shows no ionisation in this region, indicating that
0






enzyme over this pK range, and the following data indicate that this is
not a significant factor. Two assay mixtures were prepared at pK 6.02
ft
and 7.21 respectively, in a final volume of 2.80 ml. Enzyme (lOOyul)
was added to each of these media, and after 2„5 minutes the acid assay
fc *
system was brought to pH 7»21 - 0.05 by addition of 0.1 il-KOII.
Both experimental and control incubations were started by addition
of ADP (l.25^/.imole) and PEP (5yumole) at six minutes, and the initial
velocities were measured This experiment repeated with a sample
preincubated at pli 7.71s and retitrated with 0.1 M-HC1 to pH 7*21, the
ft
ft



















The comparatively large errors in these figures arise from the
ft
%
difficulty of accurately measuring the final volumes of the titrated
ft
experimental assays, but some indication is obtained that the profiles
obtained for variation of the kinetic parameters over this pH range are
real, and are not artefacts due to the increased instability of the
enzyme at the extremes of pH
Effect of PEP concentration
The activating effect of PEP on this enzyme
the work carried out on the crude material, was confirmed in a considerably











































Fig. 25. The effect of PEP concentration on the activity of
purified pyruvate kinase: direct and Lineweaver-Burk plots
data were obtained as for Fig. 22. The concentration of ADP




















Fig. 26. The effect of PEP concentration on the activity
of purified pyruvate kinase: Hill plots. The data of Fig. 25
expressed as the double logarithmic plot. Analysis of the
data was carried out as described in Chapter 3. 0 = 4.17 x
10~4M-ADP: O = 0.83 x 10~4M-ADP.
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reciprocal plots in Figure 25 are illustrations of the type of data
4
0
obtained by variation of the PEP concentration arid aro included solely
t
as an example of the forms of the curves. These methods of graphical
*
analysis are of little kinetic use, and the same data are replotted in
*
Figure 26 in the form of Hill plots.
*
i
It may be seen that variation of the coenzyme concentration over
the range 8.3 - 41•7 x 10 ^ M-ADP does not alter the kinetic parameters
of the enzyme with, respect to PEP. This independence was confirmed by
repetition of these measurements on two other enzyme batches,
Figures 25 and 26 show an S,.^ value of 0.69 mM-PEP. Subsequent
purified batches, when assayed immediately after the final stage of
purification, yielded Sc~ values ranging from 0.82 - 2,31 x 10~^ M-PEP
pu
a considerable range of estimates. From eleven purified specimens, th<
mean and S.E.M. of the 3__ PEP value was 1.44 - 0.13 x 10 M-PEP.
5U
The siginoidal shape of the substrate concentration versus velocity
%
curve, indicates the.possibility of allosteric control of this enzyme,
%
P
although many other kinetic conditions could account for sigmcidicity
. of this nature. Under the standard conditions of assay employed in
these experiments, linearity of the Hill plot over the entire experimental
♦
range of substrate concentrations is obtained. However, in some subse
quent experiments, where optimal conditions no longer hold and much lower
rates were obtained, non-linearity at the extremities of the graph was
observed. In these cases, the gradient through the abscissa, where the
concentration of PEP = the S_^ value, is used to define the Hill coeffic-50
lent.
pH dependence of the kinetic parameters of PE? utilisation
The experiments defining 5<T ' ^rriax

















































TheeffectofpHntHillcoefficientf rPEPurifi dyruvatekinas 24.andtheHillcoefficients


































TheeffectofpHntSjqPEFvaluepurifiedy uvatekinas .D trfro:
thesameexperiments _asFig.27S50valuw reexpress dmM-PEPndlotte-logS o. ♦w ADPconcentration-"1.25mM.-
'1
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in which the variable was the ADP concentration The pH range available
ft
for study was again limited due to tho extremely low rates of reaction
ft
obtained outside the extremes of pH 5.8 and 7«9j and the data obtained
are expressed in Figures 27~29.
The Hill coefficient
ft
Over the pH range which was investigated, the cooperative interaction,
of the multiple PEP binding sites appears to be unchanged, in marked
contrast to that of the liver L type enzyme, where the coefficient rises
continuously from n = 1.0 at pll ^ 6.8 to n = 3.0 at pH 8,5 (Rosengurt
et al » 1969)
•ft
J» •
li. The S,._ value.
50
These data, which are analysed graphically in the form of the pS
9
ft
(-log Sj-q) values to simplify interpretation, are subject to the same
50
limitations as mentioned for the variation in K^A'DP with pH. The slopes
of the extrapolated linear parts of this plot are theoretically integral,
-s
each ionisation producing a change of - 1 in the slope As in the
*
neighbourhood of the pK value, the enzyme or substrate group ccntributin
to .the' ionisation is not wholly in either of the ionic forms available,
curvature of the experimental data is expected, and the linear gradient
*
ft
between pH 6.9 - 7.4 must be interpolated. Depending upon the number of
points included in the determination of the regression line of slope ~1 in
this pH region, different values for the two pIC 's (defined by the inter-a
section points) are obtained as follows.
m
Inclusive pH values used
in regression
pK values obtained



































The directions of inflection define the group with the higher pK
belonging to the enzyme
enzyme or the substrate. Again
2+
however, titration of PEP in the presence of Mg ions showed no ionisation
of this substrate in the range pH 6.2 - 8.0, indicating that the group
resides on the enzyme molecule. It is not possible to decide whether
these pK values describe two separate groups, or the ionisation of one
A
group whose pK shifts on binding PEP, from the lower to the higher range.cl
third 5.9 - 6.0 9
corresponds to the ionisation of PEP which occurs at pH 6.0 in the pres
2+
ence of Mg ions. It thus appears that a doubly ionised phosphoryl
group is essential for the binding of PEP to the enzyme.
iii. The V value.
max
Under the conditions at which V obtains, the enzyme is totallyG13X
4
saturated with substrate; in this case where cooperativity exists between
binding sites for PEP, the enzyme is totally in the ES^ state (where n
9
olecules of PEP are bound per enzyme molecule). Any effect of a
variation in pH will therefore reflect an ionisation of the E3^ complex,
effects on the affinity of the enzyme for PEP being eliminated.
Over the period required to perform these experiments (2§-3 days),
the Vfflax value of the enzyme drastically decreases, in terms of /umoles /




Repeated estimation of the V value at this pH enabled a correction to
max
be made for the data at other pH values. Figure 29 indicates that two
groups in the ES^ complex ionise in the pH range 5*7 - 7»9> with pKa
values of 6.2 - 6.3 and 7o - 7*6.
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It is possible that the group ionising at pH 7 = 5 - 7»6 is identical
with the ionisation estimated at pH 7 = 1
9
7 = 3 from the graph of pS,.^ v. pH
This would indicate that the real value of the ionisation lies at the
upper end of the 7*1 range
other pK on the enzyme as being at the top of the estimated range of
ct
pH 6.7 7.0.
' The value of pK = 6.2 - 6,3 in the ES complex is not reflected in
a n
a similar inflection in the pS,-_. v. pH profile, thus involving this group50 --
<
in one of two functions. Firstly, it may.be catalytically required, but
not involved in the binding of PEP to the active site Alternatively,
as the SKn value is a catalytic constant and not an allosteric constant,
the group may be involved in the binding of PEP to the allosteric site.
The lack of effect of pH on the Hill coefficient for PEP would sugge O 1/







(5) ' PS50 and
titration of PEP

















with the provisos a) that (2) and (3) may refer to the same group and b)
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The effect of FDP on the. response of purified
pyruvate kinase to PEP. Hill plots of the data of Fig. 30.
The concentration of ADP = 4.71 x 10-4 m. The concentration






2.02 + O.OL to 0.99 ± 0.03 and the S50PEP value decreased from 1.3^ + 0.05
mM-PEP to 0.25 + 0.02'mM-PEP. The-ratio Vmax + FDP / Vmax - FDP in the
same experiments was 1.01 + 0.03.
122
6) ALLOSTERIC CONTROL OF PURIFIED TRYPANOSOIJS PYRUVATE KINASE.
i. Effects of FDP
V
The activation of a pyruvate kinase by FDP was first reported by
Hess et al., (1966) for a liver enzyme, and has since been found to obtain
in yeast and in other sources of the enzyme (e.g. Gancedo est al«, 19675
%
Taylor & Bailey, 196?)• The effects of high concentrations of PDF




this apparent normalisation of the sigmoidal response to increasing PEP
concentration, is not by itself significant. As pointed out by Atkinson
(1966), a subjective evaluation of apparent differences of this nature
may lead to the wrong conclusions, as a contraction of the curve along
• •
the abscissa leads "to a curve which superficially resembles the normal-
ised hyperbola. To demonstrate a loss of cooperativity between substrate
0
molecules, recourse must be taken to analysis by the Hill plot, and these
v
data are redrawn in terms of log V^-v versus log (s) in Figure 31.
Here it may be seen that the presence of 10 ^ M-FDP has two effects on
this enzyme. It abolishes the cooperative interactions of PEP, the Hill
0
t
coefficient decreasing from 2.12 to 0.91* and it decreases the PEP
value from 1.20 x 10"3 M-PEP to 0.25 x 10"5 m-pep. No change in the
P
t
V value of the system is apparent.
max a
>
These assays were carried out with a preincubation period of three
minutes in the presence or absence of FDP, prior to the reaction being
started by addition of ADP and PEP at this time. a greater gross
activation is obtained under these conditions than with no preincubation
period, where the reaction is started by addition of enzyme. This,
however, is more likely to be due to an increase in the stability of the
enzyme in the presence of FDP, than to a time-dependent allosterie
transition. However, large increases in activity are found in the






Fig.32.Theeff ctofPEPconc ntrationthea tiv nfpu if edyruvatekinasby





























kinase. Experimental data were
32. Hill coefficient and A50FDP
from Hill plots as described in




concentration, mimics the effect of ailosteric binding of the substrate,
t
0
as in the latter part of the sigmoid, unactivated plot, normalisation
has, in effect, occurred. Thus it is not surprising that the activation
by FDP is dependent upon the concentration of PEP, as further shown in
0
Figure 32.
When the concentrations of substrate and activator are varied




in activating the enzyme. Modified Hill .plots for FDP yield activator
constants (A^q values) and Hill coefficients for FDP as shown in Figure
33. By extrapolation to a zero concentration of PEP, it is found that




alternatively, that no interaction is occurring between multiple FDP
J
binding sites. On the other hand, as the concentration of PEP decreases,
' t *
the Aj-q value for FDP (i.e. the concentration of FDP required to give 50/=
the maximal velocity at a constant PEP concentration) increases.
0
. The question arose as to whether the primary effect of FB? is to
0
*




this substrate. The result of the variation of effector concentration
on these two kinetic parameters are demonstrated in Figure 34. Up to
*
-4




decrease the interaction between substrate binding sites, this action being




the same range of FDP concentrations, the PEP value is decreased
slightly from 1.21 mK to 0.96 mM, a drop of 20$; higher concentrations
of the activator rapidly produce a much more substantial increase in the
s
affinity of tho enzyme for PEP, the S^q value decreasing to 0o 32 mM, a
drop of a further 53'^.
Fig.34TheeffectofDPntkineticparametersPEutilisat onbyurified pyruvatekinase.Hillcoeffici nts( )andS50PEPv luwereobtain ddiff re t FDPconcentrationsasdescribediig .30&1withpreincubationriof minutesa dconcentrationfADP4.17x10~*^M.E chpointisfr mtleas eightconcentrationsfPEPfr m0.5t3.33mM.
The activation of the enzyme by fdp appears to be a property-
unique to this glycolytic intermediate. So effect of the following
I
compounds was found, when the enzyme was assayed, after three minutes
















When the effect of FDP on the K. value for ADP was investigated,
iVi
no effect on this parameter was found up to a concentration of FDP of
10
-3
m. The activation appears, therefore, to specifically affect the
binding of PEP.
11. Effects of ATP.
Allosteric control by ATP of FK from many tissues has been reported
(e.g. liver, Tanaka et al., 1967b) and this effector is thought to work
in an antagonistic manner with the activation of the enzyme by FDP.
However, in some cases, this inhibition by ATP has been shown to be eff¬
ected simply by chelation of the required divalent cation by the nucleo-
A
side triphosphate, thereby decreasing the concentration of MgADP avail-
t
able to the enzyme (Wood, 1968). On the basis of the formation constants
2—* —
of KgATP ~ and MgADP (Kelchior, 19^5)* Wood showed that many earlier
reports of ATP-inhibition could be accounted for in this manner without
9
invoicing the necessity of an allosteric binding of ATP, This led to
' |






















pyruvatekinase,Aliq otsofenzymewerpreincubatedthstand rass minuteswithDL-ct-G?(0,05M)»ATF1 67mM).andvariousconc ntrationsf
tagnesium
sulphate.Reactionswerinitiat dbyadditionofADP( .17x10~M̂)PE(1.6inM .,
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form of a large excess of L«*GP included in the assay system. The
2+ 2~
relative concentrations of the three Hg~ binding substancess L«<GP ,
ADP^ and ATP^ then ensure that up to a total nucleotide concentration
ft
3-of 5 nM* "the ADP present in the assay remains as the rnonomagnesiurn
2+
salt, when the total Mg concentration is 30 mM.
During the early stages of this investigation, glucose-6-phosphate
2+
was utilised as a Mg buffer, but the results obtained were variable and




buffer was changed to DL^iGP, and more consistent results were obtained.
■DL-oC
effect on the enzyme, partly, but not entirely, due to the presence of
sodium counter-ions, , The contribution of the glycerophosphate anion
*
to this inhibition was, however, only 15$ at 5° niM™DL'»C-CP and therefore
is thought to have little physiological significance, and was not invest:!
gated further.
The inclusion of O.Op M-BL-eC-GP in the assay system with AT?
(l.67 x 10 M) allowed the effects of the latter compound to he estimated
2+ 2+
at different levels of Mg and ADP. At low Mg concentrations e.g.
6.7 x 10 as used in the standard assay system, ATP markedly inhibited
the enzyme. However, on increasing the cation concentration, the
inhibition decreased steadily to 13$ at 33.3 x 10 ^ M-Kg4"* (Pig.35/« The
2+
slight stimulation of the enzyme by ATP found at high Mg concentrations
contaiain
with traces of ADP.
Thus, at these concentrations of PEP and ADP (l.67 and 0.42 x 10
respectively) there appears to be no allosteric control exerted by ATP
M
over the trypanosome enzyme. Mechanistically, it was expected that ATP
should at least competitively inhibit the enzyme, as a common binding site
ft





















Fig. 36, The effects of EDTA and preincubation time
on the melarsen oxide inhibition of purified pyruvate
kinase. DTT was removed from the enzyme preparation as
described in the text. Aliquots of this enzyme were then
incubated in the standard assay medium with and without"
elarsen oxide for the periods indicated prior to the
initiation of the reactions by addition of ADP (4.17 x 10
and PEP (1.67 mM). □ = +1.00 mM EDTA. A = no EDTA.
-4
)
[Melarsen oxide concentration = 4 x 10~^M.*
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*
as the enzyme product, is commonly postulated. When the substrate and
coenzyme levels were simultaneously decreased to 0.5 and 0.1'x 10*"^M
I
ft
respectively, this expected effect of ATP was still not apparent, and
#
further decreases in the substrate / coenzyme concentrations were not
possible, due to the large amounts of enzyme required to give an
V
*











7) EFFECTS OF ARSENICALS ON PURIFIED TRYPANOSOMA PYRUVATE KINASE
ft
ft




the assay medium precluded any prolonged preincubation in attempts to
ft
*
ensure equilibrium between the enzyme and the inhibitor. A further
ft
v
complication arose when attempts were made to investigate the inhibitory
effects of raelarsen oxide in the absence of any stabilising agent, as the
drug apparently increases the enzymic stability in the assay medium, as
demonstrated in Figure 36. In the presence of EDTA, however, this
ft
preferential stability in the presence of the drug disappears.
Under these assay conditions, whereas the Ij-q value of the arsenical
*
was independent of the preincubation time, it was dependent upon both the
PEP concentration and the "age" of the enzyme preparation. Freshly
+ —c
purified enzyme preparations gave a mean value of 4.3 - 0.2 x 10 -'M-
—3
melarsen oxide (seven estimations) with 1#67x 10 M-FEPy which is lower
than that obtained with crude material (10 ^ M). After 24 hours storage
—4
in the purified form, the I^q figure rose to approximately 1,2 x 10 M-




oxide. All the results reported in this work are from enzymic batches





Iso : 4-3 ±0-2 x IO"sM





described in the text.
The inhibition of purified pyruvate kinase
DTT was removed fro the enzyme as
Aliquots of this enzyme were then
preincubated with various concentrations of melarsen
oxide in the standard assay medium plus l.OOmM-EDTA for 5
minutes prior to initiation of the reactions by addition
of ADP (4.17 x 10~4 M) and PEP (1.67 mM). I50 and Hill
coefficient values are derived from the modified Hill
























kinasewithresp cttoADP.DTTwasremovedfromtenzymesd scribedh text.Aliquotsofthienzymewerpreincubatedwith(O)anwithout©) melarsenoxide(310-5 )f r5minutespriortoin tia ionfhreactions
byadditionofADPandPE(1.67mM).Lineweaver-Burkplotsw reriveddescribedinChapter3.-EDTAconcentration.=ImM.
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No allosteric interaction is found between tho arsenical and the
enzyme, as may be seen from Figure 37• A double reciprocal plot of
percentage inhibition versus melarsen oxide concentration extrapolates
to 100$ inhibition at infinite inhibitor concentration, and the modified
T,i-n -t-x $ inhibitionHill plot of log . .. . versus log melarsen oxide concen-
iw-/s mniDition
tration shows a slope of 1.09 - .06. Only one binding site per molecule
of enzyme for the inhibitor is therefore indicated with no apparent
cooperativity between inhibitor molecules.
Effect of melarsen oxide on A35P binding.
Variation of the ADP concentration in the presence and absence of
ft
—
melarsen oxide, at a fixed PEP concentration of 1,67 x 10 J M, showed
the binding' of the coenzyme to be independent of the presence of the
drug, as straightforward non-competitive kinetics were obtained (Figure
38). At 3 x 10 ^ M melarsen oxide, the value for AD? (i.e. the
MgADP complex) is not significantly different from the uninhibited value
+ -v*]
at 8.9 - 0.3 x 10 J K, whereas the maximum velocity of the. system is
markedly diminished in the presence of the drug (from 0.21 to 0.13/umol /4
' 4
5 min). Melarsen oxide thus does not interfere with the binding of ADP
to the enzyme, but with the catalytic reaction.
Effect of melarsen oxide on PEP binding
—— . ——
In contrast to the non-competitive form of the inhibition by melarsen
oxide when the concentration of ADP is the experimental variable, the
%
ft
inhibition obtained with respect to PEP is of a purely competitive nature
(Figure 39). The Hill plot of these data indicates that whereas the
inhibitor, the value
increasing from 1.32 raM to 3.23 mM at 10 ^ M-tnelarsen oxide, the cooper¬
ativity of the system is unaltered. .At this inhibitor concentration,
the maximum velocity value is similarly unchanged.
t
4
Fig. 39. The effect of melarsen oxide on.the
kinetics of purified pyruvate kinase with respect to
PGP. The concentration of ADP was 4.17 x 10~4 M. All
other experimental details were as described in Fig. 38
with the exception that the concentration of melarsen
oxide was maintained at 10~^ M.
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4
These data were obtained under standard preincubation conditions,
in which the enzyme was allowed to interact with the inhibitor for five
»
minutes in the assay medium without ADP or PEP, prior to initiation of
»
the reaction by addition of these cosubstrates. The results presented
later in this work regarding the host liver enzyme, and the effects of
preincubation time on the mode of inhibition obtained, led to an eventual
reconsideration of the tiypanosorne system. Despite the use of relative!
large amounts of the trypanosorne enzyme, the inherent instability of the
protein limited the available experimental preincubation period to 10-12
minutes} at periods up to this time, the inhibition remained competitive.
4
It is of course questionable as to whether this time period is adequate
4
for the enzyme/inhibitor system to reach an equilibrium position, and
4




Further addition of enzyme to the assay system was not possible, as
4
glycerol, in which the enzyme is stored, protects the enzyme against
ft
melarsen oxide inhibition at concentrations above For the same
4
reason, removal of the glycerol was a fundamental necessity before a
0




resulted, in each of three attempts, in the production of a totally
» ft
4
inactive residue, presumably due to the prolonged period required for thi
4
0
technique. Elution of the enzyme from a column of G-25 Sephadex with
0
0.1 M-TEA pH 7.2; 0.1 M-Tris, pH 6.4 or 7.2; 0.1 M-Tris/6.7 mM MgSO^/
67 mil KC1; or 0.1 M-Tris/o.42 mM ADP"5 /0.5 niM PEP, all in the presence of
10~^ M EDTA resulted in exceptionally low yields (•< 20;*) of activity and
4
in even lower stability of the enzyme. In these glycerol-free solutions
0
the half-life of the enzyme as assayed in the standard medium, is cf the
0
order of 15 minutes, if the previously described precautions regarding
the degassing of the column are rigorously carried out and the fractions
.i^y
*





inadequate for the procedure involved in determining1 the S,-_ value of50
the enzyme with and without melarsen oxide, and attempts at the removal
of. glycerol were abandoned. Further attempts at investigation of the
4
effects of prolonged incubation on the interaction of this enzyme and
ft
melarsen oxide will only be possible when the purification procedure
is scaled up to an extent which will yield large enough quantities of






Interaction of FDP, PEP and melarsen oxide.
0
The individual effects of FDP, FEP, and melarsen oxide on the
purified trypanosorne enzyme have been described, but the questions remain
•l) is the drug acting as a competitor to PEP at the active or at the
allosteric site? and 2) do the properties of the enzyme in the absence
of FDP have a real physiological significance? Tiie latter question
*
relies for an answer on a knowledge of the intracellular concentrations
ft
9
of both PEP and FDP, and the estimations of the concentrations of these
intermediates unfortunately, leave much to be desired. The calculations
ft
carried out at the beginning of this chapter indicated that as assayed
-3
in the standard system at 1.6? x 10 M-PEP, the amount of enzyme present
is not adequate to account for the total utilisation rate cf PEP _in vivo.




thd following manner, the same conclusion was reached.
ft
Trypanosomas were suspended in dilute solution (l ml packed cell
volume/40 ml saline) with an excess of glucose (1C00yurnoles) and main-
4
tained at room temperature for ten minutes. The cells were rapidly
sedimented at 3000g and 2°C and the supernatant withdrawn and discarded.


















FDP x I05 M
The effect of FDP on the melarsen oxide inhibition
of purified pyruvate kinase. Aliquots of enzyme, after the
removal of DTT, were preincubated in the standard assay mediui
plus 1.00 mM-EDTA for 5 minutes with and without melarsen oxide
and FDP, prior to initiation of the reactions by addition of ADP
(4.17 x 10~4 M) and PEP ( A: 0.67 mM. B: 1.67 mM). The
concentration of melarsen oxide was as follows.
0 = 10
%
-5 M. = 3 x 10-5 M. D- 10"4 M.
material homogenised. After neutralisation with-dipotassium hydrogen
phosphate (0.5 K)» was estimated in the supernatant, with the
following results *9
Cell volume PEP present "Intracellular concentration"
4 M-FBP1) O.52 ml 0.19yumole ■ 3.7 x 10
2) 0.91ml 0,42yuraole 4.6 x 10"4
3) 0.41 ml 0.21 /umole 5.1 x 10"4 M-PBP
M-PEP




indication of the true value. Firstly, sedimentation of the organisms
ft
ft
takes a finite time, and they are in the "packed" state for approximately
three minutes prior to lysis with the perchloric acid. Under these
conditions, every organism is in an artificial micro-environment of
rapidly decreasing glucose concentration and even more rapidly increasing
pyruvate concentration, and the parasites become exceedingly sluggish
in their movements. Hence the build-up of pyruvate conceivably will
increase the PEP concentration by product inhibition of the pyruvate
kinase. Secondly, the "packed cell volume" gives only the vaguest
9
indication of the total cell volume present, and no indication at all of
the percentage of the intracellular volume available to the enzymic
substrate. However, the figures as they stand substantiate the idea
ft
that in vivo, the enzyme requires FDP activation to function at the
calculated rate.
It was therefore necessary to investigate the mode of action of
raelarsen oxide os FPP. Figur
FPP
4
in so far as the drug I50 ncreasing




mode of action of the metabolic activator, i.e. a progressive effect
4





EffectofFDPnthekin ticparametersnormaldmelarsenoxidinhib d purifiedyruvatekinas
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coefficient is the primarily affected parameters and further protection
^ a
FDP concentration at which the PEP 3
is the variable (c.f. Figure 34)«
Stimulation of the enzyme by FI)P, however, has no effect on the
interaction between PEP and melarsen oxide (Table 23). An elevated
% »
9
Srn PEP value is found in the presence of melarsen oxide over the range
of FDP concentrations from zero to 6.7 x 10 ^ M. Over the same range
of activator concentrations, the presence of the drug produces no change
in either the Hill coefficient for PEP, or the maximum velocity. Thus
an identical picture is presented in the presence and in the absence of
FDP, in which the drug is competing with the enzyme substrate.
Effects of other inhibitors
The process of'enzyme purification, as far an may be judged, did
not drastically modify the properties of the kinase. The value for
— —R —s
MgADP - decreases from 12 x- 10 M to 8 x 10 M-ADP, and the I^ value
-4 ~5"
for melarsen oxide similarly drops from 10 M to 4.3 x 10 M whan
freshly purified enzyme is used. The pattern of inhibition exhibited
9
by the purified material is very Similar to that of the crude"enzyme,
the effects of various compounds on the purified enzyme being defined
in Table 24 (c.f. Table 19)•
The sensitivity of the puz;e enzyme to these inhibitors is, with the
%
9
exception of pCMB, uniformly greater than that of the unfractionated
»
enzyme. Inorganic arsenite, iodoacetate and iodoacetamide, however,
still do not inhibit the system. Of the inhibitors tested, pCMB shows
the greatest inhibitory action, with an value approximately 100-fold
9
lower than those of the arsenical derivatives. The parent drug,
♦ t
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competitive kinetics being obtained. On the other hand, the inhibition
•
•
by pCMB gave a decrease in.the maximum velocity, with no change in the
*
4
Scn value and Hill coefficient for PEP,50
\
8) ' MAMKALIAN PYRUVATE KINASES
During the early part of the study 'of the trypanosome PK, the
• •
%
commercially available rabbit muscle enzyme was conveniently used to
test the validity of the assay system, and as a comparative Host enzyme.
However, the observations on the allosteric nature of the trypanosome
enzyme as regards the cooperative effects of PEP and the action of FDP,
make this comparison to a certain extent artificial, as the muscle enzyme
0
is allosterically inactive in these respects. The kinetic properties
trypanosome enzyme
ically controlled liver L isoenzyme. The presence in mammalian -liver
of both L and M forms of PK offered the opportunity of testing the




with the presence of allosteric control of the enzyme.- The L isoenzyme,
akin
The non-allosteric M isoenzyme, by comparison with the rabbit muscle
system should have been insensitive to the trypanocide. This hypothesis
0
was not, however, entirely borne out, as may be seen from the" work
reported below.
Preparation of liver is
Th
adaptation of the method of Passeron et al., (1967). The, L-isoenzyme
9
4
of rat liver is highly unstable, another point of similarity to the
9
%
parasite enzyme, and the characteristics of both L and M type proteins
0
change on storage. To avoid complication of the kinetic results in
0
this way, freshly prepared enzyme samples (<24 hours old) were used
0
unless otherwise stated. The use of fresh material daily also allowed
• ♦
mercaptoethanol, recommended by Passeron as a stabilising agent, to be
eliminated from the enzyme solution during the purification. In this
0
9
way no interference with the arsenical reaction by exogenous thiol is
possible.
W
The livers of two rats were excised, weighed, and homogenised in
0
v
1 volume of cold 0.1 M-tris buffer. pH 7 • 5s containing EDTA (l0~^ M),
and sucrose (25$ (w/v) )• ('The high protein concentration used here
increases the yield of the delicate L isoenzyme in the absence of
%
mercaptoethanol). The tissue homogenate was centrifuged for 1 hour at
60,000g and the supernatant removed for further fractionation. To thi
0
supernatant was added the above mentioned Tris/sucrose/EDTA buffer,
*
saturated with ammonium sulphate, to give a final concentration of 20$
i
saturation with respect to the ammonium salt. After standing in ice
• t t
for 30 minutes, the sediment was collected by centrifugation at 10,000g
for 30 minutes and was discarded. The supernatant was brought to 45$
9
saturation in ammonium sulphate, and after a further 30 minutes, the
*
sediment was collected as above. This sediment was redissolved in a
0
minimal volume of tris/EDTA/sucrose, and passed through a C'-25 Sephadex
0
9
solumn equilibrated with the same solution, the protein containing




saturated ammonium sulphate solution was brought, to 55$ saturation, the
sediment removed as above and discarded, and the 55$ saturated super¬
natant made up to 70$ saturation as before. The resulting 55$ ~~ 70$
sediment was redissolved. and desalted as for the 20-45$ fraction.
According to Tanaka (1967a,b) this procedure should ensure separation o




ammonium sulphate, the M type in the higher range of concentrations.
✓
However, to ensure as far as is possible that total separations were
obtained, the individual desalted fractions were applied to a column
of DEAE cellulose, pre-equilibrated in 0,05 M~tr.is pH 7«5/lO ^ M-EDT'A,
and eluted with a KC'l gradient. The L isoenzyme, already concentrated
in the ammonium sulphate fraction (20-45$ saturation) was eluted at
0«02 0.04 M-KC1 whereas the M isoenzyme is released from the column








Purity and stability of the liver isoenzymes
%
Neither L nor M pyruvate kinase is produced in a completely pure
%
9
state by the procedure outlined above, and in fact the latter has been
shown to contain low concentrations of enolase (<£3$ PK activity),
However, as far as may be ascertained, they are free from croos-contarain-




from DEAE-cellulose showed that after the ammonium sulphate separation,
the L isoenzyme contained approximately 4$ of the M type protein, and
the selected L! type fraction, about 12$ of L type enzyme. Heapplication
of the DEAS-cellulose purified fractions to a second column of the same
w
material, or a second ammonium sulphate fractionation, showed the
1
separated isoenzymes to he homogeneous with respect to the type of PIC
4
present. The kinetic pictures obtained with these semi-purified fractions




The crude, as well as the purified L type enzyme was found to be
highly susceptible to inactivation under a-variety of circumstances, and
9
9
as the kinetic characteristics of both isoenzymes were mutable on storage
*
(see below), the data presented are from experiments on fresh preparations
iyj
♦
(i.e. <" 24 hours after purification) unless otherwise stated
Kinetic properties of the liver isoenzymes.
Prom the work presented earlier in this thesis, the hypothesis
that inhibition by melarsen oxide is connected with the allosteric
properties of the enzyme, accounting for the absence of interaction
between the drug and the muscle enzyme, was presented. Preliminary
experiments showed, however, that contrary to the expected result.
;yme
enzymes
v/a3 therefore carried out.
Interaction with ADP
isoenzymes
and To avoid difficulties in inter1-
pretation, the assay system used was identical with that used for the
parasite enzyme.
Y/ith both enzymes hyperbolic responses were obtained when the con¬
centration of the nucleotide coenzyme was varied, and again in both
cases, the K„ values obtained were independent of the concentration of
M
%
PEP. The K„ (apparent) values obtained were;M
-4
L- isoenzyme 2.61 x 10 M-ADP,




Freshly prepared specimens of this protein showed a marked homo-
tropic interaction between PEP molecules, and the mean kinetic values




2.-18 - 0.41 x 10"4 M -PEP
0
1.81 - 0,12,
Storage of the enzyme resulted in a marked decrease in the allos-
teric properties, and after four days at +2°C, the mean Hill coefficient
value decreased to 1.32 - 0.14. enzyme
thymol
*4*
isation occurs, and after four days the Hill coefficient was = I.64 - 0.10
11 M type i
Kinetic investigation of this isoenzyme showed clearly that the
an usual untrue
>) that "Pyruvate kinase M is
Fresh preparations gave values
for an interaction coefficient between FEP molecules of between 1.40 and
1.62 but after storage, either at room temperature or in the cold, this
value rapidly decreased to 1.02 - 1.22. Later work reported by these
authors agrees with this finding, as they quote a value for n of 1.4 for
this isoenzyme, thus clearly differentiating it from the muscle protein
(Tanaka et al., 1970).
Interaction with FDP.
In both isoenzyme systems, the response to PEP concentration is
3d in the presence of this activator (10 ^ M") to give a hyper-
4
bolic curve, and the affinity of the enzymes for the substrate is enhanced.
Melarsen x IOSM
4
Fig. 41. The effect of melarsen oxide on the isoenzymes of
liver pyruvate kinase. Isoenzymes were separated as described in
the text. Aliquots (approx. 0.1 I.U.) were preincubated for 5
minutes (L isoenzyme, □ ) or 30 minutes (M isoenzyme, Q ) in the
4
standard assay medium plus 1.0 mM-EDTA, with and without.melarsen
oxide. Reactions were initiated by addition of ADP (4.17 x 10*"%)






























Fig. 42. The effect of preincubation time on the inhibition
by melarsen oxide of the isoenzymes of liver pyruvate kinase. All
experimental assay conditions as described in Fig. 41, with a
concentration of melarsen oxide of 3 x 10-5 M-. O = freshly
prepared enzyme. © = enzyme after storage for 3 days at 2°C.
V |
Isoenzymes as indicated on the diagram.
Apparently, then, both forms of the .enzyme are heterotropica'lly
activated as well as being subject to homotropic substrate activation,
ft
9
Interaction with melarsen oxide,
9
Storage of the two liver enzymes led to desensitisation to the
• effect of melarsen oxide as well as to the allosteric interaction of
PEP binding sites. Also, despite the presence of EDTA in the assay
ft
medium, the reactions between enzymes and melarsen oxide were except-
ionally time-dependent,
|




responses to variation in the drug level are illustrated in Figure 41,
The L type enzyme appears to be rather more sensitive to the drug, with
an I^q value under these assay conditions of 6 x 10 ^ M-melarsen oxide
-5
as opposed to the value of 1,2 x 10 M-rnelarsen oxide obtained for the
M type enzyme. The Hill coefficients obtained at the time for these
ft
samples of enzyme were L s 1.72 . M s 1.43.
ft




effects of preincubation time and length of storage (at +2°C) on the
two isoenzymes. Both forms are subject to desensitisation on storage,
|
and further, the time of incubation required to attain equilibrium is
dependent upon the duration of storage. (it should be noted that in
4
the experiments described by Figure 41 the preincubation periods for the
ft
respective enzymes are those at which inhibition appears to be complete).
Despite the support lent to the above-mentioned hypothesis by the





inhibition, no further work was carried out on the stored enzymes.
However, the relatively enormous (compared to the trypanosome enzyme)
quantities of these enzymes which were available, did enable studies to
.TABLE25
Effectofpreincubationtimenhkinet c-param ersfPEPutilis i n byliverpyruvatekinases _
Enzyme(approx.0.05IU)wasincub tedthstandardas aymediumipr senceab fmelarsenox
ADP(3yumoles)
(8x10~"^M)forthepreincubationtim sstated,priorinit ati f
addition 5
andPEP.E chsetofparametersifrle steig tco entra ionsfPEPfr m2x10'M-FEPt5"'M-FSP Preincubationwasaroomt mperature. M M M MPreincubation Enzymetime(min) 5 5 35 40S5Q(x104M) Standard 1.27 1.41 5.32 5.41+Melarsen * oxide 9.47 8.62 5.64 5.12v(yumol/min/ragprotein)
"pep
Standard 10.6 8.3 7.7 8.1
+Melarsen oxide 0.4 8.6 3.6 3.4
Standard 1.39 1.26 1.21 1.18
+Meiarsen oxide 1.41 1.21 1.22 1,26
<\








10 35 40 40
2.18 2.39 2.61 4.81 5.22 4.73
7.31 6,07 5.82 4.96 4.92 5.21
I8.4 14.3 12.6 •8.2 8.6 10.4
19.1 14.1 9.8 4.4 5.1 6.3
1.81 I.69 1.73 1.84 1.61 1.62
1.82 1.74 1.68 1.69 1.80 1.80
Competitive Competitive
?Mixed Non-competitive Non-crapetitive Non-competitive
be carried out cn the effects of incubation time on the mode of
inhibition by the arsenical.
.Both isoenzymes portrayed the same pattern of inhibition, as follows
# •
When a short preincubation time was used ( <10 minutes), melarsen oxide
appeared to be a competitive inhibitor with respect to.PEP, although in
ft
one freshly purified sample of the L type enzyme, mixed inhibition was
found # where the Sc« PEP value was increased and the V was decreased#
pu max
i
If the length of the preincubation period was increased to 40 minutes,
*
non-competitive kinetics were obtained on variation of the PEP coneen-
»
tration# The PEP values and V* values for these experiments are50 max







Other mammalian pyruvate kinases.
ft
A
Preliminary investigation of some other sources of pyruvate kinase
P
has been undertaken, on Sephadex G-25 treated homogenates of certain
ft
ft
organs as follows. Rat heart and brain were individually homogenised
/ -3
in 0.05 M-Tris pH 7.5 / 10 M-EDTA and the supernatant from a 10,000g
%
eentrifugation for 1 hour desalted as previously described for the liver
isoenzymes. The pyruvate kinase from these sources had Hill coefficient
for PEP of 1.02 - 0.04 (brain) and C.96 - G.07 (heart) and neither enzyme
-A
was inhibited by 10 M-melarsen oxide after 15 minutes preincubation
with the drug in the previously described fashion. Another property
ft
shared by these enzymes and the commercial rabbit muscle enzyme, is
ft
ft
their insensitivity to FDP up to 10 ^ M.
A recent report (Rozengurt et al.,) 1970 has shown that the' enzyme
ft
from mammalian muscle is not totally allosterically inactive, being
ft
inhibited by phenylalanine. Fresh extracts of rat muscle, however, when
prepared in the same fashion as the.heart and brain enzymes, showed no
»
*♦*
eooperativity between PEP molecules (n = O.98 - 0.02), no-activation
A
by 10 M-FDP, and no inhibition by melarsen oxide (10 K). The lack
of response of the commercial enzyme thus does not appear to be an






The intense motility of the bloodstream forms of T.rhodesienss
#
4
is supported by an extremely high rate of utilisation of extracellular
glucose, corresponding to at least 50$ of the dry weight of the organ¬
isms per hour. This absolute requirement for a source of energy is
*
%
common to both monomorphic and pleomorphic strains, and in the absence
4
4
of such a source the organisms rapidly become immotile and degenerate.
¥
With a monomorphic strain, the results presented here would indicate,
in common with the work of Ryley (1956) &od Grant and Pulton (l957)s
»
that the glucose is practically entirely degraded to pyruvate, with a









There are two major differences between freshly isolated pleomorphic,
4
and old laboratory maintained monomorphic trypanosomes. Firstly, the
pleomorphs contain active oxidative decarboxylation systems for the
i
I
catabolism of pyruvate and <<-0G, and secondly, significant quantities
of metabolic carbon dioxide are produced during the utilisation of
glucose or glycerol. The pyruvate and ck-OG decarboxylases appear to
s
be confined to the short stumpy bloodstream forms (Figure 6). These
, •
results are in agreement with the observation of Vickerman (1965), that
o<--0G preferentially maintained the motility of the stumpy forms.
Whereas the stumpy forms utilise extracellular <<~0G efficiently and
remain motile in tiiis substrate, exogenous pyruvate will not maintain
*
%
the organisms. This implies a specificity in the properties of the
t
trypanosomal membranes, as the CO,, production from glycerol utilisation





Removal of endogenous cofactors from cell lysates produced low
0
yields of these relatively unstable oxidative decarboxylases. However,
«
it was possible to show that coenzyme A, NAD and ADP significantly
|
f
stimulated these enzymes (Table 5)- Attempts to reconstitute an
active tricarboxylic acid cycle in cofactor-depleted preparations, by
the additiorfof aspartate or malate as sources of oxaloacetate, did not
stimulate the utilisation of pyruvate, which appears to be utilised by
a one-step oxidative decarboxylation reaction in which acetyl coenzyme A
J
. is synthesised. and subsequently hydrolysed to produce acetate. Similarly,
oC-OG is decar'ooxylated to succinate, the limiting activity of succinate














Oxygen utilisation by pleomorphic strains of trypanosomes with
4





being insensitive to cyanide, and, consistent with this observation,
9
they contain no detectable amounts of cytochrome pigments. The differ-
ential effects of cyanide on whole cells and lysates utilising oC-CG
9
0
are puzzling. It is improbable that a cyanide-sensitive pathway for
%
oxygen utilisation is available to this substrate alone in the lysed
preparation, but not in the whole organism. Possibly the cyanhydrin
« ♦
4
which is known to be formed between oC-OG and cyanide may act as a
competitive inhibitor of the oL -oxoglutarate oxidase system. The
lack of effect in vivo may then be due to the impermeability of the
\




In the absence of a functional cytochrome chain, the substrate-
independent inhibitory effects of rotenone and amytal are not expected.
The lack of effect on oC-glycerophosphate utilisation in the lysed
xHC
preparations eliminates the oC -glycerophosphate oxidase as the focal
point of these inhibitors. However, this substrate differs from
glucose, oC-OG and pyruvate, in being directly linked to the oxygen
enzyme, without the intervention of HAH as a coenzym
Polarographic investigation of HABIT reoxidation showed the press..,.,
BHAP oC -glycero¬
phosphate oxidase of Grant and Sargent (i960), The rate of NABH
oxidation is markedly stimulated by addition of fructose 1;6 diphosphate
as a source of BHAP, and. both BHAP-dependent and independent pathways
to oxygen are rotenone sensitive These results, taken with the
quantitatively similar values of rotenone and amytal on glucose,
o(.-0G and pyruvate metabolism, point to oC.-glycerophosphate dehydro
genase, catalysing the reduction of BHAP to L-cC~GP by HABIT, as the
sensitive enzyme. Spectrophotometric assay of this enzyme, however,
did not bear out this hypothesis On the other hand, the sensitivity




being mediated elsewhere than at the (^-glycerophosphate dehydrogenase
step.















The apparent anomaly in these data cannot at present be satisfact¬
orily accounted for, and this system deserves further investigation.
However, it appears that the pleomorphic strains overcome the
*
problem of reoxidation of metabolic NADH in a similar fashion to the





End products and routes of glucose metabolism.
In the first instance, the formation of significant amounts of COg




yield, suggested the possibility of a functional tricarboxylic acid
0
%
cycle in SS forms, despite the lack of a cytochrome chain. Clarification
0
of this possibility has been attempted by a study and balance of the
end-products of glucose catabolism.
9
Further metabolism of glycolytic pyruvate is confined to an oxidative
• V
9
decarboxylation reaction producing acetate (Table 11). Exogenous
pyruvate is only utilisable by lysed cell preparations and its metabolism
appears to involve the production of a coenzyme A derivative as an
intermediate (Table 5)« Citrate synthase is present in very low concen¬
tration in T.rhodesiense and the inadequacy of this enzyme would account




The other tricarboxylic acid cycle enzyme which is present in
9
exceedingly low activity in this organism is succinoxidase. Thus
oC-oxoglutarate is metabolised only as far as succinate by lysed or whole
4
cells, although a small proportion ( < 2%) of the succinate may be
further metabolised to oxaloacetate and thence decarboxylated to produce
(
pyruvate (Table 11).
Aerobic glucose metabolism results in the formation of acetate,
presumably via pyruvate, and also of significant quantities of glycerol.
TABLE26
>
Acomparisonfthebs rvedandtheor ticalg sexchangesfT.rhodesien eEATRO173u ilisingglucose


























































































































































































































Glycerol is accumulated by both monornorphic and pleomorphic strains, and




utilisation of oxygen. It is worthy of note that the culture form
0
°* T.rhodesiense does not accumulate glycerol during either aerobic, or




The production routes of CO^ and succinate are not so readily
s
defined. The evolution of COp is greater than that involved in the-
* ^
formation of acetate and hence must come partially from an alternative
0









various metabolic pathways, and- a comparison of the theoretical and









the data from Table 11, and the carbon-balance data are re-presented in
ft
Table 26. The theoretical gas exchanges shown are for four possible




to occur glycolytically, yielding the equivalent reducing power for
1 mol Op per 2 mols pyruvate produced. Acetate is assumed to come
• S
from the decarboxylation of pyruvate with an R.Q. of 2.0, and glycerol
9
from the dephosphorylation of L-oO-glycerophosphate. This last process
involves the reduction of glycolytic DHAP by NADH, and hence the glycerol
*




ation of pyruvate from glucose.
V
Pathway (l)s Pyruvate is further metabolised by the tricarboxylic acid
cycle, terminating at succinate. Oxaloacetate required for this process






Pathway (2); As for pathway (l), only the oxaloacetate is assumed to be
• . «
produced by COg fixation involving PSP or pyruvate.
Pathway (3;i Assumes that a COg fixation step onto PEP or pyruvate
is followed by reduction of the product to succinate. The tricarboxy¬
lic acid cycle is assumed to be inoperative.
4
Pathway (4)s The source of succinate is via the glyoxalate cycle which
ft
simultaneously regenerates oxaloacetate.
The oxygen consumption in all but two experiments is greater than
I
*
any of the theoretical uptakes. This may reflect the metabolism of
*
♦
the 4-12$ of the utilised glucose which is not accounted for in the
balances. The yields of COg may best be described as a combination
ft
of pathways (3) and (2 or 4) at experimental periods of up to 30 minutes,
ft
ft
and as a combination of pathways (l) and (2 or 4) at longer experimental
*
periods. It has been shown that changes in the metabolic pattern occur
during an incubation period of one hour, and it is possible that not
» 4
ft
only the relative yields of metabolites change during incubation, but
also the metabolic paths. Complete definition of the pathways involved
ft
s
is not possible, due to the metabolism of the glucose which is not accounted
%
ft :
for in these balances. Complete oxidation of this substrate would disrupt
the balances, and large variation from the theoretical exchanges would be
ft
1 A'
expected. This problem can only be resolved by means of a HC balance
to determine the origin of the succinate carbons directly.
• •
Over the time course of the incubations, yields of glycerol, succinate,
ft
• and COg per glucose utilised progressively increase with the time of
ft
incubation, and pyruvate production and Og utilisation per glucose utilised
decrease. The formation of acetate remains constant in the range 0.25 -
ft
0.30yumole / yumole glucose utilised (Figure 7a-d). The increase in the
0
COg yield cannot therefore be related to an increase in the decarooxy-
ft
lation of pyruvate to yield acetate. The apparent absence of 6-phospho--
ft
m
gluconate dehydrogenase in these organisms makes the Lipmann-Dickens
ft
♦ «
shunt an unlikely source of this CO^s and no COg is evolved in the
formation of glycerol. Thus, the increase in COg production is most
probably associated with the increase in succinate production via the
0
tricarboxylic acid or glyoxalate cycles. The COg-fixation routes
0
would obviously decrease the yield of COp. The decrease in oxygen
utilisation may be correlated with the increase in glycerol formation,
ft
thus regenerating WAD anaercbically.
This time-deDendence of the metabolite vie].
morphological deterioration of the organisms, or some chemical effect.
ft
The former is unlikely as the organisms appear microscopically normal
on inspection after incubation,. In'vitro, however, a large pool of
pyruvate accumulates which in vivo would be removed via the plasma.
This large increase in pyruvate formation may have the effect of insti
gating or exaggerating the use of pathways not normally acting at a
significant rate. The experimental organisms most closely approximate
9
to their in vivo state at the time at which very little pyruvate has
accumulated. This will be at the start of the preincubation period,
0
at a point -10 minutes on Figures 7a - d. These data have been extra-
ft
polated to this point by the fitting of unweighted regression lines with
the following results?
Product yumol / yumol glucose $ Glucose









.021 i .009 1
OJOo .199 - .046 0 3








Oxygen utilisation 1.278 -
9
.012
R.Q. .124 - .042
It would appear then that the high yields of succinate and CCv,
obtained during prolonged incubation may be artefacts of the incubation
conditions, rather than the consequences of the normal metabolism of
the organism. The R.Q. is very low, and approaches that previously
reported for a monomorphic strain (Ryley, 1956; 1962). Within the
limits of error, all the C0o production can now be accounted for on the
basis of acetate formation. However the utilisation of oxygen remains
anomalously high, as the maximum uptake on the basis of the pyruvate /-
9
s>
glycerol / succinate figures is 1.024yumol //umol glucose, by pathways
(1) (2) or (4). The excess oxygen may be utilised in the metabolism of
the remaining 7$ of the glucose, any production of C09 being used possibly
by fixation to form oxaloacetate.
This discussion has been based on the simplifying assumption that
all the organisms in a trypanosome sample are metabolically equivalent.
The semi-quantitative aspects would not be changed, however, if the
4
9
trypanosome population consisted of a mixture of metabolic types, some
of which relied purely on glycolysis and produced 100$ pyruvate from
glucose, and others which totally metabolised the substrate to CO^ and
lig). The dependence of the oC-oxoglutarate and pyruvate utilisation
rates on the $ of SS forms in the samples (Figure 6) would indicate that





The pleomorphic infection of T.rhodesiense appears to rely on the
same terminal oxidase system as the passaged monomorphic strains to
maintain its aerobic redox balance. In such pleomorphic strains, tv/o
biochemically different organisms exist with regard to their competence

































Plate 2. Metabolic pathways in T. rhodesiense EATRO 173.
The metabolism of the LS form is confined to the reactions above
the horizontal division labelled "Membrane". The postulated metabolic
developments in the SS form are depicted below this line. Metabolic,
end-products are shown in square enclosures.
presence in the SS forms of oxidative decarboxylation systems for
i
pyruvate and c>^-oxoglutarateand no further enzymic differentiation
has become apparent. Succinate production in vitro by the pleomorphic
strain is not likely to be via a reaction series involving CO^ fixation,
S
on the basis of the carbon balance studies. Furthermore, the in vivo
significance of the partial tricarboxylic acid cycle which has been
suggested as the route of formation of succinate is in some doubt as a
result of the time-course studies.
The suggestion of Ryley (1962) that a lack of pyruvate oxidase
prevents the further metabolism of pyruvate by the bloodstream trypano-
somes, is invalid in the case of natural pleomorphic infections. The
I
limiting enzymic factors instead appear to be citrate synthase and the
succinoxidase system. Respite the capacity of the stumpy organisms to
synthesise acetyl CoA, the fate of this complex appears to a large
• s
9
extent to be confined to the production of acetate, in conditions
approaching those obtaining in vivo. A diagram of the metabolic
capacities of IS and S3 forms is shown in Plate 2.
#
2) EFFECTS OF tBSLAMlKYIi ARS5NICALS ON CARBQHYDRATB METABOLISM
Experiments using lysed cells show that pyruvate oxidase is the
primarily inhibited system at low concentrations of melarsen oxide.
»
At a dr-ug concentration of 10~5 M there is an increase in the ratio
of yumoles pyruvate produced per yumole glucose utilised and a decrease
4
in the gas exchange (Figure 8). The inhibition of oxygen utilisation
r
appears to reflect the further metabolism of pyruvate as neither the
glucose utilisation (Figure 8) nor the L-tf-GP oxidase (p. 79) are
significantly inhibited at this concentration of melarsen oxide. In
the lysed preparations hexokinase (I50 = 3 x 10~5 M ; Fairlamb, 1970)
and pyruvate kinase (I50 - 10"^ m) are the next most sensitive sites.
It appears, however, that this sequence of sensitivities is not a
reflection of the in vivo mode of action of the drug. It was not
149
possible to demonstrate the build-up of pyruvate from glucose in whole-
• cells by selective inhibition of pyruvate oxidase, and in fact the
primary effect is a decrease in the pyruvate yield/ TL® &glucose and
oxygen utilisations ana the evolution of CC>2 are inhibited in parallel
—7
over the range 1-60 x 10 M, whereas the yield of pyruvate per mole
(Figure 10),
glucose decreases steadil^. Evidence is presented to show a buildup
of PEP at the expense of pyruvate- in the presence of melarsen oxide




decrease in ATP production by this enzyme on inhibition, accounts for
the rapid action of the drug.
The inhibition data enable some speculation to be made regarding
✓
»
the mode of glucose metabolism. Increasing melarsen oxide concentrat™
4
ions up to 2.3 x 10 J M using cell lysates, increases the pyruvate yiel
*
*
per glucose but simultaneously decreases the carbon dioxide production,
This C02 evolution appears to come then from the further metabolism of
4
0
pyruvate;- the inhibited l-eactions have a calculable RQ.cf 2.02, equiv-
d
alent to that of the pyruvate/acetate reaction. It is assumed that
the inhibition of this reaction is by coupling of melarsen oxide with
reduced lipoamide or with dihydrolipoate dehydrogenase, thus inhibiting
the generation of reduced FAD/NAD and acetyl lipoate. Hence the
0
exchange of oxygen and CO^ is inhibited.
The first step in the oxidative decarboxylation of pyruvate by
mammalian tissues is. the formation of the TPP.CHOH.CH^ complex with
*
liberation of C02» Presumably this cdmplex in the trypanosome is
a
unable to break down spontaneously as C02 evolution is inhibited.
The data presented here are in agreement with those of Cantrell
inhibitory
pyruvate, showing a decrease in pyruvate
150
• Ma
inhibition of.glucose utilisation in whole cells of T. equiperdum. Chen
0
(19^8), however , used lysed preparations of the same organism to demonstrate
inhibited by the arsenicals This
in behaviour between whole organisms and cell lysates is borne out by the
0
present work (c.f. Figures 8 & 9)• The data of Marshall (19U8) which show
»
that in T. evansi in vivo hexokinase is the point of inhibition probably do
not indicate a difference'between species. The high arsenical concentration
0
(6 x 10~h M') used by Marshall (19^8) will obscure any primary inhibition of
pyruvate kinase.
r. ^14 4mm f 1 ■ t
3) PYRUVATE KINASE
Despite the previously documented'knowledge on the metabolism of
6
slender T.rhodesiense, it has recently been stated (Webb, 1966 p.75^)
0
that "... trypanosoraes are inactivated (by arsenicals) and killed
[although -J
'this statement. i as
responsible for a net production of ATP in the metabolism of glucose
pyruv This enzyme would therefore
0
make an ideal target for chemotherapeutic attack, an inhibition at this
site eliminating the sole energy source of the organism. Evidence ha
[in this thesis (pp. 78-85)1
s
of melarsen oxide. Part II of this work has entailed a study of the
pyruvate
enzymes Such studies may lead
to the rational synthesis of more effective trypanocides.
Interaction with cations




a univalent and a-divalent cation. The role of the monovalent cation
»
is still uncertain, but it has been suggested that it alters the enzymic
ft
conformation thus influencing the binding1 of substrates (Melchior, 1965).
0
It is now widely accepted, however, that the divalent metal ion acts in










The nucleotide specificity of the parasite enzyme appears-slightly
ft
different from that of the previously investigated mammalian enzymes,
in that the MgGDP value is lower with respect to the MgADP value
0










organisms having a generation time of 4 ~ 6 hours.- Although no esti¬
mates of phosphotransferase activity have been made on the trypanosomal
system, the apparent minimal activity of the tricarboxylic acid cycle,
ft
ft












The stabilisation and purification procedures adopted for any
enzyme are necessarily arbitrarily chosen and dependent upon both the
source and nature of the enzyme. In this case, not only the enzyme
\
activity but also its allosteric properties and interaction with
4
0
inhibitors appear to be exceptionally labile.. In contrast with the
0
liver L isoenzyme (Tanalca et al., 1965) both substrate and coenzyme
increased the rate of inactivation on storage, although dithiothreitol
protected both liver and trypanosom'e systems. The hydrophobic nature
to
of the parasite enzyme is reflected in the stabilising power of
glycerol, analagous to the effect of sucrose on the liver L isoenzyme
(Rozengurt et al.g 1969)• Subsequent to purification, the instability
of the parasite enzyme is similar to that of both liver•isoenzymes on





Interaction with PEP and FDP.
The sigmoidicity of the enzymie response to PEP is typical- of,
to
inter alia, an allosteric enzyme. No concrete significance may be
placed on the absolute value of the Hill coefficient, n, as this figure
to






substrate per enzyme molecule, or 2) the number of non-equilibrium
to
*




is clear, however, that the substrate concentration does exert some
• *
to *




This activation of the enzyme by PEP is entirely dependent on the
to
4
presence or absence of PDP. In the presence of this activating




glycolytic intermediate, the homotropic substrate interactions are
to
abolished, and plots of enzyme activity as a function of PEP concen¬
tration give the normal hyperbolic kinetic picture. A secondary effect
• •




concentrations. This-susceptibility to activation by a substance which
to
is not catalytically active, is a fundamental characteristic of an
allosteric enzyme, the activation being modulated by effector binding at
ft
a site other, than the catalytic point. Also, the desensitirsation of
the enzyme to the horaotropic. PEP interactions on storage in the cold,
ft
to




of more than one PEP molecule per enzyme molecule. This cold desens-
to
itisation has been attributed to a change in conformation, which is
dependent upon hydrophobic bond interactions, in the cases of pyruvate
*
9
decarboxylase and homoserine dehydrogenase (Stadtman, 1966) and is thus
9
in agreement with the stabilisation of the trypanosome FK by glycerol.
When the binding of PDP to the enzyme is investigated, two inter-
0
esting characteristics of the system are found. Firstly extrapolation
PEP
binding
multiple binding sites which are non-interacting. This is unusual in
so far as the presence of a homotropic substrate effect is normally
9
accompanied by a heterotropic reaction involving more than one effector
molecule. ting
catalytic and two "control" sub-units, two molecules of effector may be
bound. This may be the condition of the yeast FK system, although
some doubt exists as to the subunit composition of this enzyme. Native
9
9
enzyme molecular weights reported for yeast FK are uniformly in the
range 160,000 - 200,000 (Kuczenski & Suelter, 1970", Sischofberger et al.,
1970), but the sub-unit sizes obtained by ultracentrifugation differ
%
» •
in being 42,000 - 45,000 (Kuczenski & Suelter, 1970a) or 62,000
(Bischofberger et al., 1970). The work of these latter authors hence
appears to indicate the possibility of an atypical trimeric system, which
9
may apply to the trypanosome enzyme, in having one regulatory (n^p = l)
0
and two catalytic ("pgp = 2) sub-units. However, Hill coefficients of
9
Hppp between 1.4 and 2.6 have been reported by other workers on the yeast
enzyme (Hunsley & Suelter, 19^9) and the situation in yeast is complicated
by the dependence of FDP activation on the types and concentrations of
9
activating cations employed in the enzyme assay. Also, fipgp approaches
3.0 in this system at pH—>7.0.
The second characteristic of the heterotropic FDP activation, is
the synergism of the allosteric effector and the substrate in activating
/ -3 \




of FDP is obtained, and likewise at a high concentration of FDP, no





by FDP and PEP are therefore synergistic. No change in the value
ft
was found in the presence of FDP, and this enzyme is therefore classified
ft
as a "pure K" system in the terminology of ilonod et al., (1965).
Significance of FDP activation.
ft
ft
The activity of pyruvate kinase in mammalian liver is controlled in
ft
ft
two ways. The physiological and pathological status of the animal
*
determines the hepatic enzyme concentration and the ratio of the isoen-
zyinic forms present (Tanaka et al., 1967a,b), whereas the allosteric
ft
4
control of the L isoenzyme regulates the differentiation between gluco-
\
ft
genie and glycolytic requirements. Thus both the rate and the direction
s
of the glycolytic enzyme sequence may be influenced by controlling the
ft
activity of PK. The allosteric conti'ol of this L isoenzyme is mediated
ft
via a feed-forward activation by FDP (in the same manner a3 the trypano-^
4,
some enzyme is activated), and via a feed-back inhibition by one of the
ft
*
enzymic products, ATP, and this activation and inhibition counteract
4
• 9
each other. Hence in a condition where the hepatic cell has an excess




process to proceed. In the absence of this control, glucogenic PEP
ft
ft
synthesised by the decarboxylation of oxaloacetate would immediately be
t
dephosphorylated to pyruvate, thus promulgating a futile cycle of
ft
PEP : p Pyr
In the trypanosomal enzyme system, such a situation may exist, as
under strictly controlled conditions, little inhibition of this enzyme
by ATP is apparent. However, it must be borne in mind that neither
the glucogenic process per se, nor the storage of carbohydrate in any
form, has been demonstrated in T.rhodesiense. The parasite, in its
bloodstream form, is in an environment which ensures a constant extra¬
cellular supply of utilisable carbohydrate, and as such has no need to
develop systems for either the synthesis or storage of such material.
It may be argued that on transmission to the insect vector such systems
would be advantageous, but the organism instead appears, to compensate
by the production of pathways which increase the efficiency of the
utilisation of such carbohydrate as is available.
b
Trypanosomal glycolysis appears, then, to be permanently activated




enzyme to PEP itself may not be physiologically significant iri vivo, but
to decide this point, much more accurate data on the intracellular and
compartmental concentrations of both PEP and FDP would be required. Some





Effect of melarsen oxide.
Although it is presumptuous to postulate a single site of action
for a reaction as general as the one between an organic arsenical and
a thiol compound, evidence has been produced in this work to indicate
that the primary site of arsenical trypanocidal activity is pyruvate
kinase. The apparent dichotomy between the evidence of Chen (1948)
and Marshall (1948), who concluded that the trypanocidal action was due
ft




states "these results convincingly rule out an action on hex,o~
*
kinase as the lethal•action of mapharsen" is explicable in terms of the
intracellular concentrations of the drug, as both FK and hexokinase are
%
9
sensitive to the aromatic trivalent arsenicals, although the former
enzyme appears to be' inhibited at lower drug concentrations. The finding
A
that PK activity is suppressed by these drugs also explains the inability
of the organisms to survive utilising
_ -J glycerol!^
9
_ ' in the presence of the inhibitor.
4
9
The interaction of the enzyme with melarsen oxide at the molecular
9
• t
level is integrally connected with the binding of both PEP and FDP. The
kinetic picture obtained with respect to MgADP in the presence of the
A
drug, shows typical non-competitive inhibition, with the MgADP
unchanged and the V value decreased. The relationship between melarsen
max
oxide inhibition and PEP concentration, however, is one of competition,
as the V value remains unchanged and the S-^PEP value is increased in
max 13 5°
the presence of the arsenical under the available preincubation conditions.
C
9
This competitive effect holds both in the unactivated system, and at all
the concentrations of FDP used (up to 6.7 x 10 ^ Iff), although signifi-
•
v
cantly FDP also competes with melarsen oxide; the higher the activator
9
9
concentration, the lower the inhibition obtained at a given concentration
of drug. The tripartite system, then, consists of a synergistic compe-
9
tition between PEP and FDP to activate the enzyme, and an antagonistic
9
competition between this activation and the inhibition by melarsen oxide.
4
Significantly, the homotropic interaction between PEP molecules is
unaltered by the presence of the arsenical. Unfortunately, these kinetic
$
data do not indicate whether the drug is bound at the regulatory, the
catalytic, or some other site.
The commercially available rabbit muscle PK is seen to be unaffected
w













































noftrypanosomeyruvatki e (FOP)andrsenicaltrypa ocide
properties,, The response curve of activity to increasing PEP coneen-
tration is hyperbolic, with ~ This state is thus analogous to
the trypanosome enzyme 1) after activation by FDF, or 2) in the
|
presence of high PEP concentration, In the FDP activated state,
1 in the parasite system, and in high concentrations of PEP,
the latter part of the sigmoidal v versus s plot approaches a hyperbolic
shape. This is reflected in the theoretically sigmoidal presentation
of the Hill plot f at sufficiently high concentrations of the substrate,
\
the allosteric site may be regarded as saturated, and the kinetic
0
*
association/dissociation only involves the catalytic site. In either
of these two conditions of the trypanosome enzyme, where "p-gp—■e> 1» the
0
melarsen oxide inhibition decreases and approaches zero in a competitive
fashion with increasing PE? and FDP. Thus the muscle PK is analagous
0
to the-trypanosome enzyme in these states, both in the response to PEP
and in the insensitivity tc> raelarsen oxide.
A model consistent with these findings for the trypanosorae and muscle
enzymes may be built as shown in Figure 43. In solution in the absence
*
of drug, substrate or modifier, the enzyme can exist in two conformations
«
• 0
in equilibrium, the equilibrium lying greatly in favour of a catalytically
inactive (E^) form, The addition of FP? (l) or PEP (2) shifts this
equilibrium by combination of the effector with the enzyme at an alios-
|
teric site, to give the catalytically active configuration (-^ppp or
0
Epj)p). At a high concentration of either PEP or FDF, the equilibrium
*
will then be shifted grossly to favour the E^ type enzyme and hyperbolic
0
kinetics with respect to PEP concentration will follow. This enzyme
configuration is therefore analagous to the one in which the muscle PK
is "fixed", and cannot bind, or be inhibited bjr, raelarsen oxide (3).
%
Prolonged storage in the cold has the effect of altering, perhaps by
variation of the hydrophobic bonds of the protein, the position of
0
equilibrium between E^ and Eg, and spontaneously gives rise to the
Eg state, thus decreasing the "interaction coefficient" of the PEP
binding sites.
9
The arsenical drug may therefore be competing, not for a site on
*
the enzyme, but for a specific conformation of the enzyme, E^ (4).
4
Once melarsen oxide is bound, however, no catalytic activity remains,
100$ As the inhibition is compet¬
itive with both PEP and FDP, this reaction between enzyme and drug must
be reversible. The diagram also shows the random bireactant nature
of the enzyraic mechanism, as deduced from the mutual independence of
the and values for MgADP and PEP respectively, and may be
» *
described as a Random Bi-Bi type reaction in the terminology of Cleiand
(1963).
Some support is given to this model by the findings on the other
mammalian isoenzymes
ically activable, and both are melarsen oxide sensitive, whereas the
enzymes from heart and brain are presumably "fixed" in the Eg state in
the same manner as the muscle enzyme, show no allosteric properties,
9
and are unaffected by the arsenical.
The trypanosome enzyme, however, differs in two ways from the most
similar host enzyme, the liver L isoenzyme. Firstly the liver PK is
ATP this modifier reverses the E™ ^ Ep transition
brought about by FDP. Secondly, variation of the pK of the enzymic
• «
*
assay over the range 6.0 - 8.0 does not affect the interaction between
PEP binding sites on the parasite enzyme, the Hill coefficient being
9
invariable over this range. The value of "pgp for the liver enzyme,
however rises from n = 1 at pH = 6.8 to n -- 3 at pH 8.5 (Rozengurt jst al.,
1969). Thus the E_—> En transition in the latter case may be-effected1 n
by an increase in the H+ ion concentration, whereas this is not the case
with the trypanosome system.
#
9
The question arises, however, as to hov; low concentrations of a
*
purely competitive inhibitor can act as such an effective trypanocide.
It may have been expected that in the presence of melarsen oxide,
s
glycolysis would continue to produce PEP to a level at which the buildup
4
could overcome the competitive inhibitory effect, and the organism would
continue to function at an elevated intracellular PEP concentration.
4
0
This is improbable for three reasons. Firstly, as previously
stated, hexokinase is sensitive to melarsen oxide, and the glycolytic
4
.flux will consequently be diminished. Secondly, the trypancscme has
the property of concentrating the arsenicals from dilute solution (e.f,
e.g. Hawking 1937, 1938) leading to a cell/medium partition ratio of
ft
5 - 10 x 10^. The third, and mo3t pertinent explanation arises from
the studies on the PK from liver. Under the limited preincubation
4




similar kinetics are obtained with both liver isoenzymes i.e. competit™
4
ion betv/een PEP and the drug. However, elongation of the preincubation
period of drug + enzyme changes the kinetic analysis to a non-competitive
inhibition. This may be due to either the slow reaction of SL, vdth a
X
4
second molecule of aelarsen oxide (as depicted (7) in Figure 43) or a
4
time dependent irreversible change in the configuration of the enzyme
4
*
after binding one melarsen oxide moiety. Assuming that this occurs
with the trypanosomal enzyme in vivo, a reasonable explanation of the
4
4




dependent kinetic change has previously been noted for xanthine oxidase



















Fig.44Thepossiblemodesfinteractionb tw enmono- ubstitutedtrivalentars nicaldthiole zyme.
Mechanism of melarsen oxide binding to pyruvate kinase.
The primary competitive effect between PEP and melarsen oxide
ft
also gave rise to speculation as to the nature of the bond between drug
ft
and enzyme. Melaraine itself has no inhibitory effect upon the enzyme,
(Table 23) and hence the active constituent appears, as postulated, to
be the arsenoxide grouping. Whereas arsenite is known to affect some
enzymes in its capacity as a non-specific anion, no evidence has been
ft
produced for this type of action in the case of aromatic arsenicais.
ft
* ♦
Again, inorganic arsenite may act as a reductant and thus inhibit an
ft
enzymic process, but the stimulation of trypanosomal PK by a strong
reducing agent such as dithiothreitol argues strongly against this as
a mechanism for melarsen oxide inhibition. .Iience the conclusion must
be that this drug exerts its inhibitory effect by virtue of the inter¬






The three types of interaction between a trivalent monosubstituted
» » i
arsenical and a thiol enzyme are shown in Figure 44- Of these three
ft
reactions it has long been assumed that reaction III is the mechanism
ft
by which potent inhibition occurs. Reaction II appears unlikely due
9
to the steric difficulty in binding two enzyme molecules at the fixed
*
arsenic bond angle. Reaction I has been dismissed due to the inherent
m
instability of the product relative to the tight binding in the.form
4
of the cyclic thioarsinite (ill), and no evidence has previously been
put forward for the production of this arsinous acid type complex
between an enzyme and an aromatic arsenical. In fact the relative
ft
» ft
susceptibility of an enzyme to monosubstituted (S-As=0) and disubstituted
(Rg^As-Cl) arsenicais has been used since the work of Lotspeich and
%
%
Peters (1951) as a criterion for the determination of whether the enzyme
contains a catalytically required dithiol or monothiol grouping respect¬
ively. This method of distinction, however, leaves much to be desired,
as, for example, there is no apparent reason why a compound of the
I?2 = As--C1 form should not react equally well with one of the two ~SH
groups in a dithiol enzyme.
The two major observations whi'ch must be accounted for in the case
of the interaction of PK with arsenicals are l) the competitive nature
of the primary inhibition by melarsen oxide and 2) the insensitivity
of the enzyme to inorganic arsenite. If the primary reaction between
9
the enzyme and rnelarsen oxide were of type III (Figure 44) the cyclic
thioarsinite formed should be stable enough to resist any competition
4
by PEP i.e. it should be an irreversible inactivation of the enzyme.
9
%
Hence it is postulated that the competitive inhibition of the enzyme is
due to the formation of a. readily hydrolysable type I compound, and that
the time-dependent change to non-competitive inhibition is due to the
9 <
formation of a stable type III complex in which the enzyme is fixed in
a normally unstable conformation. . Type II complexes in this case may
be eliminated by the observation that the Hill coefficient for melarsen
9
oxide = 1.0. The inability of the pentavalent arsenicals to inhibit-
the trypanosomal enzyme, and the potent action of pCMB, lend strength
to the interpretation of the data in terms of a thiol binding reaction.
4
The differential inhibitory power of inorganic arsenite and the
organic arsenicals has been observed previously in diverse enzyraic systems
e.g. succinoxidase (Barron and Singer, 1945) aconitase (Peters, 1955).
Arsenite has practically no affinity for simple monothiols; Drumrnond and
0
Stern (i960) observed no meroaptide formation between arsenite and gluta
thione even at 100 mil arsenite. It does, however, react readily with
simple dithiols such as dimercaprol (BAL? Aldridge and Creraer, 1955)*
V

























Plate 3. The interaction of trypanosome pyruvate kinase with ADP,
PEP and melarsen oxide.
' PEP is bound at the catalytic site in the allosteric. Er conformation,
(above). Melarsen oxide competes for, and can only bind to, the Ex
conformation (below). The nature and significance of the enzymic groups
labelled A - E are discussed in the text.
cysteine, it is not possible to isolate the monothioarsinite as the
0
instantaneous product is the dithioarsinite. Thus it appears that for
e
interaction between arsinite and an enzyme, there may be a strict
%
requirement for a vicinal dithiol .group to produce inhibition. It is
*
4
significant that in no cas.e where an enzyme has been categorised as a
dithiol protein has there been shown a differential inhibition between
% «
« ?
arsenite and the monosubstituted organic arsenicals.
%




primary and necessary reaction between melarsen oxide and trypanosomal
t
E< concerns a single -SH group on the enzyme. The trypanocidal effect
follows as a result of secondary changes in the protein structure brought
• 9
about after binding the melarsen oxide in the form of a relatively
unstable monothioarsinite, and these secondary changes enable the form-
*





Substrate and inhibitor binding to the active site of pyruvate kinase.
9
The preferred model which has been presented for the action of
melarsen oxide relies upon competition between drug and substrate for
an enzymic configuration rather than for a specific binding site. Certain
•
9
speculations may be made, however, on the basis of a previously described
mechanism for the enzyme. MiIdvan and Cohn (1966) correlated the enzyme
reaction kinetics v/ith proton relaxation rate studies to dedupe the
%
structure of the ternary intermediate complex between PK, PEP, ADP and
0
4
the divalent cation. Plate 3 is based in part on the work of these
authors.
The binding of ADP to trypanosome FK involves a group in the catal-
< •
ytic site which dissociates with a pK of 6.6 (page 116). This pICa o,
region is typical of a histidyl residue and is shown as group A (Plate 3).










The data on the effect of pH on the pS^ value for PEP (pagell9)
4
combined with the titration characteristics of PEP indicate the necessity




the ionising group being in the region of pH 5'9-6.1. This required
4
ionisation may be involved in ligand formation with the divalent cation.
The other dissociable group involved in PEP binding has been shown to be




imidazole group dissociation, and this group is probably involved in
binding the nucleophilic carboxyl group of PEP (group B, Plate 3). It
%
*
is then conceivable that the proximity of the charged substrate group
will elevate the pK value of this imidazole dissociation and thus the
SL
9 t








group, converting it to a -CH^ ^roup and effecting the enol-keto
•
.




pH variation of the kinetic parameters of the trypanosome PK could not
9
be extended into the region of thiol dissociation (pH 8,5-- 9«0)'
4
However, the same technique has been used to demonstrate the involvement
4
of a thiol residue (pK = 9>0) in the binding of PEP to the FK of
di
S. carlsbergensis, another allosterically controlled enzyme (V/ieker and
Hess, 1971). A thiol group at this position, perhaps hydrogen bonded
•to a histidyl residue as postulated by Watts and Rabin (1962) for





The monothiol/melarsen oxide interaction previously described could
conceivably occur with this cysteine residue (Plate 3). The second thiol
involved in the rate-limiting formation of the stable, cyclic dithio-
0
« 4
arsinite may not be situated directly in the active site, although the
second divalent cation ligand to the protein has been suggested to
ft
involve a thiol group, D (Mildvan and Cohn, 19&5).
%
Stabilisation of the monothioarsinite by interaction of the phenyl
*
ft
ring, and perhaps of the raelaminyl residue, with protein groups, would
%
account for the inactivity of arsenite as an inhibitor. This will
ft
ft
probably occur via an apolar (hydrophobic) interaction with a phenyl-
alanyl or other aromatic side-chain (group E). The requirement for
ft
this temporary stabilisation could not be met in the case of inorganic
ft
arsenite which would therefore be unable to produce the stable, cyclic
thioarsinite.
"'Thus, in the unactivated E^, state the thiol will be accessible for
ft
the binding of melarsen oxide. Binding of PEP or FD? to an allosteric
ft
site induces a conformational change at the catalytic site and may simply
ft
sterically prohibit the binding of tnelarsen oxide. The interaction of
ft
trypanosome PK with the arsenicals may now be described by a combination
ft
of Pigs. 43, 44 and Plate 3. It must be emphasised however, that while
ft 9
the kinetic evidence outlined in this work supports this model, these
%
mechanistic speculations are solely intended as a working hypothesis on
which to base further investigation
4) HIE IN VIVO MECHANISM OP THE TRYPANOCIDAL EFFECTS OF KELAHSEN OXIDE
It is recognised that in vitro experimentation to'determine the
ft




combination of the whole cell carbon balance data and the proven
susceptibility of trypanosome FK for melarsen oxide do indicate that
ft
this is a feasible mechanism for the trypanocidal action of the drug.
The lack of effect of melamine in this system and the comparable activi
ties of melarsen oxide, phenylarsenoxide and p-aminophenylarsehoxide
indicate that the evolution of the drug into its present state has not
«
markedly affected its toxicity at its site of action, but has probably
served to increase the differential uptake of the arsenical by parasite
#
and host cells. This is demonstrated, by the higher sensitivity of the
liver enzymes.to the drug, and thus in the absence of a differential
#
^ •
permeability factor, little therapeutic benefit would be obtainable from
0
♦
this series of compounds. One further piece of evidence supporting PK
as a plausible site of action of melarsen oxide and the related arsen-
4
0
icals, was obtained by Eagle et al., in 194-6. These authors demonstrated
0
that when trypanosomes are incubated in phenylarsenoxide (0,013 rnM) they
are totally immobilised after approximately 1-2 minutes. If, 5-10
%
minutes after addition of the drug, a high concentration of a thiol
compound is added, the arsenical is partially withdrawn from the cells
and motility is totally regained by the organisms. Cysteine, for example,
«




a similar effect. Thus,, although the organisms still contained a 30 fold
•
• |
excess of the arsenical over the solution, no trypanocidal effect was






arsenicals is again easily reversible, and the more weakly bound fraction
of the arsenical is the effective trypanocide, as would be the case were
9
PK the focal point of attack. Significantly, cysteine cannot normally
reverse the binding of phenylarsenoxide to lipoate in this fashion.
0
If the time lapse between addition of the drug and the thiol is
|
increased to over 25 minutes, complete reversal is not obtained. However,
*
although this may reflect the secondary, irreversible reaction of the
0
drug with PK, after such a period some cell lysis may occur.
166
5) CONCLUSION.
The pleomorphism associated with the bloodstream forms of wild
type T.rhodesiense appears to have a biochemical as well as a morpho'
0
logical significance, although the in vivo pathways of glucose meta-
t
bolism are not as greatly different between the slender and stumpy-
organisms as was originally postulated. The capacity to synthesise
i
acetate via acetyl CoA from pyruvate is the most significant development
4
which takes place in the slender/stumpy transformation. As the time
0




formation may be, its significance in vivo must be doubtful. However,
the development of this system does not seem to be adequate to explain
the dependence of cyclical transmission upon the presence of short sturnpy
organisras in a bloodstream infection, as the further development of e.g.
P
»





tricarboxylic acid cycle. Although it has been tacitly assumed since
1 *
4




metabolism of the cultured epimastigote is via this cycle and the cyto¬
chrome chain, it should be considered whether or not carbohydrate is the
in vivo substrate. In the environment of the tsetse fly midgut after a
0
blood meal, the supply of exogenous carbohydrate would very quickly be
0
exhausted and the metabolic switch may not be from glycolysis > tri-
0
carboxylic acid cycle but from carbohydrate amino acid metabolism.
This problem deserves further investigation.
When one considers the production of AIT by the bloodstream organ¬
isms, the total dependence of the organism upon glycolytic production
of this compound appears enigmatic. The intense motility of the organ-
isms and the magnitude of the division rate with concomitant synthetic
requirements, would suggest the inadequacy of this system. The obser-
0
0






of the presence of an alternative oxygen utilising system to the
L-^-glycerophosphate oxidase may indicate that the trypanosome is not
ft
4
totally dependent upon the glycolytic system. The second of these
ft
t 4
possibilities is however to a large extent eliminated by the major
4
ft




The action of this drug has been defined by its inhibitory action
on glycolytic ATP production and the mechanism of action has been




ion that the reaction involves enzymic thiol groups, a mechanism of
ft
action of the drug has been evaluated in molecular terms. The variation
ft
ft
of the enzymic kinetic parameters with pH, carried out in an attempt to
ft
ft




was unsuccessful due to the total instability of the enzyme and the
ft
exceedingly low rates of activity in the expected ionisation range of
ft
thiol groups (8.3 - 8.6, Benesch & Benesch, 1955)*
ft
ft
The pyruvate kinase of the trypanosome has been characterised, and
ft
4
much evidence presented to show that this is an allosteric system. The
ft
ft ft
allosteric properties appear to be integrally connected v/iih the action
of the arsenical drugs, and this hypothesis has been briefly extended
ft
to some host PKs. The parasite enzyme is allosterically activated by
«
PDP and PEP and these properties have been correlated with the glycolytic





From the point of view of rational chemotherapy, it would appear
4
that the arsenicals do not depend entirely on their permeability
ft
characteristics to produce their specific'action. The inability of
these drugs to inhibit the non-allosteric pyruvate kinases of such host




by the parasite of an allosteric PK is instrumental in allowing the
arsenicals to exert their chemotherapeutic effect. Alteration of the
substituents on the phenylarsenoxide ring will, however, have a
*
4
secondary effect on the penetration of the drugs to the allcsteric host
PKs such as those of liver. Further extension, of the' work on the
interaction of melarsen oxide and its analogues with trypanosome PIC
should therefore be accompanied by an investigation of the character"
ft
istics of the interaction between the drug and mammalian «>C-k:e)to acid
oxidases (the primary site of inhibition in. the host) and of the specifi
uptake of the drug by liver and trypanosomes. It is nevertheless of
prime importance to determine the site and mechanism of action of a
therapeutically used compound, as a basis for further improvement.
Development of further organic arsenicals for use against trypanosom¬
iasis may now be based on the knowledge that one of the major activities
4
of these drugs is the inhibition of pyruvate kinase.
The other major contribution of this work is in the question of the
position'of monomorphic strains as experimental organisms. Host




acquired certain stable characteristics. The increased virulence and
the loss of pleoraorphism in these strains, associated in some cases with
an increased sensitivity to drugs, may have been thought to give a
misleading impression of the therapeutic value of the drugs. However,
although biochemically different from the natural organisms, the mode
of action of at least the arsenical series appears to be applicable to
the inonomorphic strains, to the same extent. The convenience involved
in the use of such strains therefore appears justifiable in terms of the
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